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Abstract 
 
Inflammation is widely accepted as an initiator, and involved in the 
exacerbation of many diseases. Key modulators of inflammatory responses 
are oxygenated metabolites of polyunsaturated fatty acids (PUFAs). There are 
two main classes of PUFAs, Omega-3 (n-3) and Omega-6 (n-6). Arachidonic 
acid, a derivative of omega-6 is known to produce pro-inflammatory mediators 
known as prostaglandins (C20, n-6) via cyclooxygenase (COX). COX (a 
member of the myeloperoxidase (MPO) family) is a major therapeutic target of 
intervention in inflammatory disease. We investigated whether Drosophila 
could be used to model and dissect new novel targets of inflammation. Using 
an inflammatory model based on a JAK temperature sensitive, gain-of-
function mutation (hopTum), we have characterised lipid mediator-signaling 
pathways in Drosophila. Dietary supplementation with PUFAs was able to 
modulate inflammation, with omega-6 fatty acids increasing, and omega-3 
fatty acids reducing, the severity of the hopTum inflammatory phenotype. While 
COX and MPO inhibitors were able to reduce inflammation, LC-MS analysis 
of Drosophila extracts failed to detect the existence of prostaglandins or their 
precursor, arachidonic acid (C20). Interestingly, however, we have been able 
to detect C18 oxygenated metabolites known as hydroxy-octadecadienoic 
acids (HODEs). HODEs are generated by the oxidation of omega-6 (C18, n-6) 
fatty acid, linoleic acid. Chiral analysis via LC-MS indicated a higher 
proportion of the enzymatic chiral form is generated of both 9- and 13-HODE 
in Drosophila samples. Members of the MPO family are able to produce 
HODEs. We have identified 3 candidate Drosophila COX/MPO homologues: 
Pxn, Pxt and Irc that may generate HODE inflammatory lipid mediators. We 
have shown them to have both COX and MPO activity in vitro. Deletions of 
these genes reduced the inflammatory phenotype in the hopTum assay. 
Functional characterization using deletions of these genes showed affects on 
longevity as well as survival upon infection. We show that Drosophila could be 
used to investigate 9- and 13-HODE inflammatory effects in diseases such as 
atherosclerosis.  
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1. Introduction 
 
Inflammatory disease is fast becoming a major problem in the 21st century. Ageing is 
a key component of this. By 2020, a fifth of the population will be over 65 years of 
age (Word health organisation) – and although individuals are living longer, the 
quality of life diminishes in later years due to a surge in inflammatory diseases 
(Franceschi et al., 2000). This is accomplished by changes in lifestyle. Diet has been 
shown to play a role in the development and severity of inflammatory diseases, 
especially in the initiation of disease (Hibbeln et al., 2006). 
The process of inflammation is an important response to infection and mediates 
tissue repair. It is a normal biological process that enables the movement of 
leukocytes to areas of injury (Ley et al., 2007). Without this response, healing would 
not occur. Most inflammatory responses are acute: they are short-lived and naturally 
resolve. However, these responses can become uncontrolled and persistent, leading 
to chronic inflammation that causes tissue damage resulting in disease like 
rheumatoid arthritis (McInnes and Schett, 2007). The mainstay of current therapeutic 
intervention is non-steroidal anti-inflammatory drugs (NSAIDs) that blocks the 
production of pro-inflammatory lipid mediators (Vane, 1971). While these work for 
many patients, a sub-set of patients does not respond driving the requirement to 
innovate new defined drug targets.  
Key players in inflammation are lipid inflammatory mediators that elicit immuno-
mediated responses. Immunity is an essential mechanism required for the survival of 
most organisms. It protects the organism from invading pathogens such as fungi, 
bacteria, viruses, and parasites. There are two aspects of immunity, innate and 
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adaptive (Bell, 2002). Innate immunity is the initial immediate response to detect and 
clear the invasion of a foreign body. Innate immunity is highly conserved and can be 
found in most, less primitive forms of life at different degrees of complexity (Beutler, 
2004). In contrast, adaptive immunity provides a memory so that when the organism 
encounters the pathogen again, it will be able to handle the infection more quickly 
and effectively (Litman et al., 2010). This form of immunity is absent from 
invertebrates. 
Inflammatory mediators orchestrate the responses of both humoral and cellular 
immunity. It provides another level of control to ensure integration of immune 
responses. When this level of control is not maintained, immune responses become 
deregulated and inflammatory disease can occur. Atherosclerosis and rheumatoid 
arthritis are two prime examples of inflammatory disease that require new innovative 
therapeutic treatments. We wanted to use Drosophila as a model for chronic 
inflammation, whereby it would allow us to dissect downstream lipid mediator 
signalling pathways that potentiate inflammatory disease. 
1.1 Drosophila innate immunity 
Drosophila melanogaster, better known as the fruit fly, have only an innate immunity. 
Like humans, Drosophila innate immunity can be divided into cellular and humoral 
functions (Bulet, Hetru, Dimarcq, & Hoffmann, 1999; Lanot, Zachary, Holder, & 
Meister, 2001). The cellular component involves cell-mediated actions such as 
phagocytosis, and encapsulation. In contrast, humoral refers to the actions of 
secreted macromolecules like antimicrobial peptides (AMPs). 
1.1.1 Cellular Immunity 
 The Drosophila immune system is composed of three types of blood cells that all 
differentiate from a haematopoietic progenitor stem cell known as a prohaemocyte. 
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From this prohaemocyte, three types of haemocytes are generated: plasmatocytes, 
crystal cells and lamellocytes (Lanot et al., 2001). As shown in Figure 1, each 
haemocyte lineage can be defined and distinguished according to the transcription 
factors they express (Evans et al., 2003). Haematopoiesis occurs at two distinct 
periods in development.  These stages are referred to as embryonic and larval.  
 
                       
Figure 1. Drosophila haematopoietic lineages 
Serpent (Srp) specifies the prohemocyte, the haematopoietic progenitor. Expression 
of Glial-cells missing (Gcm) and Gcm2 favours the plasmatocyte, that can 
differentiate into lamellocytes via JAK/STAT signalling and Chn, and a number of 
other cell types such as podocytes and macrophages. Expression of Lozenge (Lz) 
and Notch signalling results in crystal cell formation. (Figure adapted from 
Badenhorst, In press.) 
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The embryonic stage of haematopoiesis occurs in the head mesoderm of the embryo 
(Mori, 1979). The primary cells produced here differentiate quickly from 
prohaemocytes and distribute throughout the embryo (Tepass et al., 1994). It is 
noticeable that this first stage produces mainly plasmatocytes, which are involved in 
clearing the apoptotic cells that build up during the development of the embryo. 
Nevertheless a small number of crystal cells are also produced, but at this stage, 
lamellocytes are not present (Fossett et al., 2003). In the second stage of 
haematopoiesis, termed the larval phase, the development of the haemocytes occur 
in the lymph gland which is produced during embryonic development from cells that 
migrate from the lateral mesoderm (Shrestha and Gateff, 1982). In the lymph gland, 
all three types of cells are produced, although lamellocytes are rare under normal 
circumstances, but their production is rapidly increased in the case of parasitic 
infection (Sorrentino et al., 2002). The two stages of haematopoiesis have been 
compared to vertebrate haematopoiesis where there are also two stages present 
called primitive and definitive (Zon, 1995). 
Unlike mammals, Drosophila lack blood vessels, but instead have an open circulatory 
system whereby organs are bathed in haemolymph. Haemocytes are circulated in 
the haemolymph via contraction of the dorsal vessel, which is a single chambered 
heart (Miller, 1950). 
1.1.1.1 Drosophila haemocyte types 
Three different cell types are present within the fly: plasmatocytes, crystal cells and 
lamellocytes, each have a distinct immune function. Haemolymph contains 
approximately 95% of plasmatocytes and around 5% of crystal cells; lamellocytes as 
already mentioned are not normally present in healthy, uninfected flies (Nappi & 
Streams, 1969). Embryonic haemocytes are identified by the expression of GATA 
factor Serpent (Srp) (Lebestky et al., 2000). Srp is required for specification of the 
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haemocyte primordium within the mesoderm at early embryonic stages, and in later 
stages, involved in gene expression during haemocyte maturation (Waltzer et al., 
2002). Prohaemocytes express Srp initially before any differentiation or maturation 
markers are expressed (Jung et al., 2005). 
1.1.1.1.1 Plasmatocytes 
Plasmatocytes are the most abundant haemocytes present in the fly. They express 
Glial-cells missing (Gcm) and Gcm2 transcription factors, which are required for 
plasmatocyte differentiation (Bernardoni et al., 1997). They are comparable to 
macrophages in vertebrates, in that they carry out a number of processes that 
include: phagocytosis, secretion of extracellular matrix components, coagulation and 
melanisation (Jones et al., 1999). 
The main function of plasmatocytes is phagocytosis, which is important in the 
development of Drosophila as well as protection against invading pathogens. During 
embryonic development, apoptotic corpses are generated naturally and are cleared 
by the plasmatocytes (Tepass et al., 1994). Similarly, at pupal stage, plasmatocytes 
are responsible for engulfing cells fated for death during metamorphosis (Lanot et al., 
2001). In larvae and adult stages they are required to identify and remove foreign 
bodies like invading pathogens (Charroux and Royet, 2009). 
The process of phagocytosis involves the same steps as that seen in vertebrates, i.e. 
attachment/recognition, uptake, and disintegration (Jones et al., 1999). However, the 
mechanisms by which plasmatocytes recognise and internalise their target are not 
fully understood, though screening experiments have identified some genes involved 
in this process. For instance, the scavenger receptor Croquemort (Crq), a homologue 
of the mammalian CD36 receptor, has been identified to mediate recognition of 
apoptotic cells for ingestion (Franc et al., 1996). In terms of identifying pathogens 
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directly for internalisation, two receptors have been identified containing EGF-like 
repeats, Eater and Nimrod C1 (NimC1). Both receptors are involved in mediating 
phagocytosis of Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). 
Ablation of both receptors has shown significant impairment in clearance of the 
pathogens (Kocks et al., 2005; Kurucz et al., 2007). Identification of pathogens is a 
fundamental step towards eventual internalisation of the pathogen into a phagosome 
(Stuart and Ezekowitz, 2008). 
1.1.1.1.2 Crystal Cells 
The crystal cells (termed due to the crystalline structures seen within the cell) require 
expression of Lozenge (Lz), a homologue of the mammalian RUNX/AML1 
transcription factor for crystal cell differentiation (Waltzer et al., 2003). As well as Lz, 
Notch signalling has also shown to induce the crystal cell lineage (Duvic et al., 2002). 
Crystal cells are non-phagocytic and play an important role in melanisation. The 
process of melanisation is vital for wound healing and as a defence against 
pathogens (Galko and Krasnow, 2004). When stimulated, crystal cells rupture 
releasing prophenoloxidase, which initiates the melanisation cascade. 
Prophenoloxidase is subsequently cleaved into its activate state phenoloxidase by 
prophenoloxidase activating enzyme (PPAE) (Ligoxygakis et al., 2002). Ultimately 
this cascade leads to the production of melanin, which is deposited at sites of injury 
or during encapsulation of pathogens where it produces an inert capsule (Lemaitre 
and Hoffmann, 2007). 
There are three prophenoloxidases encoded by Drosophila genome encodes: 
prophenoloxidase A1 (DoxA1), prophenoloxidase A3 (DoxA3) and prophenoloxidase 
45 (ProPO45). Both DoxA1 and ProPO45 are expressed in crystal cells, whereas 
DoxA3 is only expressed in lamellocytes and may participate in melanisation during 
encapsulation (Irving et al., 2005). The rupturing of crystal cells to release these 
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prophenoloxidases and other components of the melanisation pathway can be 
regulated by Jun N-terminal kinase (JNK), Eiger (a tumour necrosis factor 
homologue) and small Rho GTPases like Rac2 that regulate the cell’s cytoskeleton 
(Bidla et al., 2007). 
1.1.1.1.3 Lamellocytes 
Lamellocytes are large, flat, adherent cells that are exclusively involved in 
encapsulation. Several regulators have been identified that activate lamellocyte 
differentiation. JAK/STAT signalling is one of the regulators, and was implicated by a 
mutation in the sole Drosophila Janus Kinase (JAK) that causes constitutive ligand-
independent JAK/STAT signalling, resulting in overproliferation of blood cells and 
significant lamellocyte differentiation. (Luo et al., 1995). Another regulator is Chn, the 
Drosophila homologue of NRSF/REST. Differentiation of plasmatocytes into 
lamellocytes, both in the lymph glands and in circulation is induced by Chn (Stofanko 
et al., 2008). Finally, the transcription factor Collier, has also been shown to regulate 
lamellocyte differentiation as it is required to produce lamellocytes during 
parasitisation (Crozatier et al., 2004).  
Lamellocytes mediate encapsulation of parasites such as wasp eggs with the aid of 
plasmatocytes. Leptopilina boulardi  (L. boulardi) are endoparasitoid wasps, whereby 
the female wasps inject their eggs into the haemocoel of Drosophila larvae, where 
the wasps develop and eventually consume the larva. The wasp eggs are first 
detected by plasmatocytes, which attach themselves to the egg chorion, and through 
an autoimmune mechanism cause the differentiation of large numbers of 
lamellocytes in the lymph gland and differentiation of plasmatocytes to lamellocytes 
in circulation, the signal of which is unknown (Crozatier and Meister, 2007; Stofanko 
et al., 2010). Lamellocytes form a multi-layered capsule around the foreign body 
encapsulating it. There is growing evidence that during encapsulation/melanisation, 
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the parasite is killed by the production of reactive oxygen species (ROS) and 
intermediates (Nappi et al., 1995) as NO (nitric oxide) radical levels increase during 
this action (Carton et al., 2009). The capsule is then melanised to form an inert mass. 
It is unclear whether it is the result of recruitment of crystal cells or lamellocytes, 
which mediate the melanisation. As mentioned before, lamellocytes express a 
prophenoloxidase, DoxA3 though its significance is unknown. It is likely that both cell 
types conduct melanisation during encapsulation.  
1.1.1.2 Humoral Immunity 
Drosophila also produce a primitive humoral response in conjunction with cellular 
immunity that provides vital and effective protection during injury and towards 
invading pathogens (Lemaitre & Hoffmann, 2007). In response to injury and infection, 
haemocytes release cytokine-like soluble signals that lead to the secretion of 
different mediators into the haemolymph from the fat body. These include: clotting 
factors, opsonins, proteases, and most importantly of all antimicrobial peptides 
(AMPs) (Vierstraete et al., 2003). 
AMPs are relatively small, cationic peptides that are constitutively expressed in 
barrier epithelia, but are also immune induced causing a systemic immune response 
(Imler & Bulet, 2005). Around 20 inducible AMPs have been identified and 
categorised into seven classes: Attacin, Cecropin, Defensin, Diptericin, Drosocin, 
Drosomycin and Metchnikowin (Imler & Bulet, 2005). Each class has specific activity 
towards a particular pathogen, for example, Diptericin is effective against Gram-
negative bacteria, Defensin is effective against Gram-positive bacteria, and 
Drosomycin is effective against fungi (Lemaitre & Hoffmann, 2007). 
When secreted, AMPs accumulate in the haemolymph. It is believed that AMPs 
target the cell membrane of pathogens resulting in stasis or lysis (Becker et al., 
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2010). However, the full mechanism and actions of AMPs are still poorly understood. 
It is known that two signalling cascades known as The Toll and the Imd pathway 
mediate humoral AMP production.  
1.1.2.1 The Toll Pathway 
The Toll pathway is an evolutionary conserved signalling cascade. Toll is a 
transmembrane receptor that shares sequence homology with the mammalian 
Interleukin 1 receptor (Hashimoto et al., 1988). Toll is a cytokine receptor that binds 
an extracellular cytokine known as Spätzle that is activated by pathogen recognition 
proteins (Hu et al., 2004). This pathway responds to Gram-positive bacteria, fungi 
and yeast, leading to the production of antimicrobial peptides such as Drosomycin 
(Lemaitre et al., 1996).  
Recognition of Gram-positive bacteria is mediated through detection of lysine 
containing peptidoglycan (PGN) through peptidoglycan recognition proteins 
(PGRPs), PGRP-SD and PGRP-SA (which also forms a complex with Gram-negative 
binding protein 1 (GNBP-1) (Michel et al., 2001)). Yeast detection relies on GNBP-3 
and detection of fungi relies on a serine protease known as Persephone (Psh) 
(Ligoxygakis et al., 2002; Gottar et al., 2006). Once the recognition molecules have 
bound pathogen components, they activate Spätzle processing enzyme (SPE). SPE 
proteolytically converts pro-Spätzle into activated Spätzle, which binds to Toll and 
induces dimerisation of the receptor (Weber et al., 2003). Dimerisation of Toll causes 
the recruitment of the adaptor protein Myd88 which interacts with the Toll Interleukin 
1 receptor domain (Tauszig-Delamasure et al., 2002). This in turn recruits Tube and 
Pelle (IL-1 receptor-associated kinase (IRAK)), which forms a complex with 
Myd88 that is mediated through their death domains (Towb et al., 2001). This 
complex then causes the dissociation of the NF-κB homologues Dif/Dorsal from 
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Cactus (IκB) by phosphorylation via Pelle’s (IRAK) kinase activity (Huang, Chen, 
Kunes, Chang, & Maniatis, 2010). Dif/Dorsal can then freely migrate into the nucleus 
and elicit transcriptional changes such as induction of AMP genes (Kidd, 1992). 
1.1.2.2 The IMD Pathway         
In contrast to the Toll Pathway, the Imd (Immune deficiency) pathway responds to 
Gram-negative bacteria through the production of AMPs such as Diptericin. This 
pathway however is not as well characterised as the Toll pathway; though it was first 
identified in flies due to a mutation called immune deficiency (imd) (Corbo & Levine, 
1996). These mutant flies were more susceptible to Gram-negative pathogens, 
indicating that this pathway was important in the response towards this type of 
pathogen (Lemaitre et al., 1995). 
Activation of the pathway relies on recognition of peptidoglycan (PGN) found in 
bacterial walls, especially components of Gram-negative bacteria PGN like meso-
diaminopimelic acid (mesoDAP) and tracheal cytotoxin (TCT) (Kaneko and 
Silverman, 2005). The recognition of PGN is mediated by the transmembrane 
receptor PGRP-LC and intracellular membrane PGRP-LE (Kaneko et al., 2006; Choe 
et al., 2005). PGRP-LC encodes three alternatively spliced transcripts: PGRP-LCa, 
LCx and LCy (Leulier et al., 2003). These three receptor variants have unique 
extracellular recognition domains (Werner et al., 2000). Binding of Gram-negative 
peptidoglycan by the PGRPs results in the recruitment of Imd (Corbo & Levine, 
1996). This leads to a signalling cascade that results in the cleavage of Relish via the 
caspase Dredd (Leulier et al., 2000). Cleavage of Relish produces an N-terminal Rel 
homology domain (RHD) transcription factor, which translocates into the nucleus 
resulting in up-regulation of AMPs that help protect against Gram-negative bacteria 
(Ertürk-Hasdemir et al., 2009). 
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1.2 Lipid derived mediators 
In a wider context, both cellular and humoral immunity are orchestrated by lipid-
derived mediators, which play a crucial role in many physiological processes. Lipid 
mediators are utilised as signalling molecules involved in homeostasis, for example, 
the hormone hydrocortisone produced and regulated by the hypothalamic-pituitary-
adrenal axis, to eicosanoids that are involved in inflammation. Lipid molecules that 
are pro-inflammatory, and more recently, those involved in resolution of inflammation 
have become important targets of therapeutic intervention for chronic inflammatory 
diseases like rheumatoid arthritis and atherosclerosis.  
1.2.1 Polyunsaturated fatty acid (PUFA) precursors 
Polyunsaturated fatty acids (PUFAs) are the known initial precursors to the abundant 
immuno-modulatory lipid mediators. PUFAs are long chain fatty acids that contain 
two or more double bonds in their carbon backbone. There are two main PUFAs, 
omega-3 and omega-6 that are classified by the location of the last double bond from 
the end terminal methyl group, n-3 (omega-3) and n-6 (omega-6). Many PUFAs, for 
example linoleic acid (18:2 n-6) and α-linolenic acid (18:3 n-3) cannot be synthesised 
in-vivo in animals, and so must be obtained from the diet making them essential fatty 
acids (Das, 2006). 
These essential fatty acids are metabolised further to produce the key intermediates 
that are used to synthesise immuno-inflammatory mediators. Linoleic acid (C18) can 
be extended to arachidonic acid (AA: C20), and α-linolenic acid (C18) can be 
converted to eicosapentaenoic acid (EPA: C20) (Figure 2). Both conversions rely 
upon the same enzymes; firstly, Δ6-desaturase removes two hydrogen atoms 
forming a double bond, followed by the addition of two further carbon atoms by an 
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elongase, and a further double bond added by Δ5-desaturase (Schmitz & Ecker, 
2008). 
 
                    
 
 
Figure 2. Metabolic pathways of linoleic acid and α-linolenic acid 
Omega-6 fatty acid, linoleic acid and omega-3 fatty acid, α-linolenic acid, are 
essential fatty acids obtained through the diet. They both share the same enzymes, 
which process them further to the immune-modulatory mediator precursors: 
Arachidonic acid (AA), eicosapentaenoic acid (EPA) and (Docosahexaenoic acid 
(DHA). 
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AA and EPA, as well as their precursors are incorporated and stored in the 
phospholipid membranes of cells and organelles in an esterified form (Bandeira-Melo 
et al., 2002). AA is the major PUFA as it is the most abundant C20 PUFA found in 
phospholipids, but there is very little free AA available. Once incorporated into 
phospholipid membranes fatty acids can be liberated by several phospholipases. The 
predominant phospholipase to do this is phospholipase A2 (PLA2) which hydrolyses 
the sn-2 ester bond (Arita et al., 1989) (Figure 3). A pathological and/or physiological 
stimulus from a cell or tissue drives the activation of PLA2 (Piper & Vane, 1971).  
There are several types of PLA2s found in mammals that are categorised into four 
main groups based on their biochemical properties and molecular structure (Six & 
Dennis, 2000). The first being secretory phospholipase A2 (sPLA2) of which there 
are ten known in mammals. Nine are functional and one is a pseudo gene that is no 
longer expressed as it has lost its protein coding ability (Tischfield et al., 1996). They 
function extracellularly and are stimulated by millimolar Ca2+ concentrations. The 
second group are known as cytosolic PLA2s (cPLA2s). There are 6 known cPLA2s. 
They require Ca2+ for catalytic activity and are stimulated by micromolar Ca2+ 
concentrations. Out of the 6 cPLA2s, cPLA2α has been shown to be the most 
important in the production of eicosanoids (Bonventre & Sapirstein, 2002). The third 
group is Ca2+ independent PLA2s (iPLA2s), which are also found in the cytosol. The 
final group of PLA2s inactivate platelet-activating factor (PAF) via PAF acetyl 
hydrolases (Tjoelker et al., 1995). 
Another pathway by which free fatty acid can be liberated from the phospholipid 
membrane is via phospholipase C (PLC) (Figure 3). The mechanism and action by 
which PLC liberates free fatty acid was first observed with AA (Iturralde et al., 2005), 
but many fatty acids can be liberated in this way. When a G-protein coupled receptor 
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is stimulated, it results in a conformational change to the α-subunit of the trimeric G-
protein, causing GDP to dissociate and GTP to bind (Zhu and Birnbaumer, 1996). 
The α-subunit dissociates from the β and γ subunits, allowing Gαq (the α-subunit) to 
activate PLC. PLC hydrolyses phospholipid, and in doing so, phosphatidylinositol 4, 
5-bisphosphate (PIP2) is cleaved into diacylglycerol (DAG) and inositol 1,4,5-
trisphosphate (IP3). DAG can then be hydrolysed by DAG lipase to produce 
monoacylglycerol and AA (and other free fatty acids) (Iturralde et al., 2005). 
               
 
Figure 3. Fatty acid liberating pathways 
Free fatty acid, arachidonic acid (AA) in the case of this figure, can be liberated by 
either phospholipase A2 (PLA2) or phospholipase C (PLC). PLA2 releases free fatty 
acid by hydrolysing the sn-2 acyl bond of phosphatidylinositol 4,5-bisphosphate 
(PIP2). The availability of PIP2 in the membrane is maintained by phosphatidylinositol 
phosphate kinase (PIPK5) that phosphorylates phosphatidylinositol-4-phosphate 
(PI4P) into PIP2. Gαq activates PLC which cleaves PIP2 just before the phosphate 
group producing inositol 1,4,5-trisphosphate (IP3) and diacyglycerol (DAG). DAG is 
hydrolysed by DAG lipase, releasing monoacylglycerol (MAG) and free fatty acid 
(AA). 
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1.2.2 Pro-inflammatory lipid mediators 
 The focus of therapeutic targets for inflammation has been predominantly with pro-
inflammatory lipid mediators. AA is further metabolised to produce the eicosanoids. 
Eicosanoids are C20 oxygenated lipid signalling mediators of which there are two 
main classes. The two classes of eicosanoids are classified by the enzymes that 
produce them; lipoxygenases (LOX) produce leukotrienes (4 series), which includes 
both hydroperoxy and hydroxyl-eicosatetraenoic acid (HPETE and HETE), whereas 
cyclooxygenases (COX) produce the prostanoids consisting of thromboxanes (2-
series), prostacyclins and prostaglandins (2-series) (Funk, 2001) (Figure 4). Since 
the discovery of prostanoids and their involvement in both acute and chronic 
inflammation, they have been the most widely targeted for therapeutic intervention.  
Cyclooxygenases (COX) are members of the larger myeloperoxidase superfamily 
(Daiyasu & Toh, 2000). They are haem-containing homodimers that have two 
separate catalytic sites; a peroxidase, which can reduce several hydroperoxides such 
as hydrogen peroxide, and a cyclooxygenase active site that binds AA (Kulmacz et 
al., 2003). The two sites work in tandem in a two-step process to produce the 
prostanoid precursor, PGH2. AA inserts into the cyclooxygenase active site, where a 
Tyr385 residue is oxidised by the haem to become a radical. The Ty385 radical 
causes the abstraction of a pro-S hydrogen atom on C13 of AA. This results in the 
production of the intermediate hydroperoxy endoperoxide (PGG2) (Rogge et al., 
2006). The peroxidase active site then reduces PGG2 to PGH2 (van der Donk et al., 
2002), the precursor to the prostanoid subclasses.  
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Figure 4. Production of lipid immuno-inflammatory mediators from linoleic acid 
and arachidonic acid 
Linoleic acid can be directly metabolised by either lipoxygenase (LOX) or 
cyclooxygnenase (COX) to produce hydroxy-octadecadienoic acids (HODEs). 
Arachidonic acid (AA) is processed by COX to produce prostaglandins. 
Lipoxygenases process AA into the leukotrienes and hydroxy-ocyeicosatetraenoic 
acids (HETEs). Figure adapted from Shimizu (2009). 
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There are two COX isoforms, COX-1 and COX-2. It is considered that COX-1 is 
constitutively expressed in most cells and tissues as it produces prostaglandins that 
are important for homeostatic functions such as haemostasis. In contrast, COX-2 is 
an inducible enzyme highly expressed in immune cells and tissues and is up 
regulated in immuno-inflammatory responses. However, new evidence suggests that 
both isoforms can expressed in the same tissues and both may be constitutive and 
inducible (Zidar et al., 2009). 
The main role for both of these enzymes is to convert AA into the precursor PGH2. 
PGH2 forms the precursor to all the prostanoids: prostaglandins, prostacyclin and 
thromboxanes. Each subclass enforces a different, yet essential, physiological 
response. Thromboxane (TXA2) is a potent vasoconstrictor (Ellis et al., 1976) and 
aids in the activation of platelets (FitzGerald, 1991). Prostacyclin (PGI2) on the other 
hand is a vasodilator and inhibits platelet aggregation, suggestive of a protective role 
(Rahman et al., 2011). Due to TXA2 and PGI2’s conflicting actions, they remain in a 
homeostatic balance of each other’s actions.  
The prostaglandins consist of PGD2, PGE2 and PGF2a. PGE2 is the most studied of 
the prostaglandins as it is the most abundantly distributed and has a wide range of 
physiological actions. PGE2 is involved in all the classic inflammatory cardinal signs 
like redness, swelling and pain (Legler et al., 2010). PGD2 on the other hand is 
predominantly expressed in mast cells where it plays a role in allergen responses 
(Jowsey et al., 2001). It is also expressed in the central nervous system where it has 
several neurophysiological actions such as regulating sleep and pain perception 
(Urade and Hayaishi, 2011). Both PGE2 and PGD2 have contrasting actions, as well 
as having pro-inflammatory effects, they also elicit anti-inflammatory actions that are 
involved in initiating resolution (Moghaddami et al., 2013; Ogawa et al., 2009). Lastly, 
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PGF2α like the other prostaglandins has several different actions. PGF2a is well known 
for its involvement in ovulation and parturition (Darling et al., 1982), but is also 
involved in acute and chronic inflammation as it has been shown to be elevated in 
patients with arthritis (Basu et al., 2001).  
The synthesis of each specific prostanoid from the precursor PGH2 is controlled by 
prostanoid specific synthases (Hinman, 1972). Tissue specific expression of the 
synthases allows for control and regulation of where the prostanoids are produced. 
Another level of regulation is through the availability of AA, which is the rate-
determining step in the production of eicosanoids. However, expression of these lipid 
mediators can become dysregulated and lead to a number of chronic inflammatory 
conditions that include inflammatory bowel disease and breast cancer 
(Subbaramaiah et al., 2004; Singh et al., 2005). Treatment with non-steroidal anti-
inflammatory drugs such as aspirin can alleviate inflammation. These act by inhibiting 
COX activity and prostaglandin production, making COX an ideal target for 
therapeutic intervention (Vane, 1971).  
1.2.3 Anti-inflammatory lipid mediators 
Pro-inflammatory prostaglandins have been at the forefront of the inflammatory field 
due to their involvement in inflammation (Ricciotti and FitzGerald, 2011). This in part 
was fuelled by the discovery of aspirin’s (a non-steroidal anti-inflammatory drug) 
actions, which alleviates inflammation through inhibiting COX and preventing 
production of prostaglandins (Vane, 1971). COX soon became a popular therapeutic 
target for inflammation. However, prostaglandins were soon discovered to have a 
wide range of homeostatic functions that are fundamental to an animal’s health. 
Inhibition of COX, although reduces inflammation, it impinges on the housekeeping 
functions of prostaglandins resulting in adverse affects particularly seen with COX-2 
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inhibition (Wong et al., 2005). It has therefore become more popular to embrace the 
naturally produced anti-inflammatory lipid mediators, which can potentially be 
manipulated to actively resolve chronic inflammation. 
During injury or infection, acute inflammation involving the recruitment of leukocytes 
and release of inflammation-promoting signals such as prostanoids is vital for healing 
and combating infection. It was initially thought that the resolution of inflammatory 
responses was passive relying simply on dissipation. Instead, it is an active process 
that initiates shortly after inflammation-promoting mechanisms have started (Serhan, 
2004). With the exception to lipoxin A4 (LXA4) and LXB4, which are produced from 
linoleic acid, the anti-inflammatory and pro-resolution lipid mediators are derived from 
omega-3 EPA and a further metabolite of EPA, docosahexaenoic acid (DHA). These 
particular lipid mediators include resolvin E-series made from EPA, and resolvin D-
series and maresins that are formed from DHA.  
Lipoxins derived from AA were the first lipid mediators to be identified inflammatory-
resolving actions (Serhan et al., 1984). LXA4 and LXB4 are synthesised from AA 
through a series of lipoxygenases predominantly expressed in leukocytes such as 
neutrophils. They have been shown to antagonise leukotrienes through binding to 
leukotriene receptors BLT1 and cysLT1 to inhibit the production of pro-inflammatory 
agents such as IL-8 (Gronert et al., 2001) which halts leukocyte infiltration (Chiang et 
al., 1999). Lipoxins also have a dedicated receptor, ALX that regulates the production 
of pro-inflammatory mediators such as TNFα, and prevents oxidative burst (Chiang 
et al., 2003). 
Resolvins were originally identified in mouse resolving-exudates (Serhan et al., 
2002). From the exudates, two classes of resolvins were identified, the E-series and 
D-series resolvins. There are two known E-series resolvins, resolvin E1 (RvE1) and 
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resolving E2 (RvE2), both of which are synthesised from EPA. EPA is oxygenated via 
either aspirin treated COX-2, or cytochrome P450 to produce 18-hydroperoxy-EPE 
which is further oxygenated to 5S-hydroperoxy-18-hyroxy-EPE by 5-LOX which can 
then be processed to produce either RvE1 or RvE2 (Serhan, 2002).  
The second class of resolvins, the D-series, are derived from DHA. DHA can be 
processed in two ways to produce either R or S stereochemical versions of the D-
series resolvins. Utilisation of cytochrome P450 or acetylated COX-2 produces the R 
enantiomer, whereas 15-LOX produces the S enantiomer. These enzymes produce 
17-hydroperoxy-DHA which is processed further to produce the four D-series 
resolvins, RvD1-RvD4 (Stewart, 2009).  
The resolvins have similar actions to the lipoxins. Resolvins prevent transendothelial 
migration of leukocytes, RvE1 being extremely potent in comparison to 
dexamethasone (Serhan et al., 2000). This is part can be explained by the down 
regulation of adhesion molecules such as L-selectin and integrin CD18 seen upon 
RvE1 treatment (Dona et al., 2008). RvD1 has also been shown to be a potent 
regulator of leukocyte transendothelial migration (Sun et al., 2007).  
Maresins on the other hand are less well characterised. They are produced by 
macrophages and act directly on macrophages. DHA is utilised by 14-LOX to 
produce 14S-HpDHA which is further processed to produce maresin 1 (MaR1) 
(Serhan et al., 2009). MaR1 can reduce leukocyte infiltration by up to 50-80% in 
zymosian-induced peritonitis, it is a potent enhancer to macrophages in apoptotic 
leukocyte uptake, and showed tissue regeneration possibilities in the simple flatworm 
organism planaria, due to accelerated head growth after a head resection (Serhan et 
al., 2012). 
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1.2.4 Hydroxy-octadecadienoic acids (HODEs) 
Another class of inflammatory oxidised lipids are hydroxyl-octadecadienoic acids 
(HODEs), which are highly abundant in inflammatory tissues and are now recognised 
as biological markers of oxidative stress (Yoshida et al., 2008). They are stable 
oxidative derivatives of LA consisting of 9-HODE and 13-HODE (Figure 4). HODEs 
can be generated enzymatically, or non-enzymatically from LA. The enzymatic route 
utilises either lipoxygenase or cyclooxygenase enzymes, which oxygenate LA at 
either the 9- or 13-carbon, position to produce the intermediate, hydroperoxy-
octadecadienoic acid (HPODE). HPODE intermediates are reduced by peroxidase 
activity to the stable HODE lipid mediator. HODEs can be further metabolised by 
dehydrogenases to oxooctadecadienoic acids (oxoODE) (Shearer, Harris, Pedersen, 
& Newman, 2010).         
HODEs have a well documented function in atherosclerosis, as they are the most 
abundant oxidation product found in plaques (Waddington et al., 2003). Studies show 
that HODE deposition in early lesion formation is predominantly enzymatic, shifting to 
non-enzymatic at later stages of atherosclerosis (Brinckmann & Kühn, 1997; 
Waddington et al., 2003). Raised levels of oxidised low-density lipoprotein (oxLDL) 
occurs in atherosclerosis; 9- and 13-HODE are 20 times more abundant in oxLDL 
from atherosclerosis patients compared to control patients (Jira et al., 1998). 
Recently, structural studies confirmed that 9- and 13-HODE are natural ligands and 
activators of the peroxisome proliferator activated receptor γ (PPARγ), showing that 
they can bind individually or together (Itoh et al., 2008). PPARγ signalling results in 
PPARγ forming a heterodimer with retinoic acid receptor (RXR), which binds to 
PPAR-response elements that can regulate genes involved in monocyte 
differentiation and lipid metabolism (Lawrence and Natoli, 2011; Cristancho and 
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Lazar, 2011). PPARγ is expressed in both endothelial cells and macrophages. 
Endothelial cells up regulate ICAM 1 expression through PPARγ which elicits 
monocyte adhesion that can be exacerbated further as endothelial cells also 
synthesise HODEs (Haas et al., 1990; Kaduce et al., 1989).  
It has been suggested that 13-HODE has protective properties in atherosclerosis and 
is actively produced by 15-LOX in macrophages. In early onset atherosclerosis, 13-
HODE signalling through PPARγ results in the up-regulation of the scavenger 
receptor CD36 which is involved in up take of oxLDL (Jostarndt et al., 2004). Uptake 
of oxLDL is seen to be protective initially as it removes it from the environment, but 
too much uptake leads to the action being pro-atherogenic. Though 13-HODE has 
been shown to also reduce platelet and endothelial cell interactions preventing 
thrombogenesis (Bertomeu et al., 1990).  In the later stages of the disease, the 
abundance of 9 and 13-HODE overwhelms the potential protective mechanisms and 
results in increased lipid accumulation and macrophage differentiation into foam 
cells. The mechanism behind foam cell differentiation is still not fully characterised. 
Both 9- and 13-HODE have dose dependent potent chemotactic properties towards 
leukocytes similar to 15-HETE (Henricks et al., 1991). G2A receptor signalling via 9-
HODE binding results in the production of pro-inflammatory cytokines such as IL-6, 
IL-8, granulocyte-macrophage colony-stimulating factor (GM-CSF) and causes 
suppression of cell proliferation in human keratinocytes; the same was not seen with 
13-HODE (Hattori et al., 2008). Overall, the physiological effects of HODEs are 
largely uncharacterised, though the consensus indicates 9-HODE has pro-
inflammatory effects, and 13-HODE has anti-inflammatory effects.  
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1.2.5 Eicosanoids in Drosophila immunity 
The function of Immuno-modulator lipids in Drosophila immunity has not been well 
studied. However, interest in this field is growing because of the need for new models 
to explore functions and biosynthetic pathways of these mediators. Drosophila 
provides a genetic model in which to explore these.  
Initial data suggested that invertebrates could produce prostaglandins. Studies of the 
gorgonian octocoral, Plexaura homomalla (a Caribbean coral), shown that 2-3% of 
their dry weight was composed of prostaglandin esters. These were identified as 
15R-PGA2 methyl ester acetate, 15R-PGA2 methyl ester, and PGE2 methyl ester 
(Weinheimer and Spraggins, 1969). A COX-like enzyme was later found that has 
50% sequence similarity to mammalian COX and was shown to produce the 
intermediate prostaglandin PGH2, which was converted to PGE2 and then rapidly 
acetylated to PGA2 (Valmsen et al., 2001). 
The tobacco hornworm, Manduca sexta, has also been used widely to study 
presence and function of eicosanoids. Microsomal-enriched preparations of 
haemocytes and fat body from Manduca sexta larvae were used to detect the 
presence of endogenous PGA2, PGE2, PGD2, and PGF2α prostaglandins as well as a 
lipoxygenase product that co-chromatographed with 15-hydroxy eicosatetaenoic acid 
(HETE) (Gadelhak et al., 1995; Stanley-Samuelson and Ogg, 1994). As yet, the 
enzymes that synthesise these lipid mediators have not been characterised.  
The physiological function of these prostaglandins in Manduca sexta has further 
been analysed. Chemotactic experiments using haemocyte migration towards formyl-
methionyl-leucyl-phenylalanine (fMLP) was used to show eicosanoid involvement in 
haemocyte chemotaxis. Haemocyte migration was reduced when treated with 
indomethacin (a COX inhibitor), an effect reversed by the addition of arachidonic acid 
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(Merchant et al., 2008). Eicosanoids have also been suggested to play a role in 
nodulation in Manduca sexta. Nodulation is the aggregation of haemocytes in 
response to infection. These aggregations then become melanised forming a nodule 
that quarantines it. This infection response is similar to encapsulation seen in 
Drosophila. This was shown by injection of bacteria into the haemocoel of Manduca 
sexta causing nodulation. Injection of dexamethasone (a PLA2 inhibitor) reduced the 
ability to clear the infection by inhibiting nodule formation. Nodulation was recovered 
by co-injection with either AA or EPA (Miller et al., 1994). The effects of eicosanoids 
in mediating nodulation have been shown in the beet armyworm, Spodoptera exigua 
and Rhodnius prolixus (Garcia et al., 2004; Shrestha and Kim, 2008). Collectively, 
these studies suggest that eicosanoids play an early role in helping to clear 
infections. Without them, this process is compromised.  
There is contradicting evidence for the presence of eicosanoids and their precursor 
AA in Drosophila. Initial experiments, showed that homogenates were able to 
synthesise a range of HETE acids when incubated with exogenous AA (a product of 
lipoxygenase processing of AA) and were detected using gas chromatography-mass 
spectrometry (GC-MS) (Pagés et al., 1986). However, endogenous AA could not be 
detected in homogenates, even though considerable amounts of linoleic acid were 
detected (the precursor of AA).  
The presence of AA has also been profiled in Drosophila heads, given the important 
role phosphatidylinositol (PI) plays in photoreceptor signalling. These studies failed to 
detect AA, and the precursors γ-linolenic (18:3) and dihomo γ-linolenic acid (20:3) 
(Yoshioka et al., 1985). This has been confirmed by recent LC-MS studies. 
Drosophila fed on a base diet and a diet rich in PUFA precursors were analysed and 
shown to lack AA suggesting that Drosophila cannot synthesise AA in vivo. These 
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studies also confirmed using BLAST, the absence of Δ6 and Δ5 desaturases involved 
in the synthesis of AA (Shen et al., 2010). Although it was shown that AA couldn’t be 
endogenously synthesised, AA could be detected when flies were fed on a diet 
supplemented with AA (20:4 n-6). It is possible that Drosophila are like cats, being 
unable to synthesise AA and being dependent on acquiring AA through the diet 
(Bauer, 2007), but possessing the necessary machinery to process AA to 
prostaglandins. Indeed, radioimmunoassay using anti-prostaglandin E (PGE), 
indicated that PGE2 was present within these extracts (Pagés et al., 1986). This 
raised the possibility that eicosanoid generating pathways were present in 
Drosophila. 
Consistent with this, functional studies suggest a role for prostaglandins in ovarian 
follicle maturation in Drosophila (Tootle and Spradling, 2008). Follicle maturation was 
dramatically reduced when treated with COX inhibitors such as aspirin. However, 
maturation could be rescued when ovaries were treated with an exogenous stable 
form of prostaglandin. A Pxt (Peroxinectin-like, a Drosophila peroxidase) was 
proposed as a COX candidate, having homology to COX. Knock out of the Pxt 
reduced ovarian follicle maturation (Tootle and Spradling, 2008). The same group, 
elucidated the follicle maturation phenotype seen in the absence of prostaglandin 
production is due to defects in actin remodelling by the Drosophila Singed, a Fascin 
homologue. Fascin in mammals is known to interact with prostaglandins (Groen et 
al., 2012). These new findings provide an interesting insight into the role 
prostaglandins may play in Drosophila. Though there has been no clarification of 
endogenous prostaglandins in Drosophila and immune function of prostaglandins. To 
explore potential links between lipid mediators and inflammation in Drosophila, we 
exploited a sensitised background that over-activates the JAK/STAT pathway, 
leading to an inflammatory phenotype. 
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1.3 Gain-of-function Drosophila JAK/STAT mutation as a model for 
inflammation 
The JAK/STAT pathway was first identified in mammals. In the canonical JAK/STAT 
signalling pathway ligand binding causes dimerisation of a receptor, bringing together 
two JAKs, which trans-phosphorylate each other eliciting the recruitment of the 
STAT. These are then phosphorylated, dimerise and translocate into the nucleus to 
bind to STAT induced transcriptional targets (Rawlings et al., 2004). The JAK/STAT 
pathway is evolutionary conserved and present with Drosophila. While mammalian 
JAK/STAT signalling can be mediated by multiple cytokines and growth factors, 
Drosophila only have three ligands, Unpaired (Upd), Upd2, Upd3, of which Upd is the 
most potent (Wright et al., 2011). Upd binds to the receptor Domeless, leading to 
trans-phosphorylation of Hopscotch (the Drosophila homologue of human Janus 
Kinase 3 (JAK3)) causing recruitment of Stat92E the Drosophila homologue of 
STAT5a, and the sole Drosophila STAT. 
A gain-of-function mutation in the hopscotch gene, called Tumourous-lethal (hopTum), 
leads to an inflammatory melanotic tumour phenotype. The hopTum mutation is 
caused by a single amino acid G341E substitution (Harrison et al., 1995). The 
hopTum-l mutation increases the level of tyrosine phosphorylation of the mutant JAK 
compared to the wild type. Thus the hopTum mutation causes constitutive, ligand 
independent activation of the JAK/STAT pathway (Harrison et al., 1995) (Figure 5). 
This mutation is temperature sensitive conditional. This means that the phenotype is 
more severe at elevated temperatures. For example, at temperatures above 25°C, 
the induction of melanotic tumours is severe, but the tumour phenotype is milder at 
lower temperatures (Luo et al., 1995). Melanotic tumours are aggregations of 
haemocytes that are encapsulated in a melanised capsule (Barigozzi, 1958) 
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Like mammalian JAKs, Drosophila JAK is involved in the regulation of 
haematopoiesis. Studies have shown that the hopTum mutation causes the lymph 
gland to become hypertrophic due to increased proliferation of plasmatocytes (Luo et 
al., 1995). These plasmatocytes have also been shown to prematurely differentiate 
into lamellocytes. The increase in cell numbers is speculated to cause aggregation of 
haemocytes forming clumps, resulting in the production of melanotic tumours. Crystal 
cells appear to be unaffected by the mutation (Silvers and Hanratty, 1984). 
                    
 
Figure 5. JAK gain-of-function hopTum signalling 
Wild type JAK/STAT signalling is ligand-dependent. In the presence of a ligand, 
transphosphorylation of JAKs occurs, resulting in translocation of STATs to the 
nucleus. In the hopTum mutant, signalling is constitutive and ligand-independent. The 
constant signalling of JAK/STAT results in a melanotic tumour phenotype that can be 
visualised as a black mass in the fly (arrow). Figure adapted from Kwon et al., 2008 
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This hopTum mutant provides an extremely useful model for chronic inflammation. 
Most inflammatory models in use rely on a mutant background that initiates a 
phenotype that can be used to disentangle mechanisms that regulate the phenotype. 
Such models include the apolipoprotein deficient mouse that is used to study 
atherosclerosis and the collagen-induced arthritis mouse model. I have used the 
hopTum mutant in a similar way to initiate an inflammatory response, by over-
stimulating the JAK/STAT pathway resulting in the formation of an inflammatory 
melanotic tumour. This phenotype can aid in identifying downstream mediators of 
inflammation that are required to sustain inflammation i.e. the signals that orchestrate 
the haemocytes to aggregate forming the melanotic tumour.  
1.4 Aims and objectives 
Inflammatory disease is on the rise due to a combination of lifestyle, environment and 
genetic predisposition. Inflammatory diseases have extensive effects on health and 
economic costs. For example, cardiovascular disease (CVD) alone, is responsible for 
40% of all deaths in the EU and costs the EU economy approximately €196 million 
per year (European Society of Cardiology). There is a requirement for new 
therapeutic targets to be developed and in vivo models that can be used to dissect 
underlying inflammatory mechanisms. We believe Drosophila could be a useful tool 
in aiding inflammatory research. 
The main aim of this study was to characterise Drosophila inflammatory lipid 
mediators and precursors. Given conflicting evidence, regarding presence of AA and 
prostaglandins, we also wanted to clarify whether Drosophila can synthesise AA and 
subsequently produce prostaglandins. To do this we used an inflammatory model 
based on the gain-of-function temperature sensitive hopTum mutant, which results in 
an inflammatory phenotype, a melanised inflammatory mass. This model allowed us 
to screen for effectors of inflammation. 
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The first objective was to identify factors, which could increase or reduce the 
inflammatory phenotype of our model. This involved dietary supplementation of 
essential fatty acids, the use of COX and MPO inhibitors, genetic knockdown of 
putative COX/MPO Drosophila homologues and known genes involved in lipid 
liberating pathways. The second objective was to biochemically analyse Drosophila 
samples, using LC-MS to identify directly if endogenous lipid mediators were present, 
and if fatty acid supplementation affected the presence of them. Thirdly, we 
attempted to clarify the actions of the lipid mediators identified by LC-MS by treating 
S2 cells and analysing gene expression. Fourthly, characterised the enzymatic 
actions in vitro of the Drosophila COX/MPO putative homologues identified using 
recombinant protein. And characterised the in vivo actions of the Drosophila 
COX/MPO putative homologues using sterile and septic assays. 
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2. Material and Methods 
2.1 Drosophila husbandry 
Drosophila were raised on wheat flour, yeast agar media of 10 ml per vial. Media was 
prepared using 550 g dextrose, 500 g yeast, 350 g flour and 80 g of agar (Drewitt) 
sequentially added to 11 L of water and then autoclaved. Once cooled, 25 g of 
Nipagin (MP Biomedicals, LLC) was dissolved in 250 ml of ethanol and added along 
with 40 ml of propionic acid (Sigma).  Media was decanted, left to cool, capped, and 
stored in a cold room.  
Drosophila were incubated at 25ºC unless otherwise stated, and transferred to fresh 
vials weekly. 
2.2 Drosophila inflammatory tumour assays 
The hopTum strain carries a gain-of-function, temperature sensitive mutation in the 
Drosophila JAK (Luo et al., 1995a) that causes the initial inflammatory insult. FM7 is 
a balancer chromosome (Merriam, 1969) that prevents recombination, and allows 
selection of the hopTum mutation. hopTum/FM7 virgin females were harvested from a 
stock maintained by crossing hopTum/FM7 females with FM7/Y males. This stock was 
incubated at 25ºC and was perpetuated by transferring to fresh vials every two days.  
For inflammatory tumour assays five hopTum/FM7 females were crossed with either 
five w1118 males for the control/reference point for all experiments, or five mutant 
males (in the case of mutant enhancer/suppressor studies) per vial. Crosses were 
allowed to mate for two days before being transferred to fresh media. Five initial vials 
were set up for each datum point and were incubated for 3 days before being 
transferred to a second fresh set of vials, giving a total of 10 replicates per 
experiment. Crosses were incubated for 3 days and the adult flies then removed. The 
resultant hopTum females were scored for both tumour incidence and severity. All 
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crosses were maintained on standard media or supplemented media where stated 
and all crosses were incubated at 27ºC unless otherwise stated. 
Tumour incidence and severity was scored using a Nikon SMZ645 stereomicroscope 
equipped with a C-FM reticule. The reticule has 0 to 100 notches, with each notch 
equal to 20 µm at full magnification. Tumours were measured using the highest 
magnification. Seven tumour size categories were used according to notches on the 
reticule: 0, 0.1-2.5, 2.6-5, 5.1-7.5, 7.6-10, 10.1-15 and 15+ which equates to: 0, 2-50, 
52-100, 102-150, 152-200, 202-300, and 300+ µm. 
Tumour incidence percentage for each replicate was calculated by dividing the 
number of tumour containing females by the total number of females and multiplied 
by 100. The mean and standard deviation of ten vials for each experimental regime 
was calculated. T-tests were used to determine statistical significance. A P-value 
threshold of 0.001 was used. Microsoft Office Excel 2010 was used to input data and 
generate calculations. The programme R was used to generate box and whisker 
plots. The upper line to the box represents upper quartile, the middle line represents 
the mean, and the lower line of the box is the lower quartile value. The upper line of 
the whisker is the greatest value, and the lower whisker is the lowest value. Any 
circles above and below the whiskers are outliers. Bubble graphs were generated 
from the programme Many Eyes (http://www-958.ibm.com) using the matrix chart 
function to depict tumour severity categories. 
2.2.1 Dietary supplementation of fatty acids 
Unrefined organic cold pressed safflower oil (Clear spring), which contains 64% 
linoleic acid (an omega-6 unsaturated fatty acid), was supplemented to media 
spanning five different concentrations. These were: 0%, 0.1%, 0.3%, and 0.7%. 
32 
 
Organic cold pressed flaxseed oil (Food Supplement Company), which contains 55% 
of α-linolenic acid (an omega 3 unsaturated fatty acid), was supplemented to media 
at the following concentrations: 0%, 0.1%, 0.3% and 0.7%. Flaxseed oil was also 
added in conjunction with safflower oil. Safflower oil was added at a constant 
concentration of 0.15% while simultaneously increasing flaxseed concentrations from 
0%, 0.05%, 0.1% and 0.15%.     
Coconut oil (Sigma) containing 85% saturated fat was added to media at the 
following concentrations: 0%, 0.1%, 0.3%, 0.7% and 1%. Cholesterol (Sigma) was 
dissolved in ethanol to make a stock solution and then aliquoted to media to make 
the following concentrations: 0%, 0.001%, 0.005%, 0.01% and 0.05%. 
For all supplementation experiments, hopTum/w1118 female progeny from a cross 
between five hopTum/FM7 females and five w1118 males were analysed from each vial. 
These experiments were carried out at both 25ºC and 27ºC. The same experimental 
protocol was used as is outlined in section 2.2. 
2.2.2 MPO and COX Inhibitors 
A range of concentrations was used for each MPO and COX inhibitor, which spanned 
the published IC50 values. Inhibitors were dissolved in dimethyl sulfoxide (DMSO, 
Sigma) and then added to fly media before pouring. The same screen protocol was 
used as outlined earlier in section 2.2. All COX inhibitors were obtained from Sigma; 
MPO Inhibitor 1 was obtained from Calbiochem. 
Aspirin was supplemented at the following concentrations: 0 mM, 0.3 mM, 0.7 mM, 1 
mM, 3 mM, 7 mM, 10 mM and 30 mM. These spanned the published ovine IC50 of 
0.75 mM for COX-1 and 1.25 mM for COX-2 (Johnson, Wimsatt, Buckel, Dyer, & 
Maddipati, 1995). 
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NS-398 was supplemented at the following concentrations: 0 µM, 0.3 µM, 0.7 µM, 1 
µM, 3 µM, 7 µM, 10 µM and 30 µM. These spanned the published human 
recombinant COX IC50 of 75 µM for COX-1 and 1.77 µM for COX-2 (Barnett et al., 
1994). 
SC-560 was supplemented at the following concentrations: 0 nM, 7 nM, 10 nM, 30 
nM, 70 nM, 100 nM, 300 nM, 700 nM, 1 µM, 3 µM, 7 µM, and 10 µM.  These 
spanned the published human recombinant COX IC50 of 9 nM for COX-1 and 6.3 µM 
for COX-2 (Smith et al., 1998). 
MPO Inhibitor 1 was supplemented at the following concentrations: 0 nM, 10 nM, 30 
nM, 50 nM, 100 nM, 200 nM, 300 nM, and 1000 nM. These spanned the published 
purified MPO IC50 of 300 nM (Calbiochem).  
2.2.3 Putative Drosophila MPO/COX homologues 
BLAST (Altschul et al., 1990) was used to identify Drosophila homologues of human 
COX-1, COX-2 and MPO based on amino acid sequence similarity. Mutant strains of 
each potential homologue were used. Mutant strains were either due to a point 
mutation, an insertion or a deficiency depending on availability. 
Five males from each mutant line were crossed with five hopTum/FM7 females. 
Females from the progeny that contained both the hopTum and homologue mutation 
were collected and scored for tumour incidence. The tumour assay is detailed in 
section 2.2. Details of mutants used are outlined in Table 1.  
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Table 1. Mutant strains of MPO/COX homologues 
 
Genotype Description 
w1118;Df(3R)ED5785, 
P{3'.RS5+3.3'}ED5785/ 
TM6C, cu1 Sb1 
A chromosomal deletion of 3R:13,543,832-13,769,792. This 
removes Peroxinectin-like (Pxt) mapped to 3R:13,545,176-
13,548,677 [+]. 
y1 w67c23; P{EPgy2}PxtEY03052 A transposable element insertion that is located at sequence: 3R:13,545,179 [+]. This affects Pxt. 
PBac{WH}Pxtf05258/TM6b, Tb1, 
Hu1 
A transposable element insertion that is located at sequence: 
3R:13,546,640 [+]. This affects Pxt. 
w1118; Df(3L)BSC119/TM6B, Tb1 A chromosomal deletion of 3L:2,600,282-2,823,614. This affects Peroxidasin (Pxn) mapped to 3L:2,601,455-2,630,072 [-]. 
w1118; Df(3L)Exel6091, P{XP-
U}Exel6091/TM6B, Tb1 
A chromosomal deletion that deletes segment 3L:2,656,263-
2,821,245. It was used in an overlap assay as it removes genes 
Df(3L)BSC119 does, but not Pxn itself. 
w1118; Mi{ET1}IrcMB11278 
A transposable element insertion located at sequence 
3R:12,829,982. This affects gene Immune regulated catalase (Irc) 
mapped to 3R:12,828,597-12,832,930. 
w1118; Df(3R)BSC792, 
P+PBac{XP3.WH3}BSC792/ 
TM6C, Sb1 cu1 
A chromosomal deletion of 3R:12,808,916-12,890,724. This afects 
gene Irc. 
w1118; Df(3R)Exel8165, 
repo8165/TM6B, Tb1Tb1 
A chromosomal deletion of 3R:12,838,655-12,879,706. This 
affects Peroxidase (Pxd), mapped to 3R:12,840,298-12,853,709 
[+], and cardinal (cd), mapped to 3R:18,520,681-18,523,712 [+]. 
w1118; Df(3R)Exel6192, P{XP-
U}Exel6192/TM6B, Tb1 
A chromosomal deletion of 3R:18,492,372-18,724,923. This 
affects cd. 
w1118; Df(2L)BSC149/CyO A chromosomal deletion of 2L:18,444,727-18,673,286. This affects CG10211 mapped to 2L:18,517,487-18,531,967 [+]. 
 w*; P{FRT(whs)}2A 
P{neoFRT}82B 
PBac{SAstopDsRed}LL00313 
P{Car20y}96E / TM3, Sb1 
A transposable element insertion located at sequence 
3R:12,850,518. This affects gene Pxd mapped to 3R:12,840,298-
12,853,709 [+]. 
Df(2L)C144, dppd-ho ed1/ 
In(2LR)Gla, wgGla-1 Bc1 EgfrE1 
chromosomal deletion of 2L:2,517,598-2,955,279. This affects 
gene Dual oxidase (dDuox) mapped to 2L:2,815,970-2,830,248. 
w1118; Df(2L)BSC692, 
P+PBac{XP3.RB5}BSC692/SM
6a 
A chromosomal deletion of 2L:2,830,265-2,868,633. This affects 
gene dDuox. 
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2.2.4 RT-PCR verification of MPO/COX homologue insertions 
To confirm reduced expression in insertion strains five male flies from Pxtf05258, 
IrcMB11278 and w1118 (control) were collected and snap-frozen in liquid nitrogen. A 
µMACS mRNA isolation kit (Miltenyi Biotec Ltd.Uk) was used to isolate mRNA. The 
kit uses Oligo (dT) MicroBeads that hybridise to the polyA tail of mRNA. This 
magnetically labels the mRNA allowing isolation when a µColumn is placed in a 
MACS separator. mRNA isolation was carried out according to the manufacturer’s 
protocol. Eluted mRNA was precipitated with 90 µl isopropanol (AnalaR 
NORMAPUR), 9 µl 3 M NaOAc (Sigma), and 1 µl glycogen (Sigma), and incubated at 
-80ºC for 15 min. Samples were centrifuged for 15 min at 21, 000 g and the 
supernatant removed. Pellets were reconstituted in 150 µl 70% of ethanol (AnalaR 
NORMAPUR) and centrifuged again as before but for 5 min. The supernatant was 
removed and pellets left to air-dry before being re-suspended in 10 µl nuclease-free 
deionised water (HyClone).  
cDNA was generated using a 50 µl reaction mix consisting of: 1x First Strand Buffer, 
1 mM DTT, 0.5 mM dNTP, 2 units of RNaseOUT, 4 units of Supercript II reverse 
transcriptase, 0.1 mM Oligo(dT), and 10 µl mRNA. The reaction was carried out in a 
Peltier Thermal Cycler-200 (MJ Research) using a program of: 50ºC for 1 hour and 
70ºC for 15 min continuing at 4ºC. cDNA was stored at -20ºC. All cDNA reaction 
reagents were from Invitrogen. 
RT-PCR analysis was carried out using a StepOnePlus RT-PCR system (Applied 
Biosystems). 10 µl reactions consisted of: 1x ABsolute SyBR Green ROX mix 
(THERMO scientific), 200 ng cDNA, 10 pmol 5’ primer and 10 pmol 3’ primer. The 
RT-PCR program started with 95ºC for 10 min as a hot-start enzyme was used, and 
proceeded with 40 cycles of 95ºC for 15 sec and 60ºC for 1 min. A melt curve was 
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also generated. CT values were used for analysis. RpL32 was the endogenous 
control used for normalisation. Primers used are shown in table 2. 
 
Table 2.  RT-PCR primers used to confirm Pxn and Irc levels in mutant strains 
 
Gene Orientation Primer sequences (5’ to 3’) 
RpL32 
5' CAACAGAGTCGGTCGCCGCTTCAACGGACA 
3' CAGCTCGCGCACGTTGTGCACCAGGAACTT 
Pxt 
5' GCAGCTCCTCGATGTGATTGAAAC 
3' CTAGAGTGCGAGCGAGAGGTAAGA 
Irc 
5' TGATCTACACGATCTTCATGC 
3' CTCCTCAATGACCACTCGACG 
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2.2.5 Putative Drosophila free fatty acid liberating/signalling pathway 
homologues 
BLAST (Altschul et al., 1990) was used to identify Drosophila homologues of 
pathway components that lead to the production of free fatty acids, or are involved in 
lipid signalling. Strains used to remove putative pathway homologues are outlined in 
Table 3. The same tumour assay as detailed in section 2.2 was used. 
 
Table 3. Fatty acid pathway component strains 
 
Genotype Description 
w* norpA33 
An ethyl methanesulfonate (EMS) mutation located at X:4,251,391 caused 
by a nucleotide substitution C1370T,that results in a premature 
termination codon. This affects no receptor potential A (norpA) located at 
X:4,216,659-4,259,417 [+], a homologue of Phospholipase C (PLC). 
w* norpA35 An EMS mutation located at X:4,251,818, which results in an amino acid substitution C361T. This affects norpA. 
w* norpA36 
A loss of function EMS mutation located at X:4,253,449. It is a 28bp 
deletion that causes a frame shift, deleting 9 amino acids. This affects 
norpA. 
norpA45 An unmapped mutation in norpA.  
y1 w67c23;P{SUPorP} 
Plc21CKG05991 
A transposable element insertion in Phospholipase at 21C (Plc21C) 
located at 2L:310,245 [+]. This affects Phospholipase at 21C (Plc21C) 
located at 2L:305,935-347,927 [+], which is a homologue of PLC. 
y1 w67c23; P{SUPor-P} 
Plc21CKG08451 
A transposable element insertion in Plc21C that is located at 2L:306,162 [-
].  
rud1 v54k tc1 sl2 
smd1/FM7c, sn* 
An X-ray induced loss of function allele in small wing (sl) caused by a 13 
base pair deletion located at X:16,246,728. small wing (sl) is located at 
X:16,244,348-16,250,515 [+] and is a homologue of PLC. 
w1118;Df(2R)BSC263/ 
CyO 
A chromosomal deletion of 2R:3,034,369-3,334,915. This affects secretory 
Phospholipase A2 (sPLA2) located at 2R:3,330,369-3,331,332 [+]. 
w1118; Df(2R)BSC264/ 
CyO A chromosomal deletion of 2R:3,283,390-3,377,339 that includes sPLA2. 
Gα49B1 
An EMS mutation that is a hypomorphic allele at location 2R:8,504,576. 
This affects G protein α q subunit (Gαq) located at 2R:8,500,245-
8,510,702 [+], a homologue of Gαq. 
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sktlΔ15 
A loss of function allele caused by an imprecise excision of the P element 
(fam7505) located in an intron of skittles (sktl). Sktl is located at 
2R:16,714,787-16,719,923 [-] and is a homologue of phosphatidylinositol 
4-phosphate (PI4P). 
sktlΔ20 An imprecise excision of the P element (fam
7505) located in an intron of 
sktl, resulting in a loss of function allele.  
inaExl15 
An imprecise excision of the progenitor insertion P{SUPor-P}inaEKG08585. 
This affects inactivation no afterpotential E (inaE) located at X:13,677,747-
13,705,526 [+]. A homologue of diacylglycerol lipase (DAG lipase). 
inaExl18 An imprecise excision of the progenitor insertion in inaE P{SUPor-P}inaEKG08585.  
rdgA1 
An EMS mutation located at X:8,915,781 causing a nucleotide 
substitution, C3695T in retinal degeneration A (rdgA) located at 
X:8,801,101-8,923,509 [+]. This is a homologue of diacylglycerol kinase 
(DGK). 
Itp-r83Asv35 
An EMS mutation in Inositol 1,4,5,-tris-phosphate receptor (Itp-r83A) 
located at 3R:1,360,239 that causes an amino acid change Q1572. It is a 
homologue of Inositol 1, 4, 5-triphosphate receptor. 
Itp-r83A ka1091 An EMS mutation in Itp-r83A located at 3R:1,361,196 this causes an amino acid substitution G1891S.  
Itp-r83Aka901 An EMS mutation in Itp-r83A located at 3R:1,363,712 resulting in an amino acid substitution G2630S.  
y1 w67c23; 
P{EPgy2}EY04862 
A transposable element insertion located at 2R:16,758,286 [+]. This 
affects the gene Ipk1 located at 2R:16,758,296-16,766,650 [+], a 
homologue of inositol polyphosphate kinase 1 (IPK1). 
w1118; Df(2R)BSC404/ 
CyO A chromosomal deletion of 2R:16,554,779-16,770,204 that includes Ipk1.  
w1118; Df(2R)Exel6071, 
P{XP-U}Exel6071/CyO A chromosomal deletion of 2R:16,723,538-16,944,303 that includes Ipk1.  
y1 w67c23; 
P{GSV6}GS15129/SM1 
A transposable element insertion located at 2L:574,230, affecting Ipk2 
located at 2L:573,033-574,264 [-], a homologue of inositol polyphosphate 
kinase 2 (IPK2). 
y1 w67c23; 
P{GSV6}GS14317/SM1 
A transposable element insertion located at 2L:574,219, affecting Ipk2 
located at 2L:573,033-574,264 [-], a homologue of IPK2. 
w1118; Df(2L)ED49, 
P{3'.RS5+3.3'}ED49/ 
SM6a 
A chromosomal of 2L:568,095-587,983 that includes Ipk2.  
w1118; 
Df(2R)BSC382/CyO 
A chromosomal deletion of 2R:12,663,669-12,789,130, affecting 
inactivation no afterpotential C (inaC) located at 2R:12,786,040-
12,789,080 [+]. A homologue of protein kinase C (PKCα/β). 
w1118;Df(3R)Exel621,P{
XP-U}Exel6211/TM6B, 
Tb1 
A chromosomal deletion of 3R:24,816,740-24,889,986 that includes 
Protein C kinase 98E (Pkc98E) located at 3R:24,864,878-24,874,870 [+] 
that is a homologue of PKCε. 
w1118; Df(3R)BSC806, 
P+PBac{XP3.RB5}BSC
806/TM6C, Sb1 cu1 
A chromosomal deletion of 3R:24,696,033-24,938,249 that includes 
Pkc98E. 
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y* w*; P{neoFRT}40A 
P{FRT(whs)}G13 cn1 
PBac{SAstopDsRed}LL
04932 bw1/CyO, S* bw1 
A transposable element insertion located at 2R:12,813,988-12,813,988 [-] 
that affects Protein C kinase 53E (Pkc53E) located at 2R:12,812,160-
12,832,631 [+]. A homologue of PKCα/β. 
y1 w67c23; 
P{EPgy2}Pkc53EEY14093/ 
CyO 
A transposable element insertion in Pkc53E located at 2R:12,812,005-
12,812,005 [+]. 
w1118; Df(2R)ED2751, 
P{3'.RS5+3.3'}ED2751/
SM6a 
A chromosomal deletion of 2R:12,744,676-12,984,808 that includes 
Pkc53E. 
y1 w67c23; 
P{lacW}aPKCk06403/CyO 
A transposable element insertion located at 2R:10,840,608-10,840,608 [-] 
affecting atypical protein kinase C (aPKC) located at 2R:10,831,963-
10,850,474 [-]. 
y* w*; P{neoFRT}40A 
P{FRT(whs)}G13 cn1 
PBac{SAstopDsRed}LL
03594 bw1/CyO, S* bw1 
A transposable element insertion in aPKC located at 2R:10,846,147-
10,846,147 [-]. 
Df(1)BSC543, 
w1118/FM7h/Dp(2;Y)G, 
P{hs-hid}Y 
A chromosomal deletion of X:11,815,319-12,352,077 that includes protein 
kinase C δ (PKCδ) located at X:12,326,25712,347,683 [+]. 
Df(1)ED7153, w1118 
P{3'.RS5+3.3'}ED7153/
FM7h 
A chromosomal deletion of X:11,901,120-2,461,493 that includes PKCδ. 
Df(1)BSC623, 
w1118/Binsinscy A chromosomal deletion of X:12,289,725-13,025,219 that includes PKCδ. 
Eip75BΔ1/TM6B, P{Ubi-
GFP.S65T}PAD2, Tb1 
A 3kb deletion by imprecise excision of P{PZ}Eip75B03338 affecting 
Ecdysone-induced protein 75B (Eip75B) located at 3L:17,944,053-
18,057,796 [-]. A homologue of PPARγ. 
Eip75BΔ51/TM6B, P{Ubi-
GFP.S65T}PAD2, Tb1 
A 30kb deletion by imprecise excision of P{PZ}Eip75B03338 affecting 
Eip75B. 
w1118; Df(3L)Exel6133, 
P{XP-
U}Exel6133/TM6B, Tb1 
A chromosomal deletion of 3L:18,009,803-18,132,421 that includes 
Eip75B. 
w1118; Df(3L)ED224, 
P{3'.RS5+3.3'}ED224/T
M6C, cu1 Sb1 
A chromosomal deletion of 3L:17,962,303-18,391,619 that includes 
Eip75B.  
w1118; 
Df(3L)BSC775/TM6C, 
Sb1 cu1 
A chromosomal deletion of 3L:17,788,244-18,891,426 that includes 
Eip75B. 
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2.3 Lipidomics and functional characterisation of fatty acids 
hopTum/FM7 females were crossed with w1118 males and reared on standard media, 
0.15% Omega-3 supplemented media and 0.15% Omega-6 supplemented media 
and incubated at 27ºC. Wandering third instar hopTum/FM7 and w1118 (control) larvae 
were harvested, washed with water, and weighed to make 100 mg and 200 mg 
samples. These were snap-frozen in liquid nitrogen and stored at -80ºC. Samples 
were sent to our collaborators, Professor Anna Nicolaou and Karen Massey for liquid 
chromatography-mass spectrometry analysis (LC-MS). Samples were analysed for 
arachidonic acid, prostaglandins, hydroxy-octadecadienoic acids (HODEs) and chiral 
enantiomers of HODEs. Detailed methods and materials of the lipidomics can be 
found in Massey & Nicolaou 2013. 
2.3.1 Lipid extraction 
200 mg larvae samples were defrosted and transferred to a Dounce glass 
homogeniser. Samples were homogenised in 500 µl ice-cold methanol using a glass 
pestle and mortar. The homogenate was transferred to a glass vial. The mortar was 
washed twice with 100 µl methanol and added to the homogenate. Ice cold water 
was added to make a final 15% v/v methanol:water homogenate. 20 µl of 1 ng/µl 
internal standard PGB2-d4 (Cayman Chemicals, Ann Arbor, MI) was added. The 
homogenate was left for 15 min on ice, in the dark and then centrifuged for 10 min, at 
4ºC, at 130 g to remove precipitated proteins. The supernatant was transferred to a 
glass vial and acidified to pH 3.0 using 0.1 M HCL. Acidified extracts were applied to 
the pre-conditioned solid phase extraction (SPE) cartridges (C18-E, Phenomenex, 
Macclesfield, UK) where lipid mediators were eluted with methyl formate. Extracts 
were dried under nitrogen, in the dark and reconstituted in 100 µl 70/30:v/v 
ethanol/water. 
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2.3.2 LC/ESI-MS/MS analysis 
Lipid mediator analysis was carried out using a Waters Alliance 2695 HPLC pump 
coupled to an ESI triple quadruple Quattro Ultima mass spectrometer (Waters, 
Elstree, Hertsfordshire, UK). For whole lipid analysis and identification of 
prostaglandins PGE2 and PGF2α as well as 9- and 13-HODE, chromatographic 
separation was carried out using a C18 Luna 5 µm, 150 x 2.0 mm column 
(Phenomenex). For identification of 9- and 13-HODE chiral enantiomers, 
chromatographic separation was carried out using a LUX cellulose-1 3 µm, 150 x 2.0 
mm column (Phenomenex). 
Analytes were analysed using MassLynx version 4.0 via multiple reaction monitoring 
(MRM) mode to identify lipid mediators of interest using their known MRM transitions 
from the standards used. PGE2 MRM transitions used: m/z 351>271, m/z 351>315, 
m/z 351>333. PGF2α MRM transitions used: m/z 353>193, m/z 353>247, m/z 
353>309. MRM transitions for 9-HODE: 295>171 and 13-HODE: 295>195. Relative 
abundance of lipid mediators was calculated from the area underneath the peak of 
detection seen in the LC-MS plots. 
2.3.3 Fat body prep and Oil Red O staining 
w1118 flies (control) and hopTum/FM7 females crossed with w1118 males were incubated 
at 29ºC. Wandering third instar hopTum/FM7 and w1118 (control) progeny larvae were 
collected and washed with water. 5-10 Larvae were ripped open in 200 µl of HyQ-
CCM3 (HyClone) containing 1x complete mini protease inhibitors (Roche) on ice. 
Larvae were held at the mouth hook with fine forceps and teared open using another 
pair of forceps to the posterior end. Haemocytes pour out into the media when the 
larvae are teared and these were used for Oil red O staining in section 2.3.4. The 
carcasses were placed in 1 ml of 1xPBS containing 3.7% formaldehyde (Sigma), and 
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fixed for ten minutes on ice. Carcasses were then carefully washed 5 times with 
1xPBS. 1 ml of Oil Red O working solution (600 µl 0.1% Oil Red O (Sigma) and 400 
µl water) was added for 1 min, and then removed. 1 ml of isopropanol was used to 
wash, pipetted up and down and removed immediately. Fat bodies were washed with 
1xPBS and the fat body was dissected from the carcass using a microscope and 
placed in 200 µl 1xPBS. Fat body dissections were centrifuged onto glass slides for 5 
min at 28 g on low acceleration and deceleration settings, using a cytospin3 
(Shandon). Centrifuged fat bodies were fixed with 100 µl 4% paraformaldehyde for 
10 min, and washed with 1xPBS for 10 min and mounted using Vectashield 
containing DAPI (Vecta Laboratories). Slides were visualised using a Zeiss Axiovert 
100M confocal microscope. 
2.3.4 Haemocyte Oil Red O staining 
Haemocytes generates during the fat body preparations were centrifuged at 400 g for 
3 min at 4ºC to pellet the haemocytes. The supernatant was removed and cells re-
suspended in 50 µl of HyQ-CCM3 and pipetted onto a Multispot slide (PH-001; C. A. 
Hendley) and incubated for 30 min at room temperature. The media was removed 
and cells were fixed with 3.7% paraformaldehyde for 10 min and then washed in 
1xPBS for 10 min. 50 µl of Oil Red O working solution was added and incubated for 
2.5 min. The slide was then de-stained using isopropanol and washed with 1xPBS 
three times for 3 min and then mounted in Vectashield containing DAPI. Haemocytes 
were visualised using a Zeiss Axiovert 100M confocal microscope. 
2.3.5 Eip75b ligand binding domain with GFP reporter 
w1118; P{hs-GAL4-Eip75B.LBD.HA}65.1; P{UAS-Stinger}3 flies were incubated at 
25ºC for 3 days. Adult flies were removed and the vial containing progeny was heat 
shocked in a water bath at 38ºC for 1 hour and then incubated at 25ºC until progeny 
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reached 3rd instar wandering stage. This was to induce expression of Eip75b-LBD 
GAL4. Three samples of 300 larvae were ripped open in 200 µl of HyQ-CCM3 
containing 1x complete mini protease inhibitors (Roche) on ice. Haemocytes were 
centrifuged at 400 g for 10 min at 4ºC, and then washed with 1xPBS and re-
suspended in either A) 250 µl HyQ-CCM3 (control) B) 250 µl HyQ-CCM3 + 20 µg/ml 
9-HODE (Cayman) C) 250 µl HyQ-CCM3 + 20 µg/ml 13-HODE (Cayman). Cells were 
cultured in a chamber slide (Lab-Tek II) for 48 hours at 27ºC. After incubation, cells 
were fixed with 100 µl 3.7% paraformaldehyde for 10 min. The culture chamber was 
removed and the slide washed with 1xPBS for 10 min. Cells were blocked overnight 
at 4ºC in 1xPBST (1xPBS containing 0.1% Tween-20 (Sigma)) and 1% FCS. 
Polyclonal chicken anti-GFP antibody (Upstate Bio-technology) was added at a 1:200 
dilution and incubated for 60 min. Slides were washed with 1xPBST twice for 10 min 
and FITC-conjugated anti-chicken IgY (H+L) (Jackson ImmunoResearch 
laboratories) secondary antibody added at a dilution of 1:400 and incubated for 60 
min. Slides were washed twice with 1xPBST for 10 min and mounted in Vectashield 
containing DAPI. 
2.3.6 S2 cell treatment with HODEs and Omega fatty acids for RT-PCR analysis 
A 1:5 dilution of S2 cells were grown in Insect Xpress (Lonza) media for 3 days in a 
T25 tissue culture flask (Corning). A 1:12 dilution was made from this culture and 12 
1 ml aliquots were made in 1.5 ml eppendorf tubes and centrifuged at 400 g at 4ºC 
for 10 min. The pelleted cells were washed with 1 ml 1xPBS and re-suspended in a 
final volume of 250 µl. Three replicates per treatment was made: Media alone 
(control), media + 0.15% Omega-3, media + 0.15% Omega-6, media + 0.15% 
Omega-3 and -6, media + 20 µg/ml 9-HODE, and lastly media + 20 µg/ml 13-HODE. 
Treatments were incubated in a 24 well tissue culture plate (SARSTEDT) at 27ºC for 
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48 hours. Cultures were then centrifuged and washed in 1xPBS and the cell pellets 
then stored at -80ºC 
mRNA was isolated, cDNA generated, and analysed for RT-PCR as described in 
section 2.2.4. A panel of plasmatocyte and lamellocyte gene markers were used to 
analyse samples. RpL32, GAPDH2 and α-Tubulin were used as endogenous 
controls. Primers used are shown in Table 4. 
 
Table 4. RT-PCR primers used to analyse S2 treated cells 
 
Gene Orientation 
Primer sequences (5’ to 
3’) Description 
α -Tubulin 
5, GTCGCGTGTGAAACACTTCCA α-Tubulin at 84B(α-Tubulin) is a 
housekeeping gene involved 
mitotic spindle formation and 
cytoskeleton structure. 3' AGCAGGCGTTTCCAATCT 
GAPDH2 
5' CCAGAAGACCGTCGATGG Glyceraldehyde 3 phosphate 
dehydrogenase 2 (GAPDH2) is a 
housekeeping gene involved in 
glycolysis 3' TTCCGGTGAGCTTACCGTTG 
RpL32 
5' CAACAGAGTCGGTCGCCGCTTCAACGGACA Ribosomal protein L32 (RPL32) is 
a housekeeping gene which is 
involved in protein translation 3' CAGCTCGCGCACGTTGTGCACCAGGAACTT 
lz 
5' CTCCAACTCCATCAGCATCT lozenge (lz) is a transcription factor 
that regulates crystal cell 
differentiation, therefore a marker 
for crystal cells. 3' CCAATCCGAGTCCGAGTCCG 
crq 
5' GCGATCATCGAAGCGGGAAG croquemort (crq) is a receptor 
involved in phagocytosis and is a 
marker for plasmatocytes. 3' GCATTAGCTTCTGATGGCTC 
He 
5, CCCGGGCTCGAGGTGCTCGGATAACGCACACTGCGT 
Hemese (He) is a transmembrane 
protein expressed in all cell types. 
It is thought to have similar actions 
as the glycophorins. 3' 
GGGGGATCCTGTAAACTTAGT
GTGAACTGCTCCGCC 
eater 
5' CGTCTGTCAATGCCTGACGG eater is a transmembrane pattern 
recognition receptor involved in 
phagocytosis. It is a marker of 
plasmatocytes. 3' AGACACCTTCCAGCTTCGTG 
Hml 
5' CCGATGATGACGACGAGGAT Hemolectin (Hml) is a coagulation 
factor involved in clotting and is a 
marker of plasmatocytes. 3' GATGTTGAAGCTAATGTCCC 
mys 
5' GTACCATGACCGGAGCAGAT myospheroid (mys) is a β-integrin 
that is a marker of lamellocytes 3' GATCACGGTACATGCGAGTG 
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Itgβv 
5' GGACAGCCTGATCACTGGTT Integrin βν subunit (Itgβv) is a 
variant β integrin that is a marker 
for lamelloctes. 3' CTCGCCGGCAACTACTTAAC 
cher 
5, GATCGATGGTCTTCAGGTGC cheerio (cher) encodes the protein 
fillamin-240, which is involved in 
cytoskeleton rearrangement and is 
a specific marker of lamelloctes. 3' CGGATCAGTACGAGGAGAAC 
ItgαPS4 
5' TGAGCACGTTGGTTAGCTTG Integrin αPS4 subunit (ItgαPS4) is 
an α integrin, which is a 
lamellocyte marker. 3' ACACCGACTCCTTGACCATC 
ItgαPS5 
5' GCACCCACGTCATAGGAATC Integrin αPS5 subunit (ItgαPS5) is 
an α integrin, which is a 
lamellocyte marker. 3'( ACTTCGGTTACTCCGTGGTG 
 
2.3.7 S2 cell He (Hemese) and Oil Red O staining 
S2 cells were cultured and treated as described in section 2.3.6 however, cells were 
cultured in a chamber slide and only treated with Omega fatty acids: Omega-3, -6 
and a combination of both. After 48 hours, the cells were fixed with 100 µl 3.7% 
paraformaldehyde for 10 min. The culture chamber was removed from the glass slide 
and the slide was washed in 1xPBS for 10 min. Cells were immunostained with 
mouse MAb H2 anti-Hemese as described in section 2.3.5 with the exception that 
detergent was omitted from all buffers. Cy5-conjugated anti-mouse IgG (H+L) 
(Jackson ImmunoResearch laboratories) was used as a secondary antibody at 1:200 
dilution and incubated for 60 min, then washes twice in 1xPBS for 10 min. After 
antibody-staining cells were fixed with 3.7% paraformaldehyde for 10 min, and 
washed in 1xPBS for 10 min. Oil Red O staining was immediately carried out as 
described in section 2.3.4. Slides were mounted in Vectashield containing DAPI for 
confocal microscopy. 
2.4 MPO/COX homologue cloning and induction of protein 
Irc, Pxn, Pxt as well as human COX-1 and COX-2 (controls) had to be cloned to 
produce recombinant protein for use in in-vitro assays. The amino acid sequences of 
each gene was obtained from National Center for Biotechnology Information (NCBI) 
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website. The SignalP 4.1 Server (http://www.cbs.dtu.dk/services/SignalP) was used 
to determine the presence and location of a signal peptide and pro-protein cleavage 
sites for each gene. Serial Cloner 2-5 program was used to search each sequence 
for restriction enzyme sites to determine which restriction enzymes were best to use.  
2.4.1 Bacterial pGEX-2T IPTG induction system 
The gene fragments were cloned into the pGEX-2T GST gene fusion vector (GE 
Healthcare) generating an in frame fusion of protein with GST enabling proteins to be 
GST tagged for purification. Taking into account the vector and gene sequences, a 
combination of BamH1 and EcoR1 restriction enzymes was used for cloning (Figure 
6). Primers for each gene was designed incorporating a restriction site, and was 
made to be in frame with protein sequence and vector sequence. Pxn is a large gene 
containing several different domains such as IgGs, so we only cloned the peroxidase 
catalytic domain located from 557-1165 amino acids. Primers used are shown in 
Table 5. 
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Figure 6. Cloning into the pGEX-2T GST gene fusion vector 
Human COX-1 and COX-2 gene sequences, as well as the Drosophila Irc, Pxn and 
Pxt gene sequences were cloned into the pGEX-2T vector with the restriction 
enzymes shown. The pGEX-2T vector is a bacterial vector that expresses a fusion 
protein with GST.  
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Table 5. Cloning primers for COX-1, COX -2, Irc, Pxn and Pxt 
 
Gene Orientation Restriction enzyme Primer sequences (5’ to 3’) 
COX-1 
5’ BamH1 CGCGGATCCGGGGCGCCCACGCCAGTGAAT 
3’ BamH1 CGCGGATCCTCAGAGCTCTGTGGATGGTCG 
COX-2 
5’ BamH1 CCGGGATCCTGTATGAGTGTGGGATTTGACC 
3’ EcoR1 CGCGAATTCCCTACAGTTCAGTCGAACGTTCTT 
Irc 
5’ BamH1 CGCGGATCCAGCCGAGATGTTAATGCCGA 
3’ BamH1 CGCGGATCCCTAGACGTCTTCACAAGAGAC 
Pxn 
5’ EcoR1 CCGGAATTCCGTTCCACTCGAGGTACAGAAG 
3’ EcoR1 CCGGAATTCCTTACTTGCCGAGATCTCTTC 
Pxt 
5’ BamH1 CGCGGATCCAGCCGAGATGTTAATGCCGA 
3’ BamH1 CGCGGATCCCTAGACGTCTTCACAAGAGAC 
 
2.4.1.1 PCR amplification and purification 
Gene sequences were amplified using PCR. PCR was carried out using a Veriti 96 
well thermal cycler (Applied Biosciences). To amplify, whole adult Drosophila cDNA 
was used for Irc, Pxn and Pxt. HeLa cell cDNA was used for COX-1 and COX-2. 50 
µl PCR reactions consisted of: 1x Expand long template PCR, Buffer 1 (Roche), 0.5 
mM dNTP, 2 pmol 5’ primer, 2 pmol 3’ primer, 3.75 units of Expand long template 
PCR, DNA pol mix (Roche), 1 µg cDNA template. The following program was used: 
94ºC for 5 min, 35 cycles consisting of: 94ºC for 40 sec, XºC (annealing temperature) 
for 40 sec, 72ºC for 3 min, finishing with 72ºC for 5 min and continued at 4ºC. 
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Annealing temperatures varied for the different genes; COX-1: 65ºC, COX-2: 50ºC, 
Irc: 60ºC, Pxn: 55ºC and Pxt: 57ºC.  
PCR fragments were analysed using DNA gel electrophoresis. A 1% agarose gel 
(150 ml 1xTAE buffer (Tris-Acetate EDTA: 40 mM Tris, 20 mM acetic acid and 1 mM 
EDTA), 1.5 g Agarose (Fisher Scientific), heated to dissolve, 1x GelRed nucleic stain 
(BIOTIUM)) was used. Gel electrophoresis was carried out at 120 volts for 25 min. 
PCR fragments were then purified using a QIAquick PCR gel purification 
microcentrifuge kit (QIAGEN) according to the manufacturer’s protocol. DNA was 
eluted in 30 µl water.  
2.4.1.2 Restriction enzyme digestion, DNA purification and ligation 
The purified PCR gene fragments were digested with the corresponding restriction 
enzymes shown in Figure 6. An 80 µl restriction digestion reaction was used 
consisting of: 1 µg of DNA (PCR fragment or plasmid), 1xNE4 Buffer (Biolabs), 10 
units of either EcoR1, BamH1 (Biolabs) or both for fragments being double digested, 
and made up to volume with water. Three pGEX-2Tvector digests were also 
prepared to match the gene fragment digests for cloning. Vectors that were singly 
digested were treated with 10 units of calf intestinal phosphatase (CIP (Bio Labs)). 
CIP removes the 5’ phosphate group from the DNA strand preventing self-ligation. 
Reactions were incubated at 37ºC for 1.5 hours. Digested DNA fragments were 
purified using Phenol:Chloroform:Isoamyl alcohol at a ratio of 25:24:1 and pelleted by 
ethanol precipitation. Pellets were reconstituted in 10 µl water. 
The purified digested gene fragments were ligated into their corresponding digested 
vector using a 10 µl reaction consisting of: a 1:3 molar ratio of vector to insert, 5 units 
of T4 DNA ligase (Biolabs), 1xT4 ligase buffer made up to volume with water. 
Ligations were incubated over night at 14ºC.  
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2.4.1.3 DH5α cell transformation, plasmid extraction and verification  
50 µl DH5α competent cells (Invitrogen) were added to 5 µl ligated DNA for each 
gene ligation, incubated on ice for 30 min and heat-shocked for 1 min at 42ºC and 
immediately placed on ice. 200 µl lysogeny broth (LB media: 1% Tryptone (Appleton 
Woods), 1% NaCl (Sigma), and 0.5% Yeast extract (Appleton Woods)) was added 
and incubated for 1 hour at 37ºC. Transformed competent cells were plated onto LB 
agar plates (LB media with 1.5% Bacto agar) containing 100 µg/ml ampicillin for 
selection, and incubated overnight at 37ºC. Single colonies from plates were picked 
and individually cultured in 3 ml LB with 100 µg/ml ampicillin at 37ºC. 
To verify transformations, vectors were extracted from cell cultures using a QIAprep 
Miniprep kit (QIAGEN) following the manufacturer’s protocol. DNA was eluted with 30 
µl of water. The vectors were screened by restriction digest (as described before) 
using a 20 µl reaction. Digestion products were analysed for vector and gene insert 
by agarose gel electrophoresis.  
2.4.1.4 Sequencing of potential transformed candidates 
Genes cloned into the vectors had to be sequenced to confirm that there were no 
changes in the DNA sequence and genes had been inserted in the correct 
orientation. 
PCR was used for the incorporation of fluorescently labelled Dideoxyribonucleotides 
(ddNTPs) using Big Dye 3.1 reagent (Applied Biosystems). A 20 µl reaction for both 
5’ and 3’ primers was used, consisting of 8 µl Terminator Ready Reaction Mix, 200-
500 ng of template, 3.2 pmol of primer (Table 6). The cycle conditions used were: 1 
minute at 96ºC, 25 cycles consisting of: 10 seconds at 96 ºC, 5 seconds at 50 ºC and 
4 minutes at 60 ºC. It finished at 4 ºC.  
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Table 6. GST Primers used to sequence pGEX-2T vectors containing cloned 
fragments 
 
Orientation  Primer sequences (5’ to 3’) 
5’ GTATATAGCATGGCCTTT 
3’ CATGTGTCAGAGGTTTTC 
 
Unincorporated dye terminators were removed by washing with 70% ethanol. The 
pellets were reconstituted in 10 µl of Hi Di Formamide and heated for 95 ºC. 
Sequencing was carried out using capillary electrophoresis. After sequences were 
checked, positive transformants were bulk cultured to amplify vector and extracted 
using a Midiprep kit (Qiagen), where the protocol of the manufacturer was followed. 
DNA was eluted with 150 µl of water and stored at -20ºC. 
2.4.1.5 Transformation of BL21C cells and IPTG induction 
GST expression vectors containing cloned genes had to be transfected into BL21C 
cells (Stratagene) that have the machinery to produce the proteins.  
Transformation of BL21C cells was similar to that used with DH5a cells previously 
described, except 1 µl of vector containing cloned gene was added to 40 µl BL21C 
cells. Ampicillin positive colonies from each vector construct were pre-cultured 
overnight. The pre-cultures were then added to 2 L conical flasks containing: 1 L of 
LB media, 1 % glucose and 25 µg/ml ampicillin and incubated at 37ºC for 3.5 hours. 
1 ml aliquots were taken for pre-induction analysis. Isopropyl β-D-1-
thiogalactopyranoside (IPTG), the inducing agent, was added to cultures at a final 
concentration of 0.5 mM. The cultures were incubated further for 2.5 hours at 32ºC. 
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The cells were pelleted by centrifugation at 7900 g at 4ºC for 5 min. The cells were 
washed with cold 1xPBS and pelleted. The cell pellets were stored at -80ºC. 
2.4.1.6 Purification of IPTG induced protein and SDS-PAGE analysis 
The pellets were re-suspended in 50 ml of re-suspension buffer (20 mM HEPES 
buffer (Sigma), 20% glycerol (Sigma), 12.5 M MgCl2, 2 mM EDTA, 5 mM DTT, 0.1% 
Igepal CA-630 (sigma) and 1 complete mini protease inhibitor tablet (Roche)). 
Lysozyme from chicken egg white (sigma) was added at a concentration of 1 mg/ml 
to lyse cells, and incubated on ice for 30 min. Lysed samples were sonicated on ice 
for 3 min, at 40% amplitude, at a pule rate of 6, for four times. The samples were 
centrifuged at 20,400 g for 30 min at 4ºC. The supernatant containing the protein was 
stored on ice. Aliquots of lysed culture after sonication, and supernatant after 
centrifugation, were collected for analysis.  
500 µl Glutathione Sepharose 4B (GE Healthcare) was added to a 10 ml column and 
equilibrated with 10 ml re-suspension buffer. The supernatant containing the induced 
protein was added to the column and allowed to filter through. The column was 
washed with 50 ml wash buffer (Re-suspension buffer containing 0.15 M KCL) to 
elute weakly bound proteins from the resin. To elute bound GST-tagged proteins, 10 
ml of elution buffer (Re-suspension buffer containing 0.15 M KCL and 25 mM L-
Glutathione reduced (Sigma)) was added to the column and 5x 1 ml elution samples 
were collected which should contain GST-tagged proteins. Protein induction and 
purification analysis was carried out using sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE).  
A 1:1 ratio of sample and loading buffer (NOVEX Tris-glycine SDS sample buffer 2x 
(Invitrogen) containing 2-Mercaptoethanol (Sigma)) was made and incubated at 95ºC 
for 5 min. 40 µl of each sample and 5 µl of Precision plus protein (BIO-RAD) protein 
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ladder was added to an 8% SDS gel and ran for 90 min at 125 volts in 1x SDS-PAGE 
running buffer (25 mM Tris (Sigma), 250 mM Glycine (sigma) and 0.1% SDS, pH 
8.3). The SDS gel was then stained with Brilliant Blue R Concentrate (Sigma) for 5 
min and de-stained overnight destain buffer (10% acetic acid glacial (BDH) and 40% 
methanol). The gels were dried in cellophane sheets (Invitrogen) for preservation. 
2.4.2 HeLa cell pTRE3G doxycycline inducible system 
Although GST fusion proteins were induced in bacteria, all protein was insoluble. To 
obtain soluble protein we switched to expression in human HeLa cells. As a first step, 
we modified the pTRE3G vector to include 3xFLAG (GAC TAC AAA GAC CAT GAC 
GGT - GAT TAT AAA GAT CAT GAC ATC - GAT TAC AAG GAT GAC GAT GAC 
AAG) optimised for detection with monoclonal Anti-FLAG antibody (Sigma) as well as 
a BamH1 and EcoR1 restriction site. Gene fragments from the pGEX-2T vectors 
were sub-cloned into pTRE3G-FLAG vector containing 3xFLAG insert (Figure 7).  
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Figure 7. Cloning into a pTRE3G expression vector 
A 3xFLAG insert was cloned into the pTRE3G vector using EcoRV and BamH1 
restriction enzymes. Gene sequences were restriction digested from pGEX-2T vector 
(as previously described) and the gene fragments sub-cloned into pTRE3G-FLAG 
vector using a combination of BamH1 and Ecor1 restriction enzymes. 
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The FLAG tag insert was made by annealing two primer sequences (as shown in 
Table 7). A 50 µl reaction mix was used to anneal the two sequences: 1xNE4 ligation 
buffer, 2 pmol of 5’ primer, 2 pmol of 3’ primer and made up to volume with water. 
This was placed in the following PCR program:  95ºC for 5 min, 95ºC for 0.15 sec, 
37ºC for 1 min and finishing at 10ºC for 0.30 sec.  
 
Table 7. Primers used to create 3xFLAG-tag insert 
 
Orientation Primer sequences (5’ to 3’) 
5’ ATGGACTACAAAGACCATGACGGTGATTATAAAGATCATGACATCGATTACAAGGATGACGATGACAAGAATTCCCGGG 
3’ GATCCCCGGGAATTCTTGTCATCGTCATCCTTGTAATCGATGTCATGATCTTTATAATCACCGTCATGGTCTTTGTAGTCCAT  
 
2.4.2.1 Insertion of 3xFLAG insert into pTRE3G vector 
pTRE3G vector was restriction digested with EcoRV and BamH1 in a 80 µl reaction 
consisting of: 80 µl restrictive digestion reaction was used consisting of: 1 µg of DNA 
(3xFLAG insert or vector), 1xNE4 Buffer (Biolabs), 10 units of EcoRV and 10 units of 
BamH1 (Biolabs). The restriction digest was incubated at 37ºC for 1.5 hours and then 
purified using Phe/Chl/IAA, precipitated with ethanol and the pellet was reconstituted 
in 10 µl water.  
Digested pTRE3G vector and 3xFLAG-tag insert were ligated in a 10 µl ligation 
reaction consisting of: 1:5 molar ratio of vector:3xFLAG insert, 10 units of T4 DNA 
ligase (Biolabs), 1xT4 ligase buffer made up to volume with water. Ligations were left 
over night at 14ºC. The ligated products were transfected into DH5α competent cells 
and was plated on to an LB agarose gel containing ampicillin. Eight ampicillin 
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resistant colonies were picked and cultured separately. The vectors were extracted 
from each culture using a QIAprep Miniprep kit. DNA from each culture was digested 
with Ecor1 because only the vectors containing the FLAG-tag insert will digest. A 20 
µl restriction digestion reaction was carried out and the digestion products were 
analysed on a 1% agarose gel. Vectors that were positive for 3xFLAG insert were 
sequenced. The primers used for sequencing are shown in Table 8. A Midiprep of the 
correct clone was carried out and stored at -20ºC. 
 
Table 8. pTRE3G primers used to sequence pTRE3G-FLAG vector 
 
Orientation Primer sequences (5’ to 3’) 
5’ GAAAGGCTACCACTTCCTACCCTCGTAAAGTC 
3’ CTGAGAGTTGTAAGATGAGGAGGT 
 
2.4.2.2 Insertion of MPO/COX genes into pTRE3G 
The pTRE3G-FLAG vector was digested in three ways A) EcoR1 alone, B) BamH1 
alone, and C) EcoR1 and BamH1. Single restriction enzyme cut vectors, were 
treated with CIP to prevent self-ligation. The MPO/COX cloned genes were digested 
out of the pGEX-2Tvector to be sub-cloned into the pTRE3G-FLAG vector using their 
corresponding restriction enzymes. Restriction digestions were carried out using an 
80 µl reaction as described previously. Digestions were purified using Phe/Chl/IAA 
and reconstituted in 10 µl water. Gene fragments were then ligated into digested 
vectors with corresponding restriction enzyme digests in a 10 µl reaction as 
previously described.  
57 
 
Ligated products were used to transform DH5α competent cells and were plated on 
to LB agarose plates containing ampicillin for selection. Eight colonies were picked 
for each vector construct and cultured separately. The vectors were extracted from 
each culture using a QIAprep Miniprep kit. Miniprep DNA from cultures was digested 
using a 20 µl reaction with the corresponding restriction enzymes for each gene 
fragment. Digestions were analysed on a 1% agarose gel. The vectors containing 
cloned genes were sequenced. Primers used for sequencing are shown in Table 8. 
Vectors containing the correct insertions were amplified by plasmid Midiprep and 
stored at -20ºC. 
2.4.2.3 HeLa cell culturing  
HeLa cells were incubated at 37ºC with 5% CO2 and cultured in Dulbecco’s Modified 
Eagle’s Medium (DMEM). 500 ml of DMEM was modified to contain 10% FBS, 1x 
Penicillin-Streptomycin (Sigma), 1x GlutaMAX (GIBCO) and 1x non-essential amino 
acids (Sigma). 
HeLa cultures were grown for 3 days before being split into a new culture flask. To 
split cells, media was removed and cells washed with 5 ml 1xPBS. Cells were 
detached by incubating for 5 min with 1x Trypsin-EDTA (Sigma). The flask was 
tapped to dislodge cells from the surface. DMEM was added to detached cells to 
neutralise trypsin. 2 ml of detached cells were transferred to 18 ml of fresh DMEM 
media in a T75 flask (Corning).  
2.4.2.4 Lipofectamine transfection of pTRE3G-FLAG expression vectors into 
HeLa cells 
A day before the transfection, 6x 500 µl HeLa cells were plated out into a 24 well 
plate (Corning) so at the time of transfection, they will be 50-80% confluent. 1.5 µg 
pCMV-Tet3G activator vector and 250 ng of pTRE3G-FLAG expression vector for 
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each gene was added to 100 µl serum-free media. 8 µl of Lipofectamine LTX 
(Invitrogen) was added to each transfection mixture and incubated at room 
temperature for 30 min. The DNA-lipid mixture was added drop by drop to the wells 
containing cells and mixed by rocking plate back and forth. Transfected cells were 
incubated at 37ºC with 5% CO2 overnight. The serum free media was removed and 
replaced with serum-containing media with 300 µg/ml Neomycin (Sigma) for 
selection. Cells were bulked and transferred to a T75 flask where they were 
maintained. Transformed cells were selected against by using 300 µg/ml and 
eventually bulked to make stable lines. 
2.4.2.5 Doxycycline induced protein and analysis by Western Blot 
The five HeLa transfected stable lines were freshly split and grown to a confluence of 
80%. A final concentration of 1 µg/µl of Doxycycline was added to induce protein 
production for 24 hours.  Induced cells were harvested using Trypsin. Detached cells 
were pelleted by centrifugation at 4900 g for 10 min at 4ºC. The media was removed 
and the cells were washed with 1xPBS. The pelleted cells were re-suspended in 80 
µl of 1xRIPA buffer (Sigma) containing protease inhibitors and incubated for 30 
minutes on ice to lyse the cells. Lysed cells were centrifuged at 4900 g for 10 min at 
4ºC. The supernatant was transferred to a new tube and kept on ice.   
The protein concentration of the supernatant for each induced protein was measured 
using 1x Bradford Assay (BIO-RAD) and the absorbance measured using a 
spectrophotometer. The line equation was used from a standard curve previously 
made with known protein concentrations, to calculate the concentration of each 
induced protein extract was calculated. 
50 µg of extract from each induced protein line was ran on an 8% SDS-PAGE gel as 
described in section 2.4.1.6, for HeLa (control), COX-1, COX-2, Pxn, Pxt and Irc. An 
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X Cell II Blot Module (Invitrogen) was used to transfer protein from the SDS-PAGE 
gel to a western membrane. The module was prepared by placing two sponges and a 
piece of filter paper soaked in 1x transfer buffer (25 mM Tris, 192 mM Glycine, and 
20% methanol) on top of one another. The SDS-PAGE gel was placed on top and a 
blotting membrane (Whatman), activated in methanol and equilibrated in 1x transfer 
buffer was placed on top. A further filter paper and two sponges soaked in 1x transfer 
buffer was placed on top of this and the other half of the module secured. The 
western transfer was run at 30 volts for 1.5 hours in 1x transfer buffer. 
After transferring, the membrane was blocked overnight in 1xTBST (150 mM NaCl, 
10 mM Tris, pH 8.0, 0.1% Tween 20) containing 5% non-fat dry milk. Antibody 
staining was also performed in the same buffer containing 1:1000 Monoclonal mouse 
Anti-FLAG M2 antibody (Sigma) and was incubated at room temperature for 1.5 
hours. The membrane was washed three times for 10 min with 1xTBST and was 
incubated with the secondary antibody Anti-mouse HRP IgG (H+L) (PROMEGA) 
using a 1:10,000 dilution and incubated for 1 hour at room temperature. The 
membrane was then washed three times with 1xTBST for 10 min. The membrane 
was incubated with SuperSignal West Pico Chemiluminescent Substrate (Thermo 
Scientific) for 5 min. A series of exposures were then processed. 1:10,000 
Monoclonal mouse Anti-GAPDH (PROMEGA) antibody was used as a control.  
After identifying correct protein induction conditions, a large-scale induction was 
done. The five transgenic HeLa lines and HeLa (control) cells were cultured in a 
T150 flask (Corning) and expression induced with 5 µg/µl of Doxycycline over 48 
hours. After 24 hours, media was discarded and fresh media with Doxycycline was 
added. The cells were trypsinised, and pelleted by centrifugation at 4900 g for 10 min 
at 4ºC. Cells were washed with 1xPBS and the cell pellets were then stored at -80ºC. 
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2.4.2.6 Purification of FLAG-tagged induced proteins and elution with FLAG 
peptide 
180 µl (30 µl x6) of Dynabeads Protein G (Life Technologies) was washed five times 
with 1xPBS 0.1% Tween-20 (PBST). Beads were re-suspended with 500 µl PBST 
containing 30 µl (30 µg) Monoclonal Anti-FLAG M2 antibody. The beads were rotated 
overnight at 4ºC, and then washed five times with PBST and reconstituted in 120 µl 
of PBST and stored on ice. 
1ml 1xRIPA buffer was added to the cell pellets for COX-1, COX-2, Pxn, Pxt and Irc 
and HeLa for control and incubated on ice for 30 min. The lysates were sonicated six 
times for 30 sec at 40% amplitude and at a pulse rate of 6. The samples were 
centrifuged at 4900 g for 15 min at 4ºC. 20 µl of the Ab covered beads were added to 
each lysate and incubated for 3 hours at 4ºC. The beads were washed three times 
with 1xRIPA and then with 100 mM Tris-HCL, 100 mM NaCl of pH 8.0 containing 
20% glycerol.  
FLAG-tagged protein was eluted from the beads by adding 20 µl 100 µg/ml 3x FLAG 
Peptide (Sigma) (dissolved in 100 mM Tris-HCL, 100 mM NaCl of pH 8.0 containing 
20% glycerol), and left to incubate on ice. Beads were pelleted and the supernatant 
removed to a fresh tube. Elution was repeated, and the supernatants were pooled to 
give a total volume of 40 µl. Eluted FLAG-tagged protein was stored at -80ºC. 
2.4.2.7 In vitro COX activity assay  
A COX fluorescent activity assay kit (Cayman) was used to determine 
cyclooxygenase activity. The assay indirectly measures cyclooxygenase activity by 
relying on the formation of PGG2, and then measures the peroxidation step of this to 
its alcohol form PGH2. 
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A 1:5 dilution of each FLAG-tagged purified protein was used in the assay, where 
COX-1 and COX-2 FLAG-tagged proteins were used as positive controls in 
comparison with the COX standard internal control. The assay was carried out 
according to the manufacturer’s protocol using a Fluoroskan (Ascent 1.6 
Labsystems) with an excitation wavelength of 550 nm and an emission wavelength of 
615 nm. Ascent research addition 1.2.3.1 program was used to analyse the data.  
We modified the assay to also measure at peroxidase activity. Arachidonic acid was 
substituted in the assay for 10 µl 5 mM hydrogen peroxide, making a final 
concentration of 0.27 mM.  
2.4.3 In vivo characterisation of MPO/COX homologues 
Natural longevity and survival after infection with pathogens were carried out using 
the following knock-out fly strains: Pxtf05258, IrcMB11278 and for Pxn, Pxn targeted RNAi 
(Transformant ID: 15276 VDRC) knock down in blood cells driven by P{UAS-Dcr-
2.D}1, w1118; P{Hml-GAL4.Δ}2, P{UAS-2xEGFP}AH2. w1118 and the driver alone were 
used as controls. 
For each fly strain, five replicates of 50 male flies, in total 250 flies were used per 
assay. Male Drosophila from each strain was aged between 2-5 days after eclosion 
before use in assays. Data from each assay were input into Excel to be analysed. 
Kaplan-meier graphs were produced using the program SPSS. 
2.4.3.1 Natural longevity Assay 
Drosophila were incubated at 25ºC and their survival checked and recorded each 
day. The vial they were contained in was also changed daily. 
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2.4.3.2 Natural infection with Beauveria bassiana 
B.bassiana (CABI) is a pathogenic fungal strain. It was cultured on carrot and potato 
agar media and allowed to grow for 3 days when it reached peak sporulation. Flies 
from each genetic strain were anaesthetised using CO2. For the control group, for 
each rep, flies were placed onto a sterile potato and carrot agar plate and shaken 
gently over the plate for 10 seconds and then placed into a fresh vial. For the infected 
group, flies were treated in the same way, but shaken over the B.Bassiana grown 
potato and carrot agar plate. 
Potato and carrot agar plates are made from one small potato and carrot grated and 
boiled in 1 L of water. It is then strained and made up to 1 L with water. This potato 
and carrot containing solution is substituted in place of water in the normal LB agar 
recipe.  
2.4.3.3 Wounded infection with Enterococcus faecalis 
E.faecalis was a gift from Bruno Lemaitre and is a Gram +ve bacterium. E.faecalis 
was plated out onto an LB agar plate and incubated overnight at 37ºC. A colony was 
picked and cultured in 3 ml of LB overnight at 37ºC on in shaking incubator. The 
culture was diluted to make a working stock of OD10. The Optical density of the 
culture was measured using a spectrophotometer. Flies were anesthetised on a CO2 
pad and wounded between the A5 and A4 dorsal abdominal tergites with a fine 
sterilised platinum needle with either 1xPBS for control or bacteria culture. After 
wounding, flies were placed into a fresh vial and the survival recorded every 24 
hours.  
2.4.3.4 Wounded infection with Pseudomonas entomophila 
P.entomophila was a gift from Huw Williams and it is a Gram –ve bacterium. 
P.entomophila was cultured on LB agar plates containing 10% non-fat dried milk 
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30ºC. A colony with a clear halo was pre-cultured in 3 ml LB at 30ºC in a shaking 
incubator. 1 ml of the pre-culture was added to a final volume of 200 ml LB in a 1 L 
conical flask and incubated over night using the same conditions as the pre-culture. 
The OD of the culture was adjusted to make a working stock of OD0.1. Infection of 
flies was carried out as described with E.faecalis. The survival of infected flies was 
assayed every 6 hours.  
2.4.3.5 RT-PCR analysis of infected Drosophila strains 
RT-PCR analysis was used to determine changes in expression of a panel of known 
immune-induced genes shown in Table 9.  
5 male flies were collected for both control and infected flies for each survival assay. 
For B.bassiana, 5 flies were collected every 24 hours for 0-5 days. For E.faecalis, 5 
flies were collected every 24 hours for 0-4 days. For P.entomophila, 5 flies were 
collected every 6 hours for 0-12 hours. Three repetitions per time point were taken. 
Flies were stored at -80ºC. The RNA isolation, conversion to cDNA, and RT-PCR 
reactions were carried out as described previously. RpL32 was used as the 
endogenous control to normal expression to for all analyses.  
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Table 9. Primers used to analyse Infection assays 
 
Gene Orientation Primer sequences (5’ to 3’) 
RpL32 
5’ CAACAGAGTCGGTCGCCGCTTCAACGGACA 
3’ CAGCTCGCGCACGTTGTGCACCAGGAACTT 
Pxt 
5’ GCAGCTCCTCGATGTGATTGAAAC 
3’ CTAGAGTGCGAGCGAGAGGTAAGA 
Irc 
5’ TGATCTACACGATCTTCATGC 
3’ CTCCTCAATGACCACTCGACG 
Pxn 
5’ CACCCGAACAACTGACCCAAA 
3’ CGATTATATCCTCGCACTTCT 
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3. Results 
 
Inflammatory disease is on the rise due to a combination of lifestyle, environment and 
genetic predisposition. Inflammatory diseases have extensive affects on health and 
economic costs. There is a requirement for new therapeutic targets to be developed 
and in vivo models that can be used to dissect underlying inflammatory mechanisms. 
Mouse models are currently the go-to for in vivo modelling of inflammatory diseases 
such as atherosclerosis and rheumatoid arthritis (Daugherty, 2002; Asquith et al., 
2009). We believe Drosophila could be a useful genetically tractable, cheap 
alternative tool in aiding inflammatory research. 
We have used the hopTum mutant to initiate an inflammatory response, by over-
stimulating the JAK/STAT pathway resulting in the formation of an inflammatory 
melanotic tumour (an aggregation of blood cells) (Harrison et al., 1995). hopTum 
Drosophila have allowed us to dissect downstream lipid mediators that potentiate 
inflammation. We have shown that Drosophila provides an ideal model to 
characterise function and molecular mechanisms of lipid mediators. 
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3.1 Screening for enhancers and suppressors of inflammatory 
tumours 
The use of the hopTum mutant as a model to instigate an inflammatory insult enabled 
us to assay for conditions that can either enhance or reduce the inflammatory tumour 
phenotype. The hopTum mutant causes constitutive signalling of the JAK/STAT 
pathway that results in over-proliferation of blood cells, and lamellocyte 
differentiation. This culminates in the production of inflammatory tumours. We 
speculated that lipid mediators, such as prostaglandins, play a role in the production 
of these tumours, and that the hopTum mutant could be used to elucidate factors that 
influence the production of downstream lipid mediators.  
3.1.1 The effect of dietary supplementation of lipids on tumour incidence 
By supplementing Drosophila media with omega-3 and omega-6, we wanted to see if 
we could enhance or suppress the incidence of the hopTum melanotic tumour 
phenotype. Omega-3 provides a source of α-linolenic acid, and omega-6 provides a 
source of linoleic acid, precursors to lipid mediators. These results would 
demonstrate whether production of downstream lipid mediators could be increased or 
reduced.  
Safflower oil contains 64% of linoleic acid, an unsaturated omega-6 fatty acid that is 
a precursor of arachidonic acid (Figure 2). It was anticipated that supplementation of 
linoleic acid would result in an increase in pro-inflammatory mediators by increasing 
the availability of their precursor. We used four different concentrations of linoleic 
acid and incubated the flies at a lower temperature of 25°C. Because the hopTum 
mutant is temperature-sensitive-conditional, a lower temperature will reduce 
induction of melanotic tumours, allowing for it to be used to assay for enhancers of 
the phenotype. We observed that supplementation of omega-6 significantly 
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enhanced tumour incidence. A concentration of 0.3% resulted in an increase of 
tumour incidence of 13.5% compared to control (Figure 8A). At a concentration of 
0.7% and higher, the incidence plateaued, but was still markedly increased 
compared to the control. At higher concentrations, effects were obstructed by 
lethality.  
In contrast, α-linolenic acid, an unsaturated omega-3 fatty acid that is a precursor of 
EPA (Figure 2) and is known for its anti-inflammatory properties. Supplementation 
with α-linolenic acid is therefore expected to reduce tumour incidence due to the 
production of anti-inflammatory lipid mediators. We used four different concentrations 
and incubated flies at 27°C to be able to detect suppression of tumour incidence. As 
expected, α-linolenic acid supplementation between 0-0.7% reduced overall tumour 
incidence by 43.8% (Figure 8B). We observed that α-linolenic acid supplementation 
was able to counteract the effects of linoleic acid supplementation; by supplementing 
media with a constant concentration of 0.15% of linoleic acid, and adding increasing 
amounts of α-linolenic acid we were able to reduce tumour incidence by 33.4% 
(Figure 8C). 
To determine whether the effects seen with linoleic acid and α-linolenic acid were 
unique to polyunsaturated fatty acids, we assayed both saturated fatty acids and 
cholesterol. These two types of lipid have been connected to inflammatory diseases 
like cardiovascular disease. Coconut oil contains 85% saturated fatty acids and was 
anticipated to enhance the inflammatory tumour phenotype. Saturated fatty acid was 
supplemented at five different concentrations and the flies incubated at 25°C to 
assay for enhancement of inflammation. Saturated fatty acid failed to significantly 
increase tumour incidence across all concentrations compared to the control (Figure 
8D). Cholesterol however, when assayed in the same way reduced tumour incidence 
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by 8% at a concentration of 0.005% but increased again from 0.01-0.05%, 
suggesting its affects may be dose dependent (Figure 8E).  
 
 
Figure 8. Effects of dietary supplementation of lipids on inflammatory tumour 
incidence 
Drosophila yeast-agar media was supplemented with different lipids to assay the 
effects on tumour incidence in hopTum heterozygous females. 0% represents non-
supplemented media (A) Supplementation with the omega-6 fatty acid, linoleic acid 
(%). (B) Supplementation with the omega-3 fatty acid, α-linolenic acid (%). (C) 
Supplementation with a constant concentration 0.15% of linoleic acid with increasing 
α-linolenic acid supplementation. (D) Supplementation with saturated fatty acid. (E) 
Supplementation with cholesterol. A, D and E were incubated at 27°C to assay for 
enhancement in tumour incidence. B and C were incubated at 25°C to assay for 
suppression of tumour incidence. * Indicates those values that are statistically 
significant having a P-value less than 0.001. 
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3.1.2 Effects of fatty acid liberating pathway knockouts on tumour incidence 
Our results have identified that the hopTum phenotype can be influenced by 
supplementation of key precursors of lipid mediators, such as prostaglandins. These 
key precursors are esterified to form triglycerides that are stored in the phospholipid 
membrane, which are then cleaved to produce free fatty acid. We next sought to 
elucidate the pathway components that are involved in the liberation of free fatty acid, 
making them available to be processed into inflammatory lipid mediators.  
We selected key components in the well-established arachidonic acid (free fatty acid) 
synthesis pathway in mammals that includes the PLA2 and the PLC pathway, and 
searched the Drosophila genome for homologues using BLAST (Altschul et al., 
1990). We observed that the Drosophila genome lacks homologues for mammalian 
cytosolic phospholipase A2 (cPLA2). However, secretory PLA2 (sPLA2) was 
detected as were three homologues of phospholipase C, Phosphlipase C at 21C 
(Plc21C), No receptor potental A (NorpA) and Small wing (Sl). As shown in Figure 3, 
PLA2 can directly hydrolyse free fatty acid from the phospholipid membrane. PLC 
hydrolyses PIP2 to liberate diacylglycerol (DAG) and inositol 1, 4, 5-trisphosphate 
(IP3). DAG may then be hydrolysed by DAG lipase into monoacylglycerol and AA 
(Figure 3). Knockout flies in sPLA2, small wing, norpA, and PLC21C, as well as 
Drosophila homologues of the downstream PLC components (described in Table 3) 
were selected and tested for potential effects on inflammatory tumour incidence.  
We tested whether reducing sPLA2 and PLC levels would reduce fatty acid 
production and therefore inflammatory tumour number. We expected the knockouts 
to reduce tumour incidence, so flies were incubated at 27°C to assay for 
suppression. The strongest sPLA2 mutant, Df(2R)BSC263 gave an impressive 
42.1% reduction in tumour incidence compared to the control (Figure 9A). Similarly, 
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the Small wing mutant sl2 also reduced tumour incidence by 38.71% (Figure 9A). 
However, the greatest suppression was seen with mutations in the other two PLC 
homologues, Plc21C, which decreased tumour incidence by 72.8%, and norpA, 
which reduced tumour incidence by 71.8% (Figure 9A).  
Due to the significant suppression of tumours seen with the PLC mutants, we tested 
further deletions of PLC signalling pathway components. We expected PLC pathway 
knockouts to also reduce tumour incidence, as they would prevent the availability of 
free fatty acid. Phosphatidylinositol phosphate kinase (PIPk5) is known to 
phosphorylate phosphatidylinositol 4-phosphate (PI4P) to produce PIP2, which 
regulates its availability in the phospholipid membrane. Using mutations in the 
Drosophila PIPK5 homologue Skittles, a reduction in tumour incidence of 20.9% was 
achieved (Figure 9A). Similarly, mutations in Gαq, a G protein that activates PLC, 
reduced tumours by 36.6% (Figure 9A). Finally, by reducing expression of the 
Drosophila DAG lipase homologue InaE to reduce the hydrolysis of DAG to 
monoacylglycerol (MAG) and AA reduced tumour number by 20.4% (Figure 9A). In 
contrast, mutations in the Drosophila homologue diacylglycerol kinase (DAGK) RdgA, 
increased tumour incidence by 47.8% (Figure 9A). DAGK is the enzyme that 
catalyses the conversion of DAG to phosphatidic acid (PA) and can control the 
availability of DAG. By reducing DAGK levels, we speculate that DAG levels are 
stabilised, resulting in the increased availability of DAG, leading to increased AA 
production. 
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Figure 9. Effects of fatty acid liberating pathway knockouts on tumour 
incidence 
Heterozygote females for mutant/hopTum for each pathway component were assayed 
for effects on tumour incidence (%). Flies were incubated at 27°C to assay for 
suppression of tumours, except for in the case of rdgA where 25°C was used to 
assay for enhancement of tumours. (A) The following knockouts of PLA2 and PLC 
pathway components were used: sPLA2 (Df(2R)BSC263), small wing (PLC; sl2), 
norpA (PLC; norpA45), Plc21C (PLC; Plc21CKG08451), sktl (PIPK5; sktlΔ15), Gαq 
(Ga49B1), inaE (DAG lipase; inaEXl18) and rdgaA (DAGK; rdgA1). (B) The following 
knockouts of signalling components downstream of PLC were used: Itp-r83A (IP3 
receptor; Itp-r83ASV35), Ipk1 (IPK1; P{EPgy2}EY04862), Ipk2 (IPK2; P{GSV6}GS15129), 
inaC (PKC; Df(2R)BSC382), aPKC (PKC; P{lacW}aPKCk06403), Pkc53E (PKC; 
P{EPgy2}Pkc53EEY14093), Pkc98E (PKC; Df(3R)Exel6211). Several mutant strains 
were used for each gene (Table 3), only data from the strongest allele is shown. * 
Indicates those values that are statistically significant having a P-value less than 
0.001. 
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PLC is not only involved in the liberation of free fatty acid, it plays a role in a number 
of other downstream signalling pathways such as calcium signalling through inositol 
1, 4, 5-trisphosphate (IP3). We clarified whether the effects seen with PLC knockout 
was due to failure to liberate free fatty acid or effects on calcium signalling pathways. 
PLC hydrolyses PIP2 to produce DAG and IP3, IP3 can bind to the receptor Inositol 
1,4,5-trisphosphate receptor (Itp-r83A) resulting in intracellular calcium release. 
Reduction in Itp-r83A did not suppress the tumours, but actually induced the number 
by 7% (Figure 9B).  IP3 can also be further phosphorylated by the kinases IPK1 and 
IPK2 to generate a number of inositol phosphate variants, which have been 
implicated in signalling (Berridge and Irvine, 1989). Reduction in levels of IPK1 that 
produce inositol pentakisphosphate (IP5), and IPK2, that produces IP6, reduced 
tumour incidence by 41.4% and 50.7% (Figure 9B). 
Another route, through which the PLC pathway can act, is via activation of protein 
kinase C (PKC) by DAG. To determine if PKC signalling affects tumour incidence we 
used mutants for the Drosophila PKCs. Mutations in Inactivation no afterpotential C 
(inaC) and Protein C kinase 53E (Pkc53E) reduced tumour incidence by 22.1% and 
23.41% respectively (Figure 9B). Whereas, mutations in atypical protein kinase C 
(aPKC) and Protein C kinase 98E (Pkc98E) suppressed tumours by 30.1% and 34% 
(Figure 9B). 
3.1.3 Effects of MPO and COX inhibitors on inflammatory tumour incidence 
Supplementation of fatty acids suggested that a common precursor was being 
utilised to produce pro-inflammatory lipid mediators. We therefore wanted to 
determine if we could reduce the inflammatory phenotype by using inhibitors of both 
cyclooxygenase (COX) and myeloperoxidase (MPO). These are two enzymes known 
to produce pro-inflammatory lipid mediators. Inhibition of these reduces inflammation 
(Liu et al., 2012; Vane, 1971). The effects of non-specific COX inhibitor (Aspirin and 
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Indomethacin), COX-1 specific (SC-560), COX-2 specific (NS-398) and MPO (MPO-
1) inhibitor on the tumour incidence were investigated. Concentrations above 3 mM 
had no greater effect. A net tumour suppression of 42.1% was shown between 0-10 
mM (Figure 10A). The same effect was seen when treated with the non-specific COX 
inhibitor indomethacin (data not shown). Suppression by aspirin and indomethacin 
raised the possibility of COX activity being present. To distinguish whether this COX 
activity corresponds to a COX-1 or COX-2 activity, we used specific isoform COX 
inhibitors. When using a COX-1 specific inhibitor SC-560, tumour incidence was 
reduced by 33.2% (Figure 10B). The COX-2 specific inhibitor NS-398 reduced 
tumour incidence by 35.9% (Figure 10C). Because COX is a member of the larger 
MPO family, we used an MPO inhibitor that inhibits the peroxidase activity of MPO 
(COX also has peroxidase activity). Treatment with MPO Inhibitor-1 also showed a 
marked reduction in tumour incidence between concentrations 0-50 nM of 29.7% 
(Figure 10D). 
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Figure 10. Effect on tumour incidence after treatment with MPO and COX 
inhibitors 
Inhibitors were supplemented at concentrations that span the known IC50 of the drug 
used. Concentration 0 corresponded to vehicle alone (DMSO) and was used to 
compare the effects seen with inhibitors. The effects of tumour incidence were 
assayed in heterozygous hopTum flies. (A) Aspirin, a non-selective COX inhibitor. (B) 
SC-560, a COX-1 specific inhibitor. (C) NS-398, a COX-2 specific inhibitor. (D) MPO 
Inhibitor-1, an inhibitor of MPO peroxidase activity. Dashed lines show the published 
IC50 of the inhibitor for its specific enzyme. * Indicates those values that are 
statistically significant having a P-value less than 0.001 
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For each inhibitor, we calculated the experimental IC50 i.e. the concentration needed 
to reduce tumour incidence by a half. A logarithmic curve was fitted to the data points 
and the IC50 subsequently calculated from the resultant line equation and compared 
to the published IC50 values for each drug (Table 10). The calculated IC50 can 
elucidate function of the enzyme activity present, showing it to be COX-1, COX-2 or 
MPO. All inhibitors established a lower IC50 than the published values.  
 
Table 10. Calculated IC50 in comparison to published IC50 values 
 
 
 
 
 
3.1.4 Effect of Drosophila MPO/COX homologue knockouts on tumour 
incidence 
The reduction in the incidence of inflammatory tumours by both MPO and COX 
inhibitors indicated that COX or MPO activity is present in Drosophila. Inhibition by 
COX and MPO reduced the production of pro-inflammatory lipid mediators resulting 
in suppression of tumours. We sought to identify Drosophila MPO and COX 
homologues that could account for this potential activity by BLAST. The BLAST 
search identified eight potential MPO/COX homologues for COX-1, COX-2 and MPO. 
These are ranked in order of similarity in Table 11. It is important to note that a 
similar BLAST search using Lipoxygenase enzymes failed to detect homologues. 
From the BLAST search, Pxt was identified as being homologous to both COX and 
Inhibitor Published COX-1 IC50 
Published 
COX-2 IC50 
Published 
MPO IC50 
Experimental 
IC50 
Aspirin 0.75 mM 1.25 mM - 0.18 mM 
SC-560 9 nM 6.3 µM - 1.05 nM 
NS-398 75 µM 1.77 µM - 0.08 µM 
MPO Inhibitor-
1 - - 300 nM 19.71 nM 
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MPO. This was anticipated as previous studies had suggested that Pxt was a 
Drosophila COX homologue (Tootle and Spradling, 2008). We assayed knockouts of 
each potential homologue to establish whether they could reduce tumour incidence 
like COX and MPO inhibitors.  
 
Table 11. MPO, COX-1 and COX-2 Drosophila homologues ranked in order of 
similarity 
 
COX1 Cox-2 MPO 
Candidate E value Candidate E value Candidate E value 
CG4009 2.00E-11 CG10211 2.00E-15 Pxn 9.00E-162 
Pxt 1.00E-10 Irc 9.00E-12 CG10211 1.00E-101 
CG10211 2.00E-09 Pxt 9.00E-12 cardinal 7.00E-81 
Pxd 1.00E-07 CG4009 4.00E-11 Pxt 5.00E-77 
Irc 1.00E-07 cardinal 2.00E-09 CG4009 3.00E-72 
Pxn 1.00E-07 Pxd 1.00E-08 CG4009 5.00E-58 
cardinal 1.00E-07 Pxn 2.00E-08 dDuox 1.00E-49 
dDuox 2.00E-05 dDuox 1.00E-06 Irc 3.00E-29 
     
 
Four out of the eight potential MPO/COX homologues significantly reduced tumour 
incidence compared to the control. The dDuox deficiency Df(2L)BSC692 suppressed 
tumour number by 19.5% (Figure 11A). This was on par with the candidate Pxt, 
where the mutant Pxtf05258 reduced tumour incidence by 25% (Figure 11A). The 
effectiveness of the Pxt insertion at reducing expression was clarified using RT-PCR 
that confirmed Pxtf05258 reduces Pxt transcript levels over 1000 fold (Figure 11B). 
Another candidate Irc successfully reduced tumour number. The Irc mutant IrcMB11278 
reduced the incidence of inflammatory tumours by 42.2% (Figure 11A). We also 
clarified the reduction in levels of this insertion using RT-PCR that confirmed 
IrcMB11278 reduces Irc transcript levels by over 10 fold (Figure 11B). The final 
candidate to significantly reduce the inflammatory phenotype was Pxn. The Pxn 
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mutant Df(3L)BSC119 gave the largest reduction of tumour incidence of 53.4% 
(Figure 11A). There is no specific mutation available that removes Pxn alone. To give 
strength to the suppression we observed being a result of Pxn deletion, we used 
another deficiency Df(3L)Exel160901 that overlaps the Pxn deficiency, removing 
several genes the Pxn deficiency does but not Pxn itself. Df(3L)Exel160901 failed to 
significantly reduce tumour incidence suggesting Pxn is the interactor (Figure 11A). 
Mutants of cardinal, CG4009, Pxd and CG10211 also failed to significantly reduce 
tumour incidence. 
Interestingly, using alignment of Pxn, Irc, Pxt and dDuox to human COX-1 using the 
program ClustalW (http://www.ebi.ac.uk/Tools/msa/clustalw2/), we identified 
conserved residues that are fundamental to cyclooxygenase activity. Tyr385 was 
found to be Phe385 in all four proteins. For Pxn, Irc and Pxt, Val349 was found to be 
Leu349 in all three proteins, and finally Arg120 was conserved in Pxt and found to be 
Glu120 in Pxn and Irc. This adds strength to the homologues being potential 
candidates of COX. We carried forward Pxn, Pxt and Irc due to the significant 
reduction in tumour incidence and conserved fundamental residues in COX activity. 
Although dDuox showed a reduction in tumour incidence, it was not as significant as 
the other candidates, and it lacked key conserved residues and its sequence 
similarity ranked low in all homologues.  
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Figure 11. Effect of Drosophila MPO/COX homologue mutations on tumour 
incidence 
Heterozygote mutant/hopTum females for each MPO/COX homologue were assayed 
for their effect on tumour incidence (%). Flies were incubated at 27°C to assay for 
suppression of tumours. (A) Eight potential candidate homologues were assayed. 
Pxd-: PxdLL00313, CG10211-: Df(2L)BSC149, Pxn+ (Used as an overlap deficiency to 
verify Pxn deleted effects in Pxn-): Df(3L)Exel16091, cardinal-: Df(3R)Exel6192, Pxd 
and CG4009-: Df(3R)Exel8165, dDuox-: Df(2L)C144, Pxt-: Pxtf05258, Irc-: IrcMB11278, 
and Pxn-: Df(3L)BSC119. * Indicates those values that are statistically significant 
having a P-value less than 0.001. (B) Real time PCR was used to verify expression 
IrcMB11278 and Pxtf05258 deletion. Transcript expression levels were normalised to 
RpL32. Only the strongest allele is shown for each candidate, details can be found in 
Table 1. 
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3.1.5 Discussion 
In this work we have shown that supplementing with essential fatty acids, linoleic acid 
and α-linolenic acid, could affect the production of inflammatory mediators. We have 
identified a likely biosynthetic pathway by which Drosophila produce free fatty acids 
such as AA. This relies on the Drosophila homologues of sPLA2 and PLC, small 
wing, norpA and Plc21C. We have shown that we can reduce inflammatory incidence 
with the use of COX-1, COX-2 and MPO inhibitors demonstrating that we are able to 
inhibit MPO/COX-like activity that prevents the synthesis of inflammatory lipid 
mediators like prostaglandins. We have identified three putative MPO/COX 
homologues; Pxt, Irc and Pxn. Our data suggest that Drosophila utilise a fatty acid 
precursor to modulate inflammation through either MPO or COX activity.  
3.1.5.1 The effect of dietary lipids in Drosophila inflammation. 
Our data showed that supplementation with omega-6 fatty acid linoleic acid 
significantly increased tumour incidence. This is consistent with data from nutritional 
studies that show increase in dietary omega-6 fatty acid is associated with the onset 
and progression of inflammatory diseases (Hibbeln et al., 2006). This in part is 
because an increase in omega-6 fatty acid results in an increase of pro-inflammatory 
mediators (like AA), providing an ideal inflammatory environment (Mohrhauer and 
Holman, 1963). In contrast, supplementation of omega-3 fatty acid α-linolenic acid 
reduced inflammatory tumours. This agrees well with the known anti-inflammatory 
properties of omega-3 fatty acids in other systems, and suggests that Drosophila 
metabolise α-linolenic acid into the anti-inflammatory mediators EPA and DHA.  
Interestingly, we detected competing actions of omega-3 and omega-6 fatty acid, 
where supplementation with omega-3 fatty acid reversed the pro-inflammatory effect 
of omega-6 fatty acids. It is possible that Drosophila metabolise α-linolenic acid more 
efficiently than linoleic acid, as when safflower oil and flaxseed oil were both 
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supplemented to 0.15% tumour incidence was still reduced, to the level that occurs 
when flaxseed oil alone is supplemented to the media. It is possible that the fly is 
able to beneficially shift to utilising α-linolenic acid, as it would be advantageous to 
Drosophila to produce anti-inflammatory mediators to resolve the inflammation 
induced by the hopTum tumour model, rather than potentiate the effects of this model 
further by utilising linoleic acid in producing pro-inflammatory mediators. 
Our data suggests that only polyunsaturated fatty acids affects inflammation in our 
model. Supplementation with saturated fatty acid failed to have any significant effect 
on the tumour incidence, unlike in other systems where saturated fat is known to 
exacerbate chronic inflammatory diseases (Kennedy et al., 2009). Equally, 
cholesterol which has a strong association with cardiovascular diseases like 
atherosclerosis (Libby et al., 2000), did not greatly enhance tumours. It is possible 
that pro-inflammatory activities of cholesterol are balanced by functions in tissue 
repair that may have aided the repair to the damage caused in our inflammatory 
model. Nevertheless, this data potentially provides evidence that Drosophila 
exclusively utilise polyunsaturated fatty acids to synthesise pro- and anti-
inflammatory lipid modulators. 
3.1.5.2 Biosynthetic pathways that result in liberation of free fatty acid 
We have shown that supplementation of key precursors to inflammatory mediators, 
omega-3 and -6 fatty acids affects inflammatory tumour number in our model. Key to 
this is the availability of the precursors to be utilised by enzymes like COX and MPO 
to produce the pro- and anti-inflammatory mediators. In mammals the principal route 
to fatty acid liberation such as AA, is via cytoplasmic PLA2-mediated hydrolysis of 
PIP2. Our data indicate that Drosophila lack functional cytoplasmic PLA2 but do have 
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secretory sPLA2. Knockout of the Drosophila sPLA2 significantly reduce tumour 
number. 
We have shown that reduction in the levels of Drosophila PLC homologues also 
decrease tumour incidence substantially. PLC represents another biosynthetic route 
for AA (free fatty acid). PLC activation results in the production of diacylglycerol 
(DAG), these can be hydrolysed by DAG lipase into monoacylglycerol and AA. The 
three known Drosophila PLC homologues small wing, Plc21C, and norpA 
significantly reduced tumour incidence. Plc21C and norpA mutants had the strongest 
suppression on inflammatory tumour number, even stronger than that observed with 
sPLA2. To clarify further whether PLC functions as a source of AA synthesis, we 
have knocked out components of this pathway. As shown in Figure 9A, in Drosophila, 
synthesis of PIP2 is regulated by phosphatiylinositol 4-phosphate 5 Kinase ((PIPK5) 
skittles). Gαq activates PLC (either norpA or Plc21C), which hydrolyses PIP2 to 
produce DAG and IP3. In turn, DAG is then hydrolysed by inaE (DAG lipase) into 
monoacylglycerol and AA. rdgA ( DAG kinase) mediates the conversion of DAG to 
phosphatidic acid potentially reducing the production of AA. We have shown that 
skittles, Gαq, and inaE mutants suppress inflammatory tumours, whilst rdgA mutants 
increase inflammatory tumour incidence as expected. 
We further clarified that the tumour reduction seen with these pathway components 
was due to reduced production of free fatty acid and not through other signalling 
pathways mediated through PLC. During hydroysis of DAG by PLC, IP3 is produced 
which when bound to its receptor regulates calcium signalling. Mutants in Itp-r83A 
(Inositol 1, 4, 5-tris-phosphate receptor), the Drosophila receptor for IP3 failed to 
suppress tumour incidence but resulted in an enhancement of the phenotype. It is 
possible that calcium signalling may not pertain pro-inflammatory effects, but aids in 
the prevention and resolution of inflammation.  
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IP3 can further be processed by kinases to produce other inositol signalling 
molecules. IPK1 and IPK2 are involved in phosphorylating IP3 to produce IP5 and 
IP6. Mutants in Drosophila Ipk1 and Ipk2 showed significant reduction in tumour 
incidence, more so with Ipk2, which produces IP6. The actions of IP5 and IP6 are not 
well characterised, but they have been shown to play an active role in regulating 
gene transcription and chromatin remodelling (Steger et al., 2003; Shen et al., 2003). 
Another signal transduction pathway of PLC is through activation of PKCs via DAG or 
calcium. We assayed four Drosophila PKC homologue mutants, inaC, aPKC, Pkc53E 
and Pkc98E that all sufficiently reduced tumour number, but were not as effective as 
mutants in IPKs. PKCs have an array of functions, so it is not surprising that they are 
able to reduce tumour incidence. It is important to add that although assaying for 
pathways involved in liberating free fatty acid, it is possible that particular knockouts 
can be exerting their effects on JAK/STAT signalling the model relies on. For 
example, the tumour incidence seen with IPK mutants could be the result of inhibition 
of STAT binding to its target and therefore lessens the phenotype. The stronger 
suppression seen with PLC mutants compared to sPLA2 could therefore be due to a 
combination of preventing free fatty acid liberation as well as inhibition of 
downstream signalling pathways that branch from PLC activation. 
Overall, our data suggest that both sPLA2 and the PLC homologues play a vital role 
in the availability of free fatty acid such as AA. Though the functional existence of this 
pathway resulting in production of free fatty acid is still highly speculated (Stark et al., 
1993). Our data suggests otherwise. 
3.1.5.3 Suppression of tumour incidence using MPO and COX inhibitors 
Using a non-selective COX inhibitor aspirin, as well as a COX-1 specific inhibitor SC-
560, a COX-2 specific inhibitor NS-398 and an MPO specific inhibitor MPO inhibitor-
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1, we have established that MPO/COX activity is present in Drosophila. All inhibitors 
suppressed inflammatory tumours significantly.  
Interestingly, for aspirin and SC-560 the experimentally determined IC50s for tumour 
suppression were closer to the IC50 for COX-1 (Table 10). In contrast, for NS-398 the 
experimentally determined IC50 for tumour suppression was closer to the IC50 for 
COX-2. These data suggest that Drosophila COX enzymes are intermediate between 
the COX-1 and COX-2 which share similar residues involved in the inhibitor action. In 
terms of MPO, the experimental IC50 also was lower than the published suggesting 
that peroxidase activity is present. What is striking is that all experimental IC50s are 
lower than the published values. This could be due to species differences in the IC50 
of each drug or that published IC50 values were calculated using isolated protein in 
vitro, whereas our results are generated using drugs that are supplemented to media, 
are ingested by larvae and potentially could be concentrated in these animals. 
Strengthening the argument that COX activity is present and can be inhibited is the 
presence of the Val349 residue, which is conserved in the candidate MPO/COX 
homologues identified. Val349 is known to be acetylated by aspirin and is involved in 
the inhibition of COX (Schneider et al., 2002) 
3.1.5.4 Identification of candidate MPO/COX homologues 
Using our tumour suppressor screen we have been able to exclude Pxd, CG10211, 
cardinal and CG4009 as having either MPO or COX function on the basis that they 
did not affect tumour incidence in Drosophila. This was a surprise for CG10211 as it 
was ranked most similar for both COX isoforms and MPO compared to the other 
candidates (Table 11). However, our data indicate that dDuox, Pxt, Irc and Pxn have 
MPO/COX activity. We can potentially assign MPO/COX function to Pxt and Irc due 
to the availability of gene specific insertions, which has been clarified using RT-PCR. 
The lack of specific mutations affecting only dDuox and Pxn preclude unambiguous 
84 
 
assignment of MPO/COX function to them. Though we have attained some clarity by 
using another deficiency that removes over half the genes affected in Df(3L)BSC119, 
but without affecting Pxn, and was observed to have no effect on tumour incidence. 
Currently no specific mutations exist for Pxn. However, the presence of key 
conserved residues involved in COX activity like Tyr385 are present in all four 
candidates strengthening their positions as candidates for possessing COX activity. 
Though dDuox lacks other residues important for cyclooxygenase activity. We 
discarded dDuox as a potential candidate because although dDuox deletions 
reduced tumour incidence, it was not as significant as the other candidates. Its 
sequence similarity to mammalian COX and MPO was also ranked low. dDuox has 
been shown to be involved in embryo wound healing that is reliant on calcium and 
hydrogen peroxide signalling (Razzell et al., 2013). The reduction in tumour 
incidence we observed could be due to calcium signalling dysfunction, though it is 
possible that dDuox is capable of lipid mediator production. 
Given the extensive evidence suggesting an inflammatory lipid mediator pathway is 
present in flies using an indirect assay, it is paramount to biochemically identify 
whether such molecule are endogenously present in Drosophila. By using LC-MS we 
can identify the presence of AA and prostaglandins, and determine the actual lipid 
mediators Drosophila utilise in inflammatory processes. 
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3.2 Lipidomic analysis to identify lipid mediators and 
characterisation of those mediators identified 
 
The in vivo tumour assay highlighted the involvement of pro and anti-inflammatory 
lipid mediators in regulating inflammation. The assay provided an indirect 
assessment of the existence and function of these mediators. However, it was 
paramount to identify these mediators using a refined specific detection method. 
Liquid chromatography–Mass spectrometry (LC-MS) provides a sensitive and 
accurate method to identify endogenous lipid mediators (Massey and Nicolaou, 
2013). We therefore used LC-MS to characterise the lipid mediators involved in 
inflammation in Drosophila.  
3.2.1 Identifying lipid mediators and their precursors in Drosophila using LC-
MS  
We conducted a whole fatty acid analysis using LC-MS to identify the presence of the 
key precursors of inflammatory mediators that include AA, EPA and DHA. By 
analysing hopTum larvae grown on media supplemented with 0.15% linoleic acid it 
was expected to drive production of pro-inflammatory mediators and therefore aid in 
the detection. Larvae were analysed in batches of 100 mg and 200 mg to confidently 
detect fatty acids that are of lower abundance. LC-MS whole fatty acid analysis 
revealed that both linoleic acid (C18:2n-6c highlighted in red) and α-linolenic acid 
(C18:3n-3; highlighted in green) were present, albeit linoleic acid is more abundant 
being 7% of total fatty acid (Table 12). AA (C20:4n-6 highlighted in yellow) failed to 
be detected (Table 12). EPA (C20:5n-3 highlighted in purple) and DHA (C22:6n-3 
highlighted in blue) also were not detected (Table 12). We observed that the bulk of 
fatty acids present in Drosophila exhibit a carbon chain length of C18 and below. 
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Table 12. LC-MS whole fatty acid analysis showing % of total fatty acid 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample Weight (mg) 100 200 
Fatty Acid % Total FA % Total FA 
C4:0 0 0 
C6:0 0 0 
C8:0 0 0 
C10:0 0.01 0.02 
C11:0 0.01 0.01 
C12:0 2.44 2.57 
C13:0 0 0 
C14:0 22.49 20.99 
C14:1 1.50 1.73 
C15:0 0.13 0.02 
C15:1 0 0 
C16:0 23.48 22.68 
C16:1 19.86 23.59 
C17:0 0.12 0 
C17:1 0.19 0.13 
C18:0 2.50 1.85 
C18:1n-9t 0 0 
C18:1n-9c 19.40 19.16 
C18:1n-7 0 0 
C18:2n-6t 0 0 
C18:2n-6c 7.23 6.77 
C18:3n-6 0 0 
C18:3n-3 0.19 0.21 
C20:0 0.32 0.19 
C20:1n-9 0.01 0.03 
C20:2 0 0 
C20:3n-6 0 0 
C20:4n-6 0.01 0.01 
C20:3n-3 0 0 
C22:0 0.08 0.03 
C22:1n-9 0.02 0.01 
C20:5n-3 0 0 
C23:0 0 0 
C22:2 0 0 
C24:0 0.01 0 
C24:1 0 0 
C22:5n-3 0 0 
C22:6n-3 0 0 
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The failure to detect significant levels of AA suggested that prostaglandins would be 
absent. To confirm this, we used LC-MS to detect PGE2, PGF2α and PGD2 from 200 
mg larvae samples. Known PG standards were ionised during MS resulting in a 
fragment ion distribution. Three fragment ions specific to each PG were chosen, and 
multiple reaction monitoring mode was used to identify each specific fragment ion in 
the sample. 
Using PGE2 specific mass/charge fragment ions 271, 315 and 333 at a retention time 
of 4.85 min, failed to detect PGE2 in both larvae raised on media supplemented with 
linoleic acid (omega-6 fatty acid) and α-linolenic acid (omega-3 fatty acid) (Figure 
12). This was also true for standard media, which was used as a control to establish 
if PGs were present in the Drosophila diet. PGD2 was not directly assayed, but due to 
its similar ion fragmentation pattern to PGE2, where both PGs share a fragment ion 
that has a retention time of 5.75 min, we could assay PGD2 and failed to detect PGD2 
in the extracts.  For PGF2α, the fragment ions 193, 247 and 309 at a retention time of 
3.96 min were used. PGF2α is very unstable and is quickly converted to 8-iso-PGF2α 
having a retention time of 3.44 min. Both PGF2α forms were also not detected in 
larvae grown on supplemented media or in control media (Figure 13).  
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Figure 12. LC-MS detection of PGE2 
A PGE2 standard of relative atomic mass 351 elicits a fragment ion spectrum (Top 
left) that shows the three specific fragment ions that had an m/z ratio of 271, 315 and 
333. LC-MS using MRM was used to detect PGE2 fragments at a retention time of 
4.85 min as shown in the standard chromatogram for each fragment ion. Standard 
Drosophila media was used as a control to determine PG presence in the food. 
hopTum larvae raised on media supplemented with either 0.15% omega-3 fatty acid or 
omega-6 fatty acid were assayed for the presence of PGE2. PGE2 and PGD2 share a 
similar fragment ion at a retention time of 5.75 min.  
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Figure 13. LC-MS detection of PGF2α 
A PGF2α standard of relative atomic mass 353 elicits a fragment ion spectrum (Top 
left) that shows the three specific fragment ions that had an m/z ratio of 193, 247 and 
309. LC-MS using MRM was used to detect PGF2α fragments at a retention time of 
3.96 min as shown in the standard chromatogram for each fragment ion. PGF2α is 
unstable and is quickly converted to 8-iso-PGF2α that has a retention time of 3.44 min. 
Standard Drosophila media was used as a control to determine PG presence in the 
food. hopTum larvae raised on media supplemented with either 0.15% omega-3 fatty 
acid or omega-6 fatty acid were assayed for the presence of PGF2α. PGE2 and PGD2 
share a similar fragment ion at a retention time of 5.75 min.  
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As both C20 fatty acids and C20 derived inflammatory mediators were absent, we 
examined whether lipid mediators that can be synthesised from C18 fatty acids were 
present. From the literature we identified hydroxyl-octadecadienoic acids HODEs as 
being direct products of linoleic acid and having immuno-modulator effects 
(Vangaveti et al., 2010). The LC-MS data from the PG detection was re-analysed 
using a reconstructed-ion chromatogram, whereby a known mass-charge-ratio value 
was used in a single monitoring reaction (SMR) mode to identify the molecules. We 
analysed for the presence of both 9- and 13-HODE. We were able to detect 9-HODE 
using a fragment ion of m/z 171 and a retention time of 15.18 min (Figure 14A). 
Similarly for 13-HODE, using a fragment ion of m/s 195 and a retention time of 14.98 
min revealed, it too was present (Figure 14B).  
In using the HODE spectra, we calculated the abundance of 9- and 13-HODE in w1118 
(control) and hopTum strains raised on standard media, and media supplemented with 
0.15% omega-3 fatty acid or 0.15% omega-6 fatty acid. We observed the w1118 strain 
to have a higher abundance of both 9- and 13-HODE compared to the hopTum strain.  
It is apparent that supplementation with omega-3 and -6 fatty acid affects the 
abundance of HODEs in each strain. In w1118 larvae, supplementation with omega-3 
fatty acid reduced the level of 9-HODE by 17.6%, but increased 13-HODE by 21.2% 
compared to the control (Figure 14C). Whereas supplementation with omega-6 fatty 
acid resulted in an increase of 47% for 9-HODE and a 57.8% increase in 13-HODE. 
In terms of the hopTum strain, omega-6 fatty acid supplemented larvae showed an 
increase of 22.4% for 9-HODE and an increase of 42.6% for 13-HODE (Figure 14D). 
While omega-3 fatty acid supplementation showed an increase of 12.5% for 13-
HODE, only an increase of 3.4% was seen for 9-HODE.  
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Figure 14. LC-MS identification of 9- and 13-HODE 
LC-MS using single monitoring reaction detected 9- and 13-HODE in wild type w1118 
larvae, and hopTum larvae. (A) 9-HODE was identified using a fragment ion of a 
relative atomic mass 171 at a retention time of 15.18. (B) 13-HODE was identified 
using a fragment ion of a relative atomic mass 195 min at a retention time of 14.98 
min. The relative amount of both 9- and 13-HODE was calculated for w1118 (C) and 
hopTum (D) by measuring the area under the chromatogram peaks. n=3 
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We next tested whether HODEs were produced enzymatically. For HODEs, two 
enantiomers exist; an R and an S form. Typically S enantiomers of compounds are 
produced enzymatically while the R enantiomers are usually formed by non-
enzymatic activity. LC-MS chiral analysis was conducted using w1118 and hopTum 
larvae extracts. We observed that w1118 and hopTum larvae have similar levels of R 
and S form of HODES in control and omega-3 supplemented (Figure 15). The 9-S-
HODE enantiomer was the predominant form in all media treatments. Lower levels of 
9-R-HODE, 13-R-HODE, and 13-S-HODE were detected.  
Interestingly, for w1118 larvae raised on omega-6 fatty acid supplemented media, 
there is a dramatic increase in the production of S and R forms of 9- and 13-HODE 
(Figure 15A). The same is seen in hopTum larvae, but the levels seen in w1118 surpass 
the levels observed in hopTum larvae (Figure 15B). In terms of the R-enantiomer, it too 
increases with omega-6 supplementation for both 9- and 13-HODE.  
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Figure 15.  LC-MS chiral analysis of 9- and 13-HODE 
9- and 13-HODE chiral enantiomers were separated using a LUX cellulose-1 3 µM, 
150 x 2.0 mm column. (A) w1118, and (B) hopTum larvae were assayed for the 
presence of both the R and S form for each HODE. Chiral abundance is shown as 
HODE (pg)/Sample (mg). Larvae raised on standard media (control), omega-3 
supplemented and omega-6 supplemented media were assayed. n=2 
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3.2.2 Characterisation of 9- and 13-HODE function 
9- and 13-HODE have been implicated to have an immuno-modulatory role in 
mammalian systems. We sought to clarify whether the compounds have similar 
effects in Drosophila. We used a mixture of in vivo and in vitro assays to determine 
the role 9- and 13- HODE play in Drosophila. HODEs have well documented 
functions in atherosclerosis, being detected in plaques and implicated in the 
progression of the disease. HODEs have been indicated to play a role in the 
differentiation of macrophages into lipid laden foam cells. The hopTum strain has an 
abundance of large differentiated lamellocytes that show superficial similarities to 
foam cells, though it was unclear if they accumulated lipid. 
To determine lipid content, haemocytes from control and hopTum larvae were stained 
with Oil Red O, which is a lysochrome diazo dye that specifically stains lipid that can 
be used to specifically shown lipid deposits (Koopman et al., 2001). 
We observed Oil Red O staining of hopTum haemocytes was heavily stained by Oil 
Red O, showing that they are lipid laden (Figure 16). It was noticeable that 
haemocytes in the hopTum strain are larger than control haemocytes being 40 µm 
larger than w1118 haemocytes. Larger haemocytes of the hopTum larvae contained 
more lipid than smaller haemocytes. Interestingly, Oil Red O staining of the hopTum 
melanotic tumours reveals that they contain extensive lipid deposits and are 
aggregates of lamellocytes and/or contain fat body. Conversely, Oil Red O staining of 
the fat body revealed hopTum larvae to have drastically diminished lipid storage 
compared to w1118 that showed strong staining (Figure 16). The fat body is the 
equivalent of vertebrate adipose tissue and is important for a number of functions 
such as AMP production and insulin signalling.  
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Figure 16. Oil Red O staining of w1118 and hopTum haemocytes and fat body 
Oil Red O, a lysochrome diazo dye that specifically stains lipid was used to stain 
haemocytes and fat body tissue from w1118 and hopTum larvae. hopTum tumours were 
also stained. The scale bar for haemocytes is 50 µm, and 100 µm for fat body and 
melanotic tumours. 
 
 
 
9- and 13-HODE have been shown to be ligands of the PPARγ nuclear receptor that 
is involved in adipogenesis and activation of macrophages (Itoh et al., 2008; 
Vangaveti et al., 2010). We sought to identify a PPARγ homologue in Drosophila 
using BLAST. Ecdysone-induced protein 75B (Eip75B) was shown to be the closest 
homologue of PPARγ. Eip75B is a nuclear receptor that has largely been 
characterised for its involvement in the molt stages of Drosophila (Thummel, 2001). 
We used strains in which Eip75b is deleted and assayed the effects of these on the 
hopTum inflammatory model. Knockout of Eip75b reduced tumour incidence by 39.7% 
(Figure 17A). To validate whether 9- and/or 13-HODE could bind to Eip75B and 
modify transcriptional activity, we used a Drosophila strain in which the Eip75B 
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ligand-binding domain (LBD) was fused with GAL4. The strain background also 
contains UAS-GFP that would act as a reporter for GAL4. The GAL4-UAS system is 
widely used: UAS is an enhancer that contains binding sites for the GAL4 
transcription factor. In this strain, although GAL4 can bind to UAS-GFP, transcription 
will not occur unless the Eip75B-LBD that is fused to GAL4 is activated by a ligand. 
Haemocytes heat-shocked to induce expression of Eip75B-LBD GAL4 were treated 
with 9- and 13-HODE and visualized for GFP-reporter expression. We observed no 
response to treatment with 9- or 13-HODE (Figure 17B). Interestingly, 
Diethylenetriamine NONOate (DETA), a NO donor also did not show any response 
compared to the control. DETA is a positive control as it has been shown NO binds to 
Eip75b allowing it to interact with its heterodimer partner DHR3 resulting in 
transcription (Reinking et al., 2005). 
 
 
Figure 17. Eip75B tumour assay and Eip75B-LBD reporter assay 
(A) The effect of Eip75B knockout mutants on inflammatory tumour incidence. An 
Eip75B-LBD-GAL4 fusion UAS-GFP reporter line was used to determine if 9- and 13-
HODE were ligands of Eip75B. (B) Haemocytes were cultured in control media, 
media containing Diethylenetriamine NONOate (DETA), a NO donor that is a positive 
control for Eip75B activation, and 9- and 13-HODE. Nuclei were stained with DAPI 
and the reporter activity visualised using GFP.  
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To ascertain directly the affects of 9- and 13-HODE, we used Drosophila Schneider 2 
cells (S2 cells) that are an embryo derived macrophage-like cell line, to assay the 
transcriptional effects of 9-HODE, 13-HODE, as well as omega-3 fatty acid, omega-6 
fatty acid and a mixture of omega-3 and -6 fatty acid. An equal mix of omega-3 and -
6 fatty acid was used to determine if the effects seen with omega-6 fatty acid could 
be suppressed in the presence of omega-3 fatty acid. The S2 cells were cultured for 
48 hours in each condition and the RNA subsequently extracted to analyse transcript 
levels of known markers pertaining to a particular haemocyte cell lineage. Due to 
HODEs playing a role in macrophage differentiation, we expected to see upregulation 
of differentiation markers.  
We traditionally used levels of RpL32 as an endogenous control to normalise levels 
of expression of the transcripts. It was noted that although equimolar amounts of 
mRNA was used for input, RpL32 levels varied dramatically after treatment, 
especially with fatty acids. We therefore analysed expression of two further 
housekeeping genes (Figure 18B). When transcript levels were normalised to α-
Tubulin we observed in omega-6 fatty acid treated cells, a 25-fold upregulation of 
RpL32, a gene involved in translation, and a 9-fold upregulation of Gapdh2, a gene 
involved in glycolysis (Figure 18A). Omega-3 fatty acid treatment resulted in an 
upregulation between 1 and 4-fold for RpL32 and Gapdh2. Treatment with 9- and 13-
HODE had little affect on their transcript expression. RpL32 and Gapdh2 expression 
may be upregulated due to an increase in metabolic activity as the cells actively 
uptake the supplemented fatty acids which in turn requires energy, especially if 
protein synthesis is increased. 
In terms of the differentiation markers, HODEs and omega fatty acid treatments had 
very little effect on the lamellocyte markers myospheroid (mys), Integrin Bv subunit 
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(Itgβv), cheerio (cher) and Integrin αPS4 subunit (ItgαPS4) (Figure 18A). However, 
both 9- and 13-HODE, including omega-6 fatty acid treated cells markedly increased 
expression of the lamellocyte marker ItgαPS5 by 9-fold for both HODEs and up to 
25-fold for omega-6 fatty acid. Omega 3 fatty acid treatment showed little change in 
comparison. 9-HODE treatment compared to 13-HODE treatment was observed to 
upregulate both lz, a crystal cell marker and Hml, a plasmatocyte marker (Figure 
18A). Whereas both were able to result in an upregulation of He as did the omega 
treatments. It was noticeable that omega-3 fatty acid treatment had little affect on 
differentiation markers compared to the other treatments. It was also shown that 
omega-3 fatty acid was unable to counteract the effects of omega-6 fatty acid in all 
genes assayed.  
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Figure 18. RT-PCR analysis of haemocyte differentiation makers in S2 cells 
treated with 9-HODE, 13-HODE, omega-3 and omega-6 fatty acid 
S2 cells were cultured in standard media (control), 9-HODE, 13-HODE, omega-3 
fatty acid, omega-6 fatty acid and an equal mix of omega-3 and -6 fatty acid for 48 
hours to determine differences in transcript expression of known differentiation 
markers. (B) House keeping genes α-Tubulin, RpL32 and Gapdh2 were analysed as 
endogenous controls. (A) α-Tubulin expression in control cells was used to normalise 
transcript expression of the differentiation markers of crystal cells, plasmatocytes and 
lamellocytes. Details of the genes analysed are detailed in Table 4.  
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The RT-PCR analysis identified several targets of both HODEs and Omega fatty 
acids. It was fundamental to directly assay if these changes in mRNA transcripts 
were accompanied by expression in protein levels. Hemese (He), a transmembrane 
protein that is a marker of haemocyte lineage was markedly upregulated by all 
treatments and provided an ideal target. In using anti-He antibodies to stain for He, 
we expected to see stronger staining with S2 cells treated with omega fatty acids 
compared to the control, as RT-PCR analysis showed a marked upregulation of He. 
Oil Red O staining of these cells clarified if the cells were ingesting the supplemented 
fatty acids. 
The data showed that with both omega-3 and omega-6 fatty acid treatment, S2 cells 
actively ingest the lipid and were shown to stain strongly with Oil Red O compared to 
the control, with lipid droplets clearly visible in the cell’s cytoplasm (Figure 19A). All 
three of the omega fatty acid treatments also showed a clear enhanced staining for 
He compared to the control showing that upregulation of gene transcript of He results 
in increased protein expression of He (Figure 19B). 
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Figure 19. Oil Red O and Anti-He staining of omega fatty acid treated S2 cells 
S2 cells were cultured in the presence of Omega-3 fatty acid, omega-6 fatty acid and 
an equal mix of omega-3 and -6 fatty acids for 48 hours and stained with (A) Oil Red 
O (red in merge) to visualise lipid uptake and (B) Anti-He (green in merge) to 
visualise expression of He. Dapi (purple in merge) was used to visualise nuclei. 
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3.2.3 Discussion 
Consistent with other studies, we too have concluded that Drosophila do not 
synthesise AA. We purposely assayed larvae raised on 0.15% linoleic acid to ensure 
precursor availability was not a limitation and would therefore drive production of AA. 
It was observed that Drosophila can incorporate linoleic acid but are then unable to 
elongate beyond a C18 backbone. Moreover, flies lack EPA and DHA, two 
precursors formed from α-linolenic acid, adding strength to the theory that Drosophila 
cannot elongate beyond C18. α-linolenic acid was detected, albeit in lower quantities 
than seen with linoleic acid, this could be due to the supplemented diet containing 
little α-linolenic acid and therefore driving the incorporation of the more abundant 
linoleic acid. What is noticeable, are the trace amounts of fatty acids having a carbon 
backbone greater than C18 that were just under the limit of detection, including AA. It 
is possible that these are contaminants from the media. Another possibility is that 
Drosophila have been shown to convert supplemented C22 fatty acids into C20 fatty 
acids such as AA (Shen et al., 2010). Though they cannot synthesise AA, given the 
absence of Δ5 and Δ6 desaturases, they have the ability to convert longer chain fatty 
acids to C20 fatty acids. 
The absence of AA was reflected by the absence of PGs. As with AA, there has been 
much speculation surrounding the existence of PGs in Drosophila. Several studies in 
Drosophila have suggested physiological effects that they have linked to PGs (Tootle 
and Spradling 2008; Groen et al., 2012), but all of the studies have involved indirect 
methods. We have directly assayed for PGs using LC-MS to conclusively reveal their 
absence in Drosophila. LC-MS provided a specific and accurate method to determine 
the presence of endogenous PGs. We assayed larvae raised on media 
supplemented with omega-3 fatty acid, and omega-6 fatty acid as well as standard 
media to ensure PGs were not present in the Drosophila diet. PGE2 and PGF2α, both 
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failed to be detected in media alone, and larvae raised on either omega-3 or -6 fatty 
acid supplemented media. The absence of AA and PGs in Drosophila raised the 
question of why have so many groups drawn functions to PGs when they are not 
present? This was indicative that inflammatory lipid mediators are present, just not of 
a C20 origin. The whole lipid analysis suggested that Drosophila can synthesise C18 
inflammatory mediators directly from the C18 precursors linoleic acid and α-linolenic 
acid. From the literature we identified HODEs as being a possible target because 
they are directly made from linoleic acid (Vangaveti et al., 2010). It is likely that other 
C18 lipid mediator variants are present in Drosophila, our reasoning for choosing 
HODEs to investigate was because they are partially characterised and already well 
documented in an inflammatory disease, atherosclerosis.  
In our study, LC-MS analysis of w1118 and hopTum revealed the presence of both 9- 
and 13-HODE. Interestingly, we observed that supplementation with omega-3 failed 
to increase the abundance of either HODE above the control level. However, 
supplementation with omega-6 fatty acid (linoleic acid) markedly increased their 
abundance in both w1118 and hopTum larvae. This was suggestive that they may play a 
role in inflammation due to the increase in tumour incidence when hopTum were 
raised on an omega-6 diet (Figure 8A). What was surprising was the distinct 
difference in the level of HODEs in the control w1118 compared to the inflamed model 
hopTum. Both fly strains had similar levels of 9- and 13-HODE in control and omega-3 
supplemented, but there was a marked increase in the levels when supplemented 
with omega-6 in the w1118 strain, more so than the increase seen in the hopTum strain. 
We expected to see a larger abundance of 9- and 13-HODE in the inflamed hopTum 
flies, but in fact it is the opposite. An explanation for this could be that the w1118 flies 
become overburdened with linoleic acid, and synthesise HODEs to subsequently 
‘stock pile’ them in the phospholipid membrane in an esterified form. The levels of 
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abundance we have measured do not discriminate between esterified HODEs or free 
HODEs. It is the free HODEs that would be active, similar to AA; there is very little 
free AA, which regulates the production of pro-inflammatory mediators. In terms of 
the hopTum strain, due to the inflamed nature of the fly, it would be disadvantageous 
to synthesise even more HODEs that would exacerbate the inflammatory phenotype. 
It is likely that there are inhibitory pathways that are switched on to reduce their 
production. Conversely, it is possible that there is a rapid turnover of linoleic acid to 
synthesise HODEs, resulting in an increase of free HODES, that are rapidly 
oxygenated further to produce 9- and 13-oxooctadecadienoic acids (9- and 13-
oxoODEs) (Massey and Nicolaou, 2013). By measuring the levels of oxoODES in 
w1118 and hopTum flies, it would clarify if there were a higher turnover of HODEs in 
hopTum.  
Work in chapter two identified enzymes that potentially produce pro-inflammatory 
mediators. We observed that the S-enantiomer for both 9- and 13-HODE was 
present in w1118 and hopTum flies at significantly higher levels than the R-enantiomer. 
This was indicative of enzymatic production because enzymes have a preference for 
substrates in the S form. For example, COX only abstracts the hydrogen of an S 
enantiomer of AA (Schneider et al., 2002). When supplemented with omega-6 fatty 
acid, the abundance of the S form increased suggesting that dietary intake of omega-
6 fatty acid can influence the levels of HODEs. 
Both the presence and enzymatic production of HODEs posed the question of what 
their function was in Drosophila. As described in section 1.2.4, HODEs have been 
predominantly documented in atherosclerosis, an inflammatory disease (Waddington 
et al., 2003; Vangaveti et al., 2010). In particular their involvement in the 
differentiation of macrophages to lipid-laden foam cells. We too expected to pertain 
inflammatory effects to HODEs. This in part was due to a similar phenotype seen in 
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the hopTum mutants that was comparable to that seen in atherosclerosis. The 
increase in cell size and the noticeable strong lipid staining of hopTum haemocytes 
was similar to the lipid-laden foam cells seen in atherosclerosis. The increased cell 
size difference seen in the hopTum strain was not surprising as they have a significant 
increase in differentiation of lamellocytes that are around 50 micrometres in size. 
What was surprising, and has never been shown before, is that the lamellocytes are 
lipid laden posing the possibility that the intake of lipid results in the eventual 
differentiation of a plasmatocyte into a lamellocyte. Fuelling this theory further was 
the diminishment of lipid content seen in the hopTum larvae fat body compared to that 
seen in w1118. It is likely that in this mutant, lipid is liberated from the fat body  
(analogous of mammalian adipose tissue) and taken up by haemocytes where it can 
be processed into lipid mediators such as HODEs and cause the eventual 
differentiation into lamellocytes. The lipid-laden cells aggregate, forming layers that 
result in a melanised capsule that we show to be largely lipid based similar to an 
atherosclerotic plaque.  
HODEs have been shown to be ligands for PPARγ, a nuclear receptor involved in 
adipogenesis and activation of macrophages (Itoh et al., 2008). We identified Eip75B 
as being a homologue of PPARγ. We have shown that deletion of the Drosophila 
homologue Eip75B reduces tumour incidence significantly. The Eip75B-LBD reporter 
assay that was used to conclude HODE actions were elicited though Eip75B failed to 
be conclusive. In the presence of HODEs we expected them to bind to the Eip75B-
LBD-GAL4 fusion, and activate the transcription of GFP at the UAS docking site. 
Surprisingly, GFP reporter activity wasn’t achieved in cells cultured with DETA, a 
nitric oxide (NO) donor. DETA treated cells should have shown reporter activity 
because NO is known to bind to Eip75B and regulate transcription (Marvin et al., 
2009). The data is therefore inconclusive and suggests the Eip75B-LBD-GAL4, UAS-
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GFP reporter line to be non-functional. For future reference, the possible relationship 
between Eip75B and HODEs could be clarified using a combination of chromatin 
immune precipitation sequencing (ChIP-seq) and RNA sequencing comparing control 
and HODE cultured cells.  
Although we have not unequivocally determined if HODEs bind to Eip75B, we have 
identified transcriptional targets that pertain to a role in differentiation of haemocytes. 
In culturing S2 cells with known precursors of immuno-modulatory lipids, omega-3 (α-
linolenic acid and omega-6 (linoleic acid) as well as 9- and 13 HODE, we were able 
to identify potential transcriptional changes.  9-HODE may play a role in upregulating 
lz. Expression of the transcription factor lz is specific to crystal cell fate. It has also 
been shown to regulate the binding of Notch, to Notch enhancers, resulting in 
selected gene activation that locks the cell into a particular differentiation fate 
(Terriente-Felix et al., 2013). It is possible that 9-HODE specifically functions to direct 
a cell differentiation fate through Lz. However, both 9- and 13-HODE were observed 
to upregulate Hml, a multi-domain protein that is secreted by haemocytes and is 
involved in clot formation which eventually forms a melanised mass (Lesch et al., 
2007). This could be a reason as to why we saw an increase in tumour incidence in 
Drosophila raised on an omega-6 diet, the precursor of 9- and 13-HODE (Figure 8A). 
It was also shown that both 9- and 13-HODE treated cells showed a marked 
upregulation of ItgαPS5, a marker of lamellocytes (Stofanko et al., 2010). ItgαPS5 is 
an alpha integrin, its specific function has not been characterised though it is most 
likely involved in cell adhesion and have receptor signalling capability. It is uncertain 
whether HODEs do direct differentiation of lamellocytes due to unchanged 
expression with other lamellocyte markers mys, ItgαPS4, cher and Itgβv, though it is 
possible that HODEs can elicit aspects of differentiation given the upregulation seen 
with lz, Hml and He.  
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Omega-3 and -6 fatty acid treated cells showed a significantly higher expression in 
transcript levels of the differentiation markers affected than HODEs. This in part 
could be due to fatty acid treated cells producing more HODEs, increasing the 
concentration above that at which we used to treat the HODE treated cells. Therefore 
eliciting a greater effect on transcript levels of differentiation markers. It is possible 
that other unknown immuno-inflammatory mediators are synthesised from the omega 
fatty acids and exerting an effect on gene transcript expression. An example could be 
dinor isoprostanes that have been documented in plants. These are C18 
prostaglandin-like molecules that are formed from α-linolenic acid and have immuno-
modulatory effects (Parchmann, 1998).  
All cell treatments affected the gene transcript levels of the three housekeeping 
genes we assayed, RpL32, Gapdh2, and α-Tubulin. Housekeeping genes are used 
to normalise gene transcript levels because their levels of expression do not change 
dramatically. With omega fatty acid treatment, notably omega-6 fatty acid treated 
cells; both RpL32 and Gapdh2 transcript levels were considerably increased. We 
assume that there is an increase in protein translation and metabolic activity because 
RpL32 is involved in protein translation and Gapdh2 is involved in the glycolysis 
pathway. It is not surprising that there would be an increase in metabolic activity as 
the cells actively uptake the supplemented fatty acids which in turn requires energy, 
especially if protein synthesis is increased. By staining omega fatty acid treated cells, 
we confirmed that an increase seen in gene transcript levels of He, resulted in 
increased protein expression, as the cells stained stronger for He than the control. 
This suggests that an increase in gene transcript level results in an increase of 
protein level, adding strength to the increased protein translation that RpL32 
indicates.  
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To conclude, we have confirmed that AA, EPA and DHA are not present in 
Drosophila and that they are unable to elongate carbon fatty acid chains beyond 
C18. We validated the absence of PGs through non-detection of PGE2, PGF2α and 
PGD2 using LC-MS. We were able to detect two C18 derivatives of linoleic acid, 9- 
and 13-HODE. LC-MS chiral analysis established HODEs were enzymatically 
produced and the level of which could be increased by linoleic acid supplementation. 
We were unable to conclude HODEs as being a ligand for the Drosophila 
PPARγ homologue Eip75b. However, we have identified haemocyte differentiation 
markers that HODEs upregulate possibly leading to a particular differentiation cell 
lineage.  
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3.3 Functional characterisation of the MPO/COX candidates Pxt, 
Pxn and Irc 
 
We had identified three potential MPO/COX enzymes Pxt, Pxn and Irc that reduced 
inflammatory tumour incidence when deleted. We speculated that these enzymes 
have MPO/COX activity and were the source of the inflammatory mediators that 
exacerbated the inflammatory phenotype. LC-MS analysis had shown the absence of 
the pro-inflammatory mediator PGs. However, detection of the inflammatory linoleic 
derivatives HODEs revealed the enzymatic S-enantiomer to be the most prominent 
indicating an enzymatic route to their synthesis. Given the findings, and the 
speculation from previous studies that Pxt (one of our candidates) was involved in 
PG synthesis (Tootle and Spradling, 2008; Groen et al., 2012), it was vital to 
establish conclusively whether our candidate enzymes had functional COX and MPO 
activity. We cloned the Drosophila MPO/COX candidates, as well as the mammalian 
COX-1 and COX-2 enzymes and made recombinant fusion proteins to elucidate their 
in vitro activity. We sought to clarify if they can or cannot utilise AA by 
cyclooxygenase activity and whether they could use hydrogen peroxide as a 
substrate to determine peroxidase activity. The recombinant protein can also be used 
to assay for PG and HODE production.  
3.3.1 IPTG induction of GST fusion recombinant protein in a bacterial 
expression system 
We initially cloned the Drosophila MPO/COX candidates and mammalian COXs into 
a GST fusion expression vector pGEX-2T, and overexpressed the GST-tagged 
recombinant protein in E. coli using Isopropyl β-D-1-thiogalactopyranoside (IPTG). 
The pGEX-2T vector utilises the well-characterised lac operon inducible system 
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(Müller-Hill, 1996). In an un-induced state, binding of a repressor to the operator 
prevents RNA polymerase elongation and thus the gene of interest is not transcribed 
(Figure 20A). In the presence of IPTG, it binds to the repressor resulting in a 
conformational change causing it to disassociate from the operator, allowing RNA 
polymerase to elongate and transcribe the gene. Overexpression using this system 
resulted in significant overexpression of our recombinant proteins. Analysis of 
induced proteins using whole lysates from cells revealed that the proteins of interest 
were overexpressed abundantly (Figure 20B). However, the majority of this protein 
was shown to be insoluble, as protein was present in cell pellets when the extracts 
were centrifuged to pellet insoluble material (Figure 20B). Subsequent modification of 
the induction and lysis procedures failed to have any significant effect on recovery of 
soluble protein. The insoluble nature of the protein was likely due to the absence of 
correct post-translational modification machinery in the bacteria. As we needed 
functional soluble protein for assaying, we used a mammalian expression system in 
the hope that the correct posttranslational modifications would be added to over-
expressed protein to ensure soluble protein.  
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Figure 20. IPTG induction of recombinant protein using the lac operon 
inducible system 
The candidate MPO/COX enzymes Pxn, Pxt, and Irc as well as the mammalian 
COX-1 and COX-2 controls were overexpressed in E.coli using the lac operon 
inducible system. (A) A repressor that binds to the operator prevents RNA 
polymerase elongation, inhibiting transcription of the target gene. In the presence of 
IPTG (the inducer), it binds to the repressor relieving inhibitor and allowing RNA 
polymerase to transcribe. (B) Induced cells were analysed for recombinant protein 
using SDS-PAGE. Both the whole cell lysate and soluble fraction were analysed. The 
absence of protein in the soluble fraction indicated the protein was insoluble.  
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3.3.2 Doxycycline induction of FLAG-tagged recombinant protein using the Tet-
On 3G inducible expression system 
A Tet-On 3G inducible expression system was used to overexpress the recombinant 
proteins in HeLa cells. The genes of interest were sub-cloned from the pGEX-2T 
vector and ligated into a pTRE3G expression vector that was engineered to have a 
3xFLAG tag that resulted in expression of FLAG-tagged fusion protein. The Tet-on 
3G inducible system works by overexpressing a pTRE3G transactivator that is non-
functional until the addition of doxycycline (Dox), which binds to the transactivator 
resulting in a conformational change of the transactivator, which allows it to then bind 
to tet operator located in the pTRE3G promoter upstream of the gene of interest 
(Figure 21A). Binding of the transactivator to the pTRE3G promoter initiates 
transcription of gene. Overexpression of recombinant protein was achieved by 
induction of Dox in HeLa cells. Subsequent FLAG-affinity purification revealed 
overexpression of soluble protein for each gene of interest by western blot (Figure 
21B). To ensure purification was specific to FLAG, non-transfected HeLA cells were 
used as a control. The overexpression of soluble recombinant protein allowed for in 
vitro assays to distinguish the activity of the Drosophila candidate MPO/COX 
homologues. Mammalian COX-1 and COX-2 were cloned and overexpressed in the 
same way to provide an internal control to compare the activity of Drosophila 
recombinant protein.  
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Figure 21. Dox induction of recombinant protein using the Tet-On 3G inducible 
system 
The candidate MPO/COX enzymes Pxn, Pxt, and Irc as well as the mammalian 
COX-1 and COX-2 controls were overexpressed in HeLa cells using the Tet-On 3G 
inducible system. (A) An overexpressed transactivator is activated when bound to 
doxycycline (Dox) resulting in a conformational change. The activated transactivator 
bound to Dox then binds to a tet operator sequence in the pTRE3G promoter 
sequence and elicits transcription of the downstream gene. (B) Purified FLAG-tagged 
fusion protein was visualised by western using anti-FLAG antiobodies. Non-
transfected HeLa cells were used as a control. 
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3.3.3 Determining cyclooxygenase activity of Drosophila Pxn, Pxt and Irc in 
vitro 
Purified recombinant FLAG-tagged protein enabled us to characterise the in vitro 
activity of the MPO/COX candidates Pxn, Pxt and Irc. We first tested whether these 
enzymes display in vitro COX activity. Although we found that flies lack PGs, we had 
observed that COX inhibitors suppress inflammatory tumours incidence suggesting 
that COX-like activity may be present, even if the precursors of PGs are not. We 
used a fluorometric COX activity assay to determine if the MPO/COX candidates we 
identified were capable of COX activity. As mentioned previously, the synthesis of AA 
to PGs is a two-step process. COX utilises AA to produce a first endoperoxide 
intermediate PGG2 through cyclooxygenase activity, which is then converted to the 
PG precursor PGH2 via peroxidase activity. The fluorometric assay monitors the 
peroxidase step that converts PGG2 to PGH2, by using ADHP (10-acetyl-3,7-
dihydroxyphenoxazine), a peroxidase substrate that reduces PGG2 to PGH2, and in 
doing so, ADHP is converted to fluorescent resorufin, which can be measured. As 
shown in Figure 22A, we observed significant COX activity from the three Drosophila 
MPO/COX candidates. The activity was comparable with that seen with the COX-1 
and COX-2 internal standards, and the COX-1 standard provided with the kit (Figure 
22A). We showed that COX activity required AA addition as only basal COX activity 
was detected without the addition of AA. This suggested that the Drosophila 
candidates were able to utilise AA and possess cyclooxygenase activity.  
To further clarify the presence of peroxidase activity and the candidate MPO/COX 
enzyme’s ability to utilise hydroperoxides, we assayed peroxidase activity using 
hydrogen peroxide. The fluorometric assay used above was modified in that 
hydrogen peroxide was added as a substrate rather than AA. This directly assays 
peroxidase activity. We observed significant peroxidase activity with the addition of 
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hydrogen peroxide (H202) (Figure 22B). The activity seen was similar across all the 
enzymes assayed. It was shown that addition of an MPO inhibitor markedly inhibited 
all peroxidase activity. The results suggested that Pxn, Pxt and Irc could utilise 
hydrogen peroxide as a substrate and that they have peroxidase activity, which can 
be inhibited by an MPO inhibitor. 
                       
Figure 22. Fluorometric assay determining COX and MPO activity  
(A) A fluorometric assay was used to measure COX activity of the three Drosophila 
MPO/COX candidates and mammalian COX-1 and COX-2 enzymes with the addition 
of AA. The assay monitors the peroxidase step that converts PGG2 to PGH2 by using 
ADHP (10-acetyl-3,7-dihydroxyphenoxazine), a peroxidase substrate that is used to 
reduce PGG2 to PGH2 and in doing so, is converted to the highly fluorescent 
resorufin, which can be measured. (B) Peroxidase activity and the utilisation of 
hydroperoxides, using hydrogen peroxide was measured. In this assay, hydrogen 
peroxide is reduced by ADHP converting it to fluorescent resorufin and converting 
hydrogen peroxide to two molecules of water and an oxygen molecule. MPO 
Inhibitor-1 was used to measure inhibition of peroxidase activity. n=5 
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3.3.4 Discussion 
We have shown that the MPO/COX candidates Pxn, Pxt and Irc that were highlighted 
for their amino acid sequence similarity to mammalian COX, can utilise AA to 
produce the PG precursor PGH2, indicating that they possess COX activity in vitro. 
The detection of COX activity from the Drosophila candidate enzymes suggests that 
they are able to emulate the actions of COX-1 and -2. It is an indication that the 
candidates must be able to radicalise a residue to initiate the COX reaction. 
Consistent with this, the Tyr385 residue that is radicalised to abstract the C13 
hydrogen from AA is conserved in Pxn, Pxt and Irc (Rogge et al., 2006; Wu et al., 
2011). We further demonstrated that the Drosophila candidates could utilise 
hydrogen peroxide as a substrate by their peroxidase activity, the second step to 
forming the PGH2 precursor to PGs. MPO activity of the candidates was successfully 
inhibited by MPO Inhibitor-1, suggesting the reduction in tumour incidence seen with 
MPO Inhibitor 1 from the tumour assay potentially was due to inhibition of Pxn, Pxt 
and Irc in producing pro-inflammatory mediators.  
Interestingly, although Pxn, Pxt and Irc can utilise AA in vitro, our LC-MS data 
showed that AA is not present in vivo. Although these enzymes have COX activity, 
the absence of precursor results in absence of PGs. It is likely that the Drosophila 
candidate MPO/COX enzymes can oxygenate a number of fatty acid substrates. 
Although mammalian COX-1 and -2 preferentially oxygenate AA, they also can 
oxygenate a number of substrates, though less efficiently (Laneuville et al., 1995). 
COX-2 is well documented as the most promiscuous in its oxygenation of substrates 
due to differences in the residues found in the substrate-binding pocket compared to 
COX-1 (Vecchio et al., 2012). In particular COX-1 and COX-2 can oxygenate linoleic 
acid to generate 9- and 13-HODE. We would suggest that Pxn, Pxt, and Irc are also 
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substrate promiscuous, and although AA is not found in vivo, this would explain why 
they could utilise AA in vitro. 
The recombinant protein of the Drosophila MPO/COX candidates allows for an 
additional in vitro experiments to be conducted. As of yet, we have only partially 
characterised the enzymes. We suspect that incubation of the candidate enzymes 
with linoleic acid would result in production of HODEs. Given that HODEs are known 
to be synthesised from COX-1 and COX-2 (Vecchio et al., 2012), this would provide 
a route for enzymatic HODE production in Drosophila. Considering inhibition of COX 
has been shown to prevent the production of HODEs (Engels et al., 1991), this could 
explain why a reduction in tumour incidence was seen with both non-specific and 
specific COX-1 and -2 inhibitors in our tumour assay. 
In conclusion, we have shown that the Drosophila MPO/COX candidates have 
cyclooxygenase and peroxidase activity. In vitro they are able to utilise AA to produce 
the precursor to PGs, PGH2. Due to absence of AA in vivo, we speculate that like 
mammalian COX enzymes, the Drosophila candidates can oxygenate C18 
substrates. These data suggest that the absence of PGs in vivo is not due to 
absence of COX activity, but rather, the absence of the C20 precursor AA. We 
speculate the Drosophila candidates Pxn, Pxt and Irc to be the source of HODEs.  
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3.4 In vivo characterisation of Pxn, Pxt, and Irc 
 
We have shown that inflammatory tumour number can be reduced with the use of 
MPO and COX inhibitors. MPO/COX-like Drosophila candidate deletions have also 
reduced inflammatory tumour incidence. These candidates, Pxn, Pxt and Irc have 
been observed to have MPO and COX activity by in vitro characterisation, suggesting 
a role in producing lipid immuno-modulators. Lipid mediators are well known to be 
involved in numerous homeostatic functions within animals, and are especially 
important during inflammation to aid combat infection and mediate tissue repair 
(Pentland and Needleman, 1986; Goldmann et al., 2010). Our data suggests that the 
Drosophila MPO/COX candidates play a role in producing lipid mediators involved in 
homeostatic functions as well as inflammation. We used deletions of the Drosophila 
candidates Pxn, Pxt and Irc, to determine the affect on the survival of the animals in 
response to a range of stimuli. Longevity of flies raised in standard conditions, after 
being physically stressed (shaken), sterile wounded, and after infection with fungi, 
Gram-positive and a Gram-negative bacteria. We anticipated, that the lack of lipid 
mediator production due to deletion of MPO/COX candidates would have a 
significant impact on survival. 
To reduce levels of Pxt and Irc, we used transposon element insertions for Pxt and 
Irc as was used in the tumour assay. Due to the large size of the chromosomal 
deletion used for Pxn in the tumour assay, we used RNAi driven by a blood specific 
GAL4 line, Hml-GAL4 to ablate Pxn, which is predominantly expressed in blood cells. 
RT-PCR verified knockdown of Pxn by over 10 fold. The GAL4 driver Hml-GAL4 
alone was used as a control for Pxn knockdown experiments, and w1118 was used for 
Pxt and Irc.  
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3.4.1 The effect of Pxn, Pxt, and Irc knockdown on Drosophila ageing and 
survival in response to sterile wounding 
We first assayed longevity of MPO/COX knockdown strains in response to three 
different sterile stimuli. To assay longevity, Drosophila strains were aged for 3-5 days 
and incubated at 25°C throughout the assay, and survival recorded every 24 hours. 
We first measured the effects of the MPO/COX candidate knockdowns on longevity 
while the flies were raised in standard control conditions. We observed a 33% 
reduction in longevity with the Pxt knockdown (Figure 23). Whereas reduction of Irc 
and Pxn were shown to significantly increase the longevity of the Drosophila by 28% 
and an impressive 48% with Pxn knockdown compared to the controls. In contrast, 
when flies were shaken in a sterile petri dish for 10 seconds and then raised in 
control conditions, both Irc and Pxn deficient flies were strongly affected (Figure 23). 
Pxn showed a 13.8% reduction in survival, and Irc was the most effected having a 
37% reduction in longevity compared to controls. Pxt on the other hand although 
showed a significant reduction in survival compared to the w1118 control, its survival 
was comparable to that seen with Pxt knockdown in the ageing assay. When fly 
strains were wounded between the A4-A5 dorsal abdominal tergites with sterile 
1xPBS, we observed all three deletions to have reduced survival compared to the 
controls (Figure 23). The sterile longevity assays suggest removal of Pxn and Irc can 
be beneficial in control conditions, but are required when the fly is subjected to stress 
damage and wounding. In contrast flies with reduced Pxt levels show equivalent 
reduction in survival in all three assays, indicating a potential important homeostatic 
role that is fundamental to the fly’s survival.  
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Figure 23. The effect Pxn, Pxt, and Irc knockdown on Drosophila ageing and 
survival in response to sterile wounding 
Kaplan Meier graphs showing the survival of male Drosophila deficient in the MPO/COX 
candidates were assayed for longevity. The transposon element insertions Pxtf05258 and 
IrcMB11278 were used to delete Pxt and Irc. For Pxn, the UAS-Pxn RNAi line driven by UAS-
Dcr2, Hml-GAL4 was used to knockdown Pxn.  w1118 and UAS-Dcr2, Hml-GAL4 (alone) were 
used as controls. The mutants were assayed under normal control conditions to determine 
effects on longevity. The shaken assay was conducted by shaking flies for 10 seconds in a 
sterile petri dish and then raised in normal control conditions. The wounding assay was 
conducted using a fine sterilised platinum needle, which was used to wound flies between 
the A4-A5 dorsal abdominal tergites with sterile 1xPBS. Wounded flies were then raised in 
standard control conditions. Flies were assayed for survival every 24 hours. 5 groups of 50 
flies were assayed for each strain and the mean survival calculated per point. Kaplan Meier 
graphs were generated using SPSS. 
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3.4.2 The effect of Pxn, Pxt, and Irc knockdown on survival in response to 
infection  
It was anticipated that Pxn, Pxt and Irc would be fundamental in the response to an 
infection as the synthesis of immuno-modulator lipid mediators is important to 
orchestrate the clearance of pathogen and initiating tissue repair. Thus, knockdown 
of these genes would be expected to have a significant affect on the survival of the 
animal in response to infection. To determine whether Pxn, Pxt and Irc are required 
during an infection, we monitored survival of knockdown strains in response to 
Drosophila pathogens. We assayed three pathogen groups, fungi, Gram-negative 
and Gram-positive bacteria. Beauveria bassiana is an entomopathogenic fungal 
pathogen of Drosophila that infects Drosophila when its spores attach to the cuticle of 
the fly, and uses proteases to penetrate the fly (Bidochka and Khachatourians, 1994; 
Joshi et al., 1995). We grew B.bassiana on potato and carrot agar plates for 3 days 
at which point peak sporulation occurs. The Drosophila strains were shaken gently 
over the cultured plate for 10 seconds to infect them with spores, and then raised 
under normal control conditions. As a control, flies were shaken over sterile potato 
and carrot agar plates.  
We observed that infection of flies with B.bassiana strongly reduced survival of the 
Pxt mutant by 73% compared to infected w1118 (Figure 24A). Irc also showed a 
reduction in survival of 45%. Surprisingly, the Pxn mutants had an increased survival 
upon infection of 22% compared to the infected control line. Although Pxn mutants 
initially died faster than the uninfected Pxn mutants, by day 42 both the infected and 
uninfected Pxn mutants displayed identical survival.  RT-PCR analysis of w1118 
infected, and non-infected flies revealed that B.bassiana infection does not affect Pxn 
and Pxt transcript levels (Figure 24B). However, Irc was slightly upregulated in 
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infected flies suggesting that induction of Irc expression may play a role in the ability 
of the fly to overcome an infection.  
 
        
Figure 24. The effect of B.bassiana infection on Pxn, Pxt, and Irc mutant 
survival 
Kaplan Meier graphs showing the survival of male Drosophila deficient in the MPO/COX 
candidates were assayed for longevity after infection with B.bassiana. The transposon 
element insertions Pxtf05258 and IrcMB11278 were used to delete Pxt and Irc. For Pxn, the UAS-
Pxn RNAi line driven by UAS-Dcr2, Hml-GAL4 was used to knockdown Pxn. w1118 and UAS-
Dcr2, Hml-GAL4 (alone) was used as controls to compare survival to. (A) The flies were 
shaken on a 3-day-old B.bassiana plate for 10 seconds and then raised under normal control 
conditions. Control flies were shaken on a sterile potato and agar plate. Longevity was 
assayed every 24 hours. (B) Five w1118 control and five B.bassiana infected flies were 
collected for RNA extraction after 0, 1, 2, 3, 4, and 5 days, cDNA synthesised and Pxn, Pxt 
and Irc transcript levels measured against RpL32. 5 groups of 50 flies were assayed for each 
strain and the mean survival calculated per point. Kaplan Meier graphs were generated using 
SPSS. 
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Pseudomonas entomophila, an entomopathogenic Gram-negative bacterium that is 
highly pathogenic to Drosophila (Vodovar et al., 2005), was used to elucidate 
whether deletions in Pxn, Pxt and Irc affected the survival of the fly in response to a 
Gram-negative pathogen. It is not entirely understood how P.entomophila infects and 
causes the eventual death of Drosophila. It is thought that secretion of insecticidal 
toxins such as PSEEN2485 and PSEEN2697 play a significant role in the process 
(Vodovar et al., 2006). We cultured P.entomophila on agar containing 10% non-fat 
dried milk and pathogen colonies were selected by its protease activity. A liquid 
culture was subsequently made, and a working stock of OD0.1 was used to wound the 
different Drosophila strains. As a control, flies were also wounded with 1xPBS and 
both infected and non-infected flies were raised in normal control conditions and the 
survival assayed every 6 hours.  
We observed, as expected that all Drosophila strains were affected by infection with 
P.entomophila compared to non-infected. Curiously, we observed that Pxn, Pxt and 
Irc deletions, although sensitive to pathogen, survived significantly longer than the 
wild type w1118 and UAS, Dcr2 flies (Figure 25A). Both Pxt and Irc mutant flies 
survived 33 hours longer than w1118 infected flies, whereas Pxn mutant flies survived 
even longer, having an increase in longevity by 156 hours. RT-PCR analysis 
confirmed that Pxn, Pxt and Irc were induced during infection of w1118 (control) flies 
(compare infected to non-infected flies in Figure 25B). Irc and Pxt transcript levels 
were induced 9-fold while Pxn transcript levels were increased 4-fold. The data 
suggests that production of Pxt, Irc and especially Pxn may be detrimental to the fly’s 
survival during an infection of P.entomophila, as knockdowns increase survival 
compared to control flies. 
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Figure 25. The effect of P.entomophila infection on Pxn, Pxt, and Irc mutant 
survival 
Kaplan Meier graphs showing the survival of male Drosophila deficient in the MPO/COX 
candidates were assayed for longevity after infection with the Gram-negative bacterium, 
P.entomophila. The transposon element insertions Pxtf05258 and IrcMB11278 were used to delete 
Pxt and Irc. For Pxn, the UAS-Pxn RNAi line driven by UAS-Dcr2, Hml-GAL4 was used to 
knockdown Pxn. w1118 and UAS-Dcr2, Hml-GAL4 (alone) was used as controls to compare 
survival to. (A) The flies were wounded with P.entomophila of an OD0.1 using a sterile 
platinum needle and then raised under normal control conditions. Control flies were wounded 
in the same way, but with sterile 1xPBS. Longevity was assayed every 6 hours. (B) Five 
w1118 control, and five P.entomophila infected flies were collected for RNA extraction after 0, 
6 and 12 hours, cDNA synthesised, and Pxn, Pxt and Irc transcript levels measured against 
RpL32. 5 groups of 50 flies were assayed for each strain and the mean survival calculated 
per point. Kaplan Meier graphs were generated using SPSS. 
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To elucidate if the Drosophila MPO/COX candidates played a role during a Gram-
positive bacterial infection; we observed the effects on the survival of these mutants 
in response to Enterococcus faecalis. E.faecalis is an entomopathogenic bacterium 
and is best characterised for its infection of the bowels, in which Drosophila have 
been used extensively as a model for mammalian gut infection (Apidianakis and 
Rahme, 2011). E.faecalis was cultured, and a working stock of OD10 was used to 
wound the different Drosophila strains. Non-infected flies were wounded in the same 
way but with sterile 1xPBS. Both infected and non-infected flies were assayed for 
survival every 24 hours.  
In infecting with E.faecalis, we observed a similar trend seen with P.entomophila 
infection. All three MPO/COX candidate mutants showed increased survival 
compared to wild type. Pxn, Pxt and Irc each survived an extra four days compared 
to wild type (Figure 26A). Wild type survival plummets during the first three days of 
infection, whereas the reduction in survival of MPO/COX candidate mutant’s is more 
gradual. RT-PCR analysis of E.faecalis w1118 infected and non-infected flies revealed 
that Irc expression was induced by 9-fold in control wounding, and 16-fold after 
infection (Figure 26B). However, Pxn induction was 5-fold higher in un-infected flies 
than seen with E.faecalis infected Drosophila. This may not be surprising, because 
Pxn itself is secreted from blood cells and is involved in tissue genesis (Bhave et al., 
2012). Conversely, Pxt induction was largely variable for both infected and sterile 
wounded wild type flies. The results suggest Irc and Pxn may play a role in 
overcoming Gram-positive bacterial infections. However, it is difficult to disentangle 
whether the induction is a response to the infection, or simply a response to the 
wounding. 
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Figure 26. The effect of E.faecalis infection on Pxn, Pxt and Irc mutant survival 
Kaplan Meier graphs showing the survival of male Drosophila deficient in the MPO/COX 
candidates were assayed for longevity after infected with the Gram-positive bacterium, 
E.faecalis. The transposon element insertions Pxtf05258 and IrcMB11278 were used to delete Pxt 
and Irc. For Pxn, the UAS-Pxn RNAi line driven by UAS-Dcr2, Hml-GAL4 was used to 
knockdown Pxn.  w1118 and UAS-Dcr2, Hml-GAL4 (alone) was used as controls to compare 
survival to. (A) The flies were wounded with E.faecalis of an OD10 using a sterile platinum 
needle and then raised in normal control conditions. Control flies were wounded in the same 
way, but with sterile 1xPBS. Longevity was assayed every 24 hours. (B) Five w1118 control, 
and five E.faecalis infected flies were collected for RNA extraction after 0, 1, 2, 3, and 4 
days, cDNA synthesised, and Pxn, Pxt and Irc transcript levels measured against RpL32. 5 
groups of 50 flies were assayed for each strain and the mean survival calculated per point. 
Kaplan Meier graphs were generated using SPSS 
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3.4.3 Discussion 
Lipid inflammatory mediators are an important part of immunity especially in 
response to an infection or tissue damage. We anticipate that deletion of Drosophila 
MPO/COX homologues would have severe effects on the survival of the flies. This in 
part would be due to their inability to produce lipid mediators that are required for 
actions such as activating macrophages and chemotaxis of blood cells. We observed 
variable effects between Pxn, Pxt and Irc mutants using different assays. 
Pxt mutant flies showed a reduction in survival in the absence of infection. This 
suggested that Pxt has a homeostatic function that is fundamental to the survival of 
the fly. In contrast, Pxt knockdown increased the fly’s survival during both Gram-
negative and Gram-positive bacterial infection compared to infected control, but was 
severely affected during fungal infection. An explanation for the weak survival seen in 
the Pxt mutant could be due to actin defects. It has been shown that Fascin-1, an 
actin bundling protein is a downstream target of Pxt (Groen et al., 2012). Fascin-1 is 
regulated by downstream pathways of PGs (Adams and Schwartz, 2000; Yamakita, 
1997), which Pxt is believed to synthesise, but we have shown PGs to be absent in 
Drosophila, so it is possible that Pxt mediates Fascin-1 through a C18 lipid mediator 
such as HODEs. Pxt mutants share identical phenotypes to Fascin-1 mutants, 
whereby actin remodelling is largely affected, showing a reduction in actin bundling. It 
is possible that the effects seen with actin remodelling in Pxt mutants are the reason 
for its poor survival (Groen et al., 2012). Fascin-1 is involved in the formation of 
lamellipodia that is required for cell motility (Adams, 1997). It is possible that in the 
Pxt mutants, given the lack of actin bundling, there could be reduced haemocyte 
motility, rendering them inert and unable to help clear infection and repair tissue 
damage. Actin-remodelling dysfunction could also explain why there is a severe 
reduction in survival with B.bassiana infection. Due to reduction in actin bundling, it is 
128 
 
possible that there is a defect in the basement membrane, allowing the hyphae of the 
fungus to penetrate more easily.  
Reduction in Pxn levels significantly increased longevity of the fly in standard control 
conditions. Survival analysis revealed Pxn could be involved in tissue repair 
responses because survival of the Pxn mutants was greatly reduced during shaken 
and wounded assays. During the shaken and wounding assay, extensive tissue 
damage is inevitable; the inability for the fly to repair this could lead to its reduced 
survival. Pxn mutants have been observed to have disordered collage IV networks, 
an important component of the basement membrane, that is strengthened by 
sulfilimine bonds (Vanacore et al., 2009). Pxn has been shown to form sulfilimine 
bonds through the generation of hypohalous acids, highlighting a role in tissue 
biogenesis (Bhave et al., 2012). It is therefore possible that while Drosophila may 
survive longer without Pxn, if Drosophila encounters tissue damage, their ability to 
repair the damage is compromised resulting in a reduced survival. Pxn was induced 
during control wounding, which would also add to the theory that it is involved in 
tissue repair. Pxn may play an active role in the immune response towards both 
Gram-negative and Gram-positive bacteria due to its induced expression during 
infection of these pathogens. However, it is unclear why Pxn deletion results in an 
increase in survival in response to fungal infection, especially as it was not induced 
during this infection.  
As with Pxn, we expect Irc mutants are involved in tissue damage responses as we 
observed an increased longevity during standard control conditions, but was reduced 
when shaken and sterile wounded. It suggested that the animals were unable to heal 
and therefore lead to an increased mortality. We had shown that all three MPO/COX 
candidates have MPO activity. MPO can convert hydrogen peroxide into several 
different toxic species, the major oxidant being hypochlorous acid (HOCL) (Spickett 
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et al., 2000). MPO is upregulated during infection to produce the toxic products to aid 
in pathogen killing (Christensen & Rothstein, 1985). It is likely that Pxn, Pxt and Irc 
have a similar role as we observed induction of these in response to both bacterial 
infections. We suggest that during these infections, wild type flies die faster because 
of a rapid acute surge in the production of highly reactive species. Although the 
reactive compounds are produced to combat infection, they are extremely damaging 
to the hosts tissues (Bergamini et al., 2004).  
During infection, hydrogen peroxide is actively released by blood cells as a means to 
kill the pathogen (Babior, 1984). As part of a feedback loop, PG production is 
induced by hydrogen peroxide during infection (Murthy et al., 1990). An increase in 
survival of Pxn, Pxt and Irc during bacterial infections could therefore be due to a lack 
of lipid-mediator production. It is possible that in the wild type, lipid mediators are 
induced by either hydrogen peroxide or by other means, to create a potent immune 
response that overwhelms the fly, resulting in reduced longevity.  
To conclude, our results have shown an interesting insight into the role Pxn, Pxt and 
Irc play during Drosophila longevity and infection. We believe that they are involved 
in immune responses that are potentially mediated through the production of lipid 
mediators such as HODEs. For instance, although it is claimed actin dysregulation is 
mediated through PG signalling in Drosophila, it is possible that it is actually HODEs 
mediating actin remodelling. Further clarification is needed to establish whether lipid 
mediators such as HODEs are involved in immune responses against pathogens.  
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4. Discussion 
 
Inflammatory disease is on the rise due to a combination of lifestyle, environment and 
genetic predisposition. Inflammatory diseases have extensive affects on health and 
economic costs. For example, cardiovascular disease (CVD) alone, is responsible for 
40% of all deaths in the EU and costs the EU economy approximately €196 million 
per year (European Society of Cardiology). There is a requirement for new 
therapeutic targets to be developed and in vivo models that can be used to dissect 
underlying inflammatory mechanisms. Mouse models are currently the go-to for in 
vivo modelling of inflammatory diseases such as atherosclerosis and rheumatoid 
arthritis (Daugherty, 2002; Asquith et al., 2009). We believe Drosophila could be a 
useful genetically tractable, cheap alternative tool in aiding inflammatory research. 
Consistent with other inflammatory models that rely on a mutant background to 
initiate an inflammatory insult that can be used to disentangle mechanisms that 
regulate the phenotype, such as the apolipoprotein deficient mouse used to study 
atherosclerosis (Meir and Leitersdorf, 2004), we too have used a mutant Drosophila 
model that provides an extremely useful model for inflammation. We had used the 
hopTum mutant in a similar way to initiate an inflammatory response, by over-
stimulating the JAK/STAT pathway resulting in the formation of an inflammatory 
melanotic tumour (an aggregation of blood cells) (Harrison et al., 1995). This 
phenotype aided us in identifying downstream lipid mediators and the presence of 
MPO and COX activity. 
Prostaglandins have been at the forefront of the inflammatory field due to their 
involvement in inflammation (Ricciotti and FitzGerald, 2011). This in part was fuelled 
by the discovery of aspirin’s (a non-steroidal anti-inflammatory drug) actions, which 
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alleviates inflammation through inhibiting COX and preventing production of 
prostaglandins (Vane, 1971). COX soon became a popular therapeutic target for 
inflammation. However, prostaglandins were soon discovered to have a wide range 
of homeostatic functions that are fundamental to an animal’s health. Inhibition of 
COX, although reduces inflammation, it impinges on the housekeeping functions of 
prostaglandins resulting in adverse affects particularly seen with COX-2 inhibition 
(Wong et al., 2005).  
The existence of prostaglandins in other systems has been expected due to the 
numerous functions of prostaglandins. There has been much speculation of the 
presence of prostaglandins and arachidonic acid (AA) in invertebrates, including 
Drosophila. We have clarified that Drosophila lack AA, the important rate determining 
fatty acid of eicosanoid production (Norman, 2000). We have shown that Drosophila 
lack the ability to elongate beyond C18 fatty acids, but it is possible that Drosophila 
need to acquire AA through their diet as do cats (Bauer, 2007). The fact that AA is 
detected in Drosophila raised on AA supplemented media, and that they are able to 
convert C22 fatty acids into AA gives light to a possible dietary requirement (Shen et 
al., 2010). We believe this is not true, because our LC-MS data validated the distinct 
lack of PGE2, PGD2 and PGF2a, the derivatives of AA. The lack of PGs in 
Drosophila is contrary to previous studies that have suggested PGs have 
physiological roles in flies (Groen et al., 2012; Tootle and Spradling, 2008; Carton et 
al., 2002).  
It is likely that the physiological roles PGs have been attributed to in Drosophila is 
actually through C18 fatty acid derivatives. We have shown that flies have hydroxy-
octadecadienoic acids (HODEs), 9- and 13-HODE in which the enzymatic S form is 
the most abundant. HODEs have been documented to have immuno-modulatory 
effects and have been most studied in atherosclerosis (Vangaveti et al., 2010; 
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Waddington et al., 2003; Henricks et al., 1991). They are produced by COX, and 
inhibition of COX reduces levels of HODEs (Engels et al. 1991). We find that 
treatment of hopTum flies with COX inhibitors reduces the inflammatory phenotype. 
Although HODEs are the most abundant oxidation product found in plaques 
(Waddington et al., 2003), their role in atherosclerosis is not well characterised. 
Drosophila provides an excellent model system to study the downstream targets of 
HODEs and to dissect their actions and molecular mechanisms. What now makes 
Drosophila an ever better model, is that they lack C20 lipid mediators that often 
overshadow the effects of C18 lipid mediators in mammals.  
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5. Conclusion 
 
In this work, we have used the hopTum Drosophila mutant as a model to elucidate 
downstream lipid mediator signals that are involved in inflammation. The hopTum 
mutant initiates an initial inflammatory insult through constitutive activation of the 
JAK/STAT pathway that results in an inflammatory melanotic tumour (aggregation of 
blood cells). This phenotype aided in assaying for enhancers and suppressors of the 
inflammatory phenotype.  
We have shown that dietary supplementation of polyunsaturated fatty acids, linoleic 
acid and α-linolenic acid affects tumour incidence, whereby α-linolenic acid was 
shown to suppress the effects of linoleic acid. In contrast, supplementation with 
saturated fat and cholesterol had little effect on the tumour incidence. The use of 
both non-selective and specific COX-1 and -2 inhibitors as well as MPO-1 inhibitor 
significantly reduced tumour number suggesting the presence of MPO or COX 
activity. We identified three Drosophila proteins that were homologous to COX-1, 
COX-2 and MPO, namely Pxn, Irc and Pxt. Deletions of these genes showed 
substantial reduction in the incidence of inflammatory tumour number. We have 
shown that the liberation of free fatty acids i.e. the precursors to lipid inflammatory 
mediators is through a combination of PLC and sPLA2 hydrolysis.  
We used LC-MS to identify that Drosophila lack AA, consistent with other studies, 
showing that Drosophila are unable to elongate fatty acid chains beyond C18.  
Contrary to speculation in the literature, we have shown that Drosophila also lacks 
the prostaglandins PGE2, PGD2 and PGF2. However, we identified 9- and 13-HODE, 
C18 oxygenated derivatives of linoleic acid, and demonstrated that the abundance of 
these could be increased with dietary linoleic supplementation. We showed that 
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HODEs were enzymatically produced given that the chiral S-enantiomer of 9- and 13-
HODE was most dominant. 9-HODE was also shown to be the most abundant in 
Drosophila compared to 13-HODE. We identified a Drosophila PPARγ homologue, 
(Eip75b) as a potential receptor for HODEs. We showed that Eip75b deletion 
reduced tumour incidence, but were not able to demonstrate conclusively that it binds 
9-HODE or 13-HODE.  
In an effort to identify downstream mediators of HODEs and polyunsaturated fatty 
acids, we treated S2 cells with 9- and 13-HODE, as well as omega-3 and -6 fatty 
acids, and showed upregulation of several haemocyte differentiation markers, 
suggesting that HODEs play a role in activating and differentiating cells. Future RNA 
sequencing of 9- and 13-HODE treated cells will provide a larger repertoire of genes 
affected by HODEs.  
Over-expression and purification of Pxn, Pxt and Irc protein revealed that, these 
enzymes demonstrate in vitro cyclooxygenase activity, having the ability to utilise AA 
to produce the prostaglandin precursor PGH2. We also showed that these enzymes 
also possess MPO activity, as they were able to use hydrogen peroxide as a 
substrate. This is compelling evidence to suggest they are able to produce 
oxygenated lipid inflammatory mediators. In future work, we will assay whether these 
enzymes are capable of metabolizing linoleic acid to produce HODEs in vitro.  
Finally, we have shown that deletion of the COX/MPO homologues, Pxn, Pxt and Irc 
has significant effects on the survival of Drosophila both in response to sterile and 
septic wounding. Our data is consistent with Pxn, Pxt and Irc producing lipid 
mediators like HODEs that are fundamental to immune responses and tissue repair.  
Although e lacks the canonical mammalian inflammatory components, arachidonic 
acid and prostaglandins, we believe that Drosophila can be used as a model to 
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elucidate the molecular mechanisms and functions of C18 lipid mediators such as 
HODEs. Drosophila provides an ideal system to investigate function of these families 
of immune-modulatory lipid mediators as they lack C20 lipid mediators, which could 
obscure the function of C18 mediators in mammalian systems. The work shown here 
lays the foundation for these investigations. 
136 
 
 
Figure 27. Summary schematic of findings 
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